Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRP,Agouti-related protein,40058,0.285547693051063,0.00474604752386204,0.276245439904293,0.294849946197832,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL27,C-C motif chemokine 27,39868,0.255229845723903,0.00579526241650304,0.243871131387557,0.266588560060249,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN1,CCN family member 1,39758,0.372022059457604,0.00688931422630959,0.358519003574037,0.385525115341171,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES1,Liver carboxylesterase 1,39854,0.295496346943952,0.00746644278070031,0.28086211909378,0.310130574794125,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,F7,Coagulation factor VII,39899,0.121756970058326,0.00277610879750018,0.116315796815226,0.127198143301427,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,FURIN,Furin,39913,0.126970253849127,0.00317305942685059,0.120751057372499,0.133189450325754,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCG,Pro-glucagon,39477,0.492849494990978,0.0113919102098748,0.470521350979623,0.515177639002332,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHR,Growth hormone receptor,37124,0.109240134281453,0.00266820360399741,0.104010455217618,0.114469813345288,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.286262309831313,0.00712761786199556,0.272292178821801,0.300232440840824,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBC,Inhibin beta C chain,39858,0.155885314429959,0.00388170463487382,0.148277173345606,0.163493455514312,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0890537989083214,0.00200768053333276,0.0851187450629892,0.0929888527536536,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLR,Low-density lipoprotein receptor,39882,0.40904537106079,0.00402087439182779,0.401164457252808,0.416926284868773,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPL,Lipoprotein lipase,39868,-0.183844250863832,0.00440805737591916,-0.192484043320634,-0.17520445840703,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFGE8,Lactadherin,39858,0.242976810546141,0.00384642409910754,0.23543781931189,0.250515801780392,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPY,Pro-neuropeptide Y,40030,0.374238623884016,0.0058037076681758,0.362863356854392,0.385613890913641,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.112845004039183,0.00285707242505964,0.107245142086066,0.1184448659923,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.153693509517963,0.00373480324962826,0.146373295148692,0.161013723887235,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROC,Vitamin K-dependent protein C,39908,0.0956022252904783,0.00241403137826388,0.0908707237890811,0.100333726791876,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.188982459567549,0.00438632675857871,0.180385259120734,0.197579660014363,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.130293675430373,0.00304286062565828,0.124329668604083,0.136257682256664,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF9,Protein turtle homolog A,37437,0.303148985119798,0.00767345515941625,0.288109013007343,0.318188957232254,1.1125369292536e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH,Parathyroid hormone,37039,0.293063777801559,0.00741432579148047,0.278531699250258,0.307595856352861,1.1125369292536e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.151285809019978,0.00399977596600196,0.143446248126614,0.159125369913342,5.55060221379726e-300
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.187711509664986,0.00497462600880858,0.177961242687721,0.197461776642251,1.40551846059609e-298
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.0988549764730467,0.00272580476270691,0.0935123991381412,0.104197553807952,8.00439195402244e-277
NMR metabolomics,X23501.Triglycerides in Large VLDL,APCS,Serum amyloid P-component,37333,0.116796569825397,0.00327111946961243,0.110385175664957,0.123207963985837,7.22815554165653e-267
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADIPOQ,Adiponectin,37453,-0.221604140763915,0.00621155388307342,-0.233778786374739,-0.209429495153091,1.48385624047387e-266
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTR,Transthyretin,37309,0.0839883424066258,0.00236651312312163,0.0793499766853074,0.0886267081279442,8.32720893606307e-264
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPM,Carboxypeptidase M,39955,0.114558660288331,0.00326088146461975,0.108167332617676,0.120949987958985,1.40393602153929e-260
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL23,C-C motif chemokine 23,39931,0.136180037474775,0.00389674975449675,0.128542407955961,0.143817666993589,5.83739504098034e-258
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.272756486287931,0.0078195171416452,0.257430232690306,0.288082739885556,9.01785617136725e-257
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP1,Neuropilin-1,39949,-0.0909476168054617,0.00262237466919101,-0.0960874711570761,-0.0858077624538473,3.12400643218737e-254
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.403700836714808,0.0116436293957421,-0.426522350330463,-0.380879323099154,3.95988777884545e-254
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.276312716261154,0.00801162476171088,0.2606099317282,0.292015500794107,2.44466010151996e-251
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG2,Desmoglein-2,39858,-0.0865634172983452,0.00253081956964568,-0.0915238236548507,-0.0816030109418397,1.59541337979752e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS15,Enteropeptidase,39788,0.288581165078772,0.00844049503441139,0.272037794811325,0.305124535346218,2.68452950404261e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR37,Prosaposin receptor GPR37,39585,0.208341944220107,0.00609956030715238,0.196386806018088,0.220297082422126,9.94008951509526e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCHE,Cholinesterase,37208,0.0885727641277119,0.00259998836826905,0.0834767869259046,0.0936687413295193,5.49209666626877e-244
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.465145349839653,0.0137108874277941,0.438272010481176,0.492018689198129,1.54672138091254e-243
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.276594436941006,0.00823432415180976,0.260455161603459,0.292733712278554,4.65857447002101e-239
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.251155151329163,0.00753725132919932,0.236382138723932,0.265928163934394,2.07785618225829e-235
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.357709720681176,0.0107694278821626,0.336601642032138,0.378817799330215,5.38073981614661e-234
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.32710454690275,0.0101290487766791,0.307251611300459,0.346957482505041,1.12736811595304e-221
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA1,Glutathione S-transferase A1,39841,0.259755396187276,0.00808093970448601,0.243916754366484,0.275594038008069,9.89983950655627e-220
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0859720082292479,0.002677562623413,0.0807239854873584,0.0912200309711373,2.44753074101306e-219
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.187335987750145,0.00592081124287938,-0.198940777786189,-0.175731197714101,3.14612011503306e-213
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.0943763242046561,0.00299444607980848,0.0885072098882315,0.100245438521081,1.42805968237757e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.076589943016335,0.00242513882405031,0.0718366709211964,0.0813432151114736,3.30664107795963e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.230314847485335,0.00731769954190036,0.21597215638321,0.24465753858746,4.29637387900924e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA4,Kallistatin,37241,0.0700697262434025,0.00221932540922866,0.0657198484413143,0.0744196040454907,4.39831648780772e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAT,Tissue-type plasminogen activator,40002,0.148856872447128,0.00472949164625268,0.139587068820472,0.158126676073783,4.44242250239406e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.198902340410509,0.00633496228807716,0.186485814325878,0.21131886649514,5.19537059751488e-210
NMR metabolomics,X23501.Triglycerides in Large VLDL,F9,Coagulation factor IX,39908,0.0543426626262789,0.00173233512519841,0.05094728578089,0.0577380394716677,1.06943021468925e-209
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0865599395047655,0.00277358676909268,0.0811237094373439,0.0919961695721872,1.41871387008797e-207
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFI,Complement factor I,37453,0.0592823953255694,0.00189523599468345,0.0555677327759898,0.0629970578751489,1.81369549700299e-207
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN3,Contactin-3,39858,0.0970706732622988,0.0031150306157059,0.0909652132555152,0.103176133269082,5.09383297432715e-207
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0571893960371071,0.00184050642972016,0.0535820034348556,0.0607967886393586,7.33287566589917e-206
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFM,Afamin,37453,0.0560093591073007,0.00180205798833893,0.0524773254501564,0.059541392764445,5.9558315404445e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA3,Glutathione S-transferase A3,39477,0.226064236270622,0.00729102529208494,0.211773826698135,0.240354645843108,6.9090978914965e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFH,Complement factor H,36763,0.0691851559980411,0.0022324458265574,0.0648095621779886,0.0735607498180937,1.85721366788183e-203
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0933452527038512,0.00302207447035937,0.0874219867419469,0.0992685186657556,1.936578345142e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPIND1,Heparin cofactor 2,37424,0.0820697760628606,0.00267730754194828,0.076822253280642,0.0873172988450793,1.38881976329357e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHBG,Sex hormone-binding globulin,37445,-0.150110638452623,0.00489814564073438,-0.159711003908462,-0.140510272996784,1.6794853079702e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9,Complement component C9,37445,-0.15405189805207,0.00503954403336038,-0.163929404357456,-0.144174391746683,1.56209461559751e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0871445231319956,0.00286077835166092,-0.092751648701251,-0.0815373975627402,4.70209431883065e-197
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0799602614902877,0.00264819026949762,0.0747698085620724,0.085150714418503,7.88464194644849e-195
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIP2,Cysteine-rich protein 2,39749,0.103514451585049,0.00342890844441968,0.0967937910339867,0.110235112136112,1.00407026517084e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY1,Aminoacylase-1,39868,0.177732111083851,0.00589450972014714,0.166178872032363,0.18928535013534,2.61095430058735e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0970311686373694,0.00324789711017499,-0.103397046973312,-0.0906652903014264,6.0598542861578e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0883095961044821,0.00296992376183471,0.082488545531286,0.0941306466776781,3.46221004657607e-189
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0959537982568148,0.0032422280958912,0.089599031188868,0.102308565324762,1.66799190580069e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.16006003697603,0.00540231728254998,0.149471495102232,0.170648578849828,5.44317769415624e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLTP,Phospholipid transfer protein,39976,-0.101148950220879,0.00343626644871825,-0.107884032460367,-0.0944138679813912,1.50607437488398e-185
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.166517184006747,0.00566121943793739,0.155421193908389,0.177613174105104,3.94486504748086e-185
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0685555558232922,0.00233458546759865,0.0639797683067988,0.0731313433397855,7.89346712885446e-184
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFP,Properdin,37453,0.0646910576611116,0.00220642163205504,0.0603664712622838,0.0690156440599395,2.79363048174366e-183
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRP,Gastrin-releasing peptide,37043,0.145463760568483,0.00496400582710569,0.135734309147356,0.15519321198961,6.36523537811275e-183
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP5,Retinol-binding protein 5,39788,0.156124023707192,0.00535175364410755,0.145634586564741,0.166613460849643,2.60476248803157e-182
NMR metabolomics,X23501.Triglycerides in Large VLDL,F10,Coagulation factor X,37445,0.073791133543739,0.00252629794324316,0.0688395895749824,0.0787426775124956,5.87494084005352e-182
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUSB,Beta-glucuronidase,39919,0.163542419026935,0.00561931238267897,0.152528566756885,0.174556271296986,1.60968051473176e-181
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPB1,Beta-ureidopropionase,37437,0.254981941146116,0.00877973763189284,0.237773655387606,0.272190226904626,5.8068792093155e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.101639859674744,0.00350853619527348,-0.10851659061748,-0.0947631287320078,6.84049729050697e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0831588891870621,0.0028906786690927,0.0774931589956404,0.0888246193784838,1.71704421013958e-177
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0530494479491599,0.00184447163717566,0.0494342835402956,0.0566646123580242,2.81378082912499e-177
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.075719803033706,0.00265058204684953,0.0705246622218809,0.0809149438455311,3.96193519284752e-175
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBP,Protein AMBP,40003,0.0527486749272334,0.00185240326523207,0.0491179645273786,0.0563793853270883,4.55608882513267e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.299120454780342,0.0105527344538916,0.278437095250714,0.319803814309969,2.1442095544375e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0763587118317691,0.00270026483977445,-0.081651230917727,-0.0710661927458112,9.97216451476683e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.14139212991338,0.00501579330548609,0.131561175034627,0.151223084792133,1.04384816446027e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYNU,Kynureninase,40058,0.122446725861678,0.00435993206325394,0.1139012590177,0.130992192705656,1.69618894159961e-169
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL16,C-C motif chemokine 16,40052,0.139690983116493,0.00500139478525417,0.129888249337395,0.149493716895591,1.05073850575208e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.22565679985728,0.00807165879613526,0.209836348616855,0.241477251097705,3.00895218214576e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.136261441230703,0.00489918726875561,0.126659034183942,0.145863848277464,3.26971318447341e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH1,Somatotropin,39846,-0.478298590289483,0.0173171326967925,-0.512240170375196,-0.44435701020377,4.44557487056076e-164
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR3,Anterior gradient protein 3,39464,0.155833008899897,0.0056590815023506,0.14474120915529,0.166924808644504,4.89799939991353e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0793791002334495,0.00288720602307901,0.0737201764282147,0.0850380240386844,1.28583226372517e-162
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCA,Alpha-synuclein,37124,0.305626260111623,0.0111051197404343,0.283860225420372,0.327392294802874,3.36728307234401e-162
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOST,Sclerostin,39846,0.100580972693591,0.0036718840339777,0.0933840799869943,0.107777865400187,1.7751802860034e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.065533188906051,0.00240874659124046,0.0608120455872197,0.0702543322248823,2.20146667401739e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.193105632128753,0.00711402841537816,0.179162136434612,0.207049127822894,1.19948021805332e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.142311455949765,0.00524353320795507,0.132034130862173,0.152588781037357,1.44627497182796e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELN,Elastin,37437,0.0871862954785916,0.00321551351478796,0.0808838889896071,0.093488701967576,1.02055053823172e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.153404816824008,0.00566892377259948,-0.164515907418303,-0.142293726229713,1.05134842023945e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO3,Beta-enolase,37043,0.156247895537154,0.00577888830325044,0.144921274462783,0.167574516611525,9.625684336569e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.18630903476903,0.00691788378530576,0.172749982549831,0.199868086988229,3.01474707479682e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKB,Creatine kinase B-type,37437,-0.149967975457396,0.00557194988869791,-0.160888997239244,-0.139046953675548,1.70839846581599e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR2,Cadherin-related family member 2,39788,0.18806969631172,0.00700279003898924,0.174344227835301,0.201795164788139,2.01173092952853e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.178109412273847,0.00664015913839255,0.165094700362598,0.191124124185097,1.86347133661953e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS1,Protein MTSS 1,37382,0.282976057466886,0.0105719963497158,0.262254944621443,0.303697170312329,7.78836906930135e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0851878907036384,0.00321051524330497,0.0788952808267606,0.0914805005805161,7.29144579541544e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.172093995954616,0.00649764021938105,0.159358621124629,0.184829370784603,3.04581253881028e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAB2,Stabilin-2,37437,0.070912771266246,0.00268795789012092,0.065644373801609,0.076181168730883,1.27185320209567e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPC,C-type natriuretic peptide,39866,0.11556597092967,0.00439437839830053,0.106952989269001,0.124178952590339,2.89860504907547e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.216694933279196,0.00825077916033327,0.200523406124943,0.232866460433449,3.11625678807303e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRN,"Attractin, Isoform 2",37453,0.0409153431636523,0.00156188564128156,0.0378540473067404,0.0439766390205641,1.31471178621305e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLKB1,Plasma kallikrein,37187,0.0626134299555996,0.00239566515002153,0.0579179262615574,0.0673089336496418,6.89555015900316e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.144937594572261,0.00555774806888297,0.13404440835725,0.155830780787272,2.52904875535531e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0540047264403079,0.00207551533172337,0.0499367163901301,0.0580727364904857,3.12039290010357e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0638712745277792,0.00245720905710661,0.0590551447758503,0.0686874042797082,6.04948828393024e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0336379678256333,0.00129357674286927,0.0311025574096095,0.036173378241657,1.80348673929855e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUMB,Protein numb homolog,37056,0.21095063200063,0.00811195515824263,0.195051199890475,0.226850064110786,1.94570312212295e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.160957840347318,0.00619173406267674,0.148822041584471,0.173093639110164,1.95059778191818e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0704322051794676,0.00270946492068221,0.0651216539349305,0.0757427564240048,1.98591348022633e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEG1,Protein HEG homolog 1,37124,0.0673513655112002,0.00260134765415278,0.0622527241090608,0.0724500069133397,3.12542344874388e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.308926758571067,0.0119711026011974,0.28546339747272,0.332390119669414,6.76460783723309e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,P4HB,Protein disulfide-isomerase,39776,0.096387714035975,0.00374574613881977,0.0890460516038883,0.103729376468062,4.19555813169324e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0950803139745537,0.00369782939007354,-0.102328059579098,-0.0878325683700096,6.47914079843511e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.153744212743162,0.00600917239601403,0.141966234846975,0.16552219063935,1.81302802165871e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF21,Fibroblast growth factor 21,40011,0.293228100930941,0.0114781426029519,0.270730941429155,0.315725260432726,3.74825850412134e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0638267902824358,0.00250170929177255,0.0589234400705616,0.06873014049431,9.40194000760455e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.114137262898402,0.00447415917251442,0.105367910920273,0.12290661487653,1.04147542309365e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,MME,Neprilysin,39788,0.192929980030908,0.00756877886894197,0.178095173447781,0.207764786614034,1.63495882206402e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH9,Myosin-9,37437,0.272213451671625,0.0107009876864216,0.251239515806238,0.293187387537011,1.72092558194944e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,EEF1D,Elongation factor 1-delta,37437,0.222932069856606,0.00876381239202979,0.205754997568227,0.240109142144984,1.73629409655885e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORT1,Sortilin,39846,0.0909957994427366,0.0035909283608371,0.0839575798554959,0.0980340190299774,6.2369658735136e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLN,Promotilin,39866,0.217222096492497,0.00857814318635247,0.200408935847247,0.234035257137748,9.53725166714672e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.184634693793205,0.00728082302476243,0.170364280664671,0.19890510692174,1.39230368235235e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.34242492586935,0.013531781235745,0.31590263464729,0.36894721709141,4.45529055772844e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11R,Junctional adhesion molecule A,39858,0.137548385299995,0.00545108303982509,0.126864262541938,0.148232508058052,8.45730755580973e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0514059421095474,0.00204139876287622,0.04740480053431,0.0554070836847848,2.79969252815202e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.291134591720811,0.0115991493312164,0.268400259031627,0.313868924409996,7.58102855620357e-136
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTYMK,Thymidylate kinase,37437,0.165526372765589,0.00659708072669738,0.152596094541262,0.178456650989916,7.60489922721605e-136
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLA,Alpha-galactosidase A,37088,0.091166549688913,0.00363243895379567,0.0840469693394735,0.0982861300383525,7.70309530080165e-136
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.220380926642212,0.0087996734219275,0.203133566735234,0.23762828654919,8.0669693414829e-136
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.11985086280837,0.00478960398259125,0.110463239002491,0.129238486614249,1.38521495161731e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCLY,Selenocysteine lyase,39984,0.118259767231766,0.00474192825010034,0.10896558786157,0.127553946601963,9.88318182329106e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0518012843097868,0.00207816548341607,0.0477280799622913,0.0558744886572823,4.56650242762698e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.273013125492354,0.0109777846316045,0.251496667614409,0.294529583370298,5.63501298552052e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR5,Cadherin-related family member 5,39868,0.0920622634890454,0.00373836856036749,0.0847350611107251,0.0993894658673657,1.82374520268284e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.103434248090698,0.00420342074222772,0.0951955434359318,0.111672952745465,2.95518415771108e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.201840166809774,0.00822545624632258,0.185718272566982,0.217962061052566,1.61476516856445e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.188923867366237,0.00768722275487637,0.17385691076668,0.203990823965795,1.62785648971873e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORD,Sorbitol dehydrogenase,39963,0.161814011314149,0.00660637194563569,0.148865522300703,0.174762500327595,4.10590042836583e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0922285107974922,0.00376686732143931,-0.0996115707475132,-0.0848454508474711,5.30365083728432e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHK,Ketohexokinase,37043,0.152589613732036,0.00622638088213245,0.140385907203056,0.164793320261016,9.73856097670476e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYAP1,Synapse-associated protein 1,37124,0.13534081201881,0.00553571044996424,0.12449081953688,0.146190804500739,3.67294688236838e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS8,Prostasin,39805,0.0939042110961247,0.00386991540404126,0.0863191769042038,0.101489245288046,9.37746445498871e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL16,Pro-interleukin-16,40058,0.096368666771686,0.00397233771935868,0.088582884841743,0.104154448701629,9.77815395591358e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN2,Ficolin-2,39810,0.0946742319923141,0.00390514112426448,0.0870201553887558,0.102328308595873,1.55664006129937e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,FN1,Fibronectin,37453,0.0620728045344837,0.00256284938663922,0.0570496197366709,0.0670959893322966,6.53769682227911e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL22,C-C motif chemokine 22,39686,0.117484084358849,0.00486122108855463,0.107956091025282,0.127012077692416,9.55618123165606e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.068185972660538,0.00281730002381282,0.0626640646138649,0.0737078807072112,9.92113794643504e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.100019235498914,0.00414042838069272,0.0919039958727566,0.108134475125072,1.0943860683292e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,FYB1,FYN-binding protein 1,39836,0.213408763755857,0.00885615682942027,0.196050696370193,0.23076683114152,4.70156242049177e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0912414648980093,0.00378654530588774,-0.0986630936975492,-0.0838198360984693,4.77805625327477e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPY,Pancreatic prohormone,39826,0.232732244628672,0.00966330986582295,0.213792157291659,0.251672331965685,6.39986919687036e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0645849819750095,0.00268379812461765,0.0593247376507589,0.0698452262992601,9.91322139895059e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0906100756130351,0.00377400753677259,0.0832130208409608,0.0980071303851093,3.71392494468343e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.157772946922887,0.00659289907748319,0.14485086473102,0.170695029114754,2.27686629939822e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.157503572778459,0.0065791941841157,0.144608352177592,0.170398793379325,5.20267217500755e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.12053782174866,0.00503887984952159,0.110661617243598,0.130414026253723,6.77496401923371e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTD,Biotinidase,37453,0.0471411783483714,0.00197661638360361,0.0432670102365083,0.0510153464602344,3.42382102769033e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.127813378431041,0.00536686124670766,0.117294330387494,0.138332426474588,7.75593510678662e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0745683385077063,0.00314187348522581,0.0684102664766637,0.0807264105387488,1.97348855656645e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPY30,Protein dpy-30 homolog,39979,0.135703482380005,0.00571926990651645,0.124493713363232,0.146913251396777,2.33408563715446e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4R,Reticulon-4 receptor,40030,0.075915660228397,0.00319975098921798,0.0696441482895298,0.0821871721672643,2.4035266634255e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.250612251398135,0.0105477419858865,0.229938677105798,0.271285825690473,2.73452665596482e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.13474596415793,0.0056809549697794,0.123611292417162,0.145880635898698,2.81379600309452e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,MVK,Mevalonate kinase,39587,0.181223727053185,0.00764216239061386,0.166245088767582,0.196202365338789,3.59766968111525e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEP,Leptin,39868,0.154759328737754,0.00654050104282679,0.141939946693813,0.167578710781694,1.0885301596435e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0511127264130666,0.00218151347214654,0.0468369600076594,0.0553884928184739,2.1303420070834e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3F,Semaphorin-3F,39868,0.0575917297779923,0.00246453063505867,0.0527612497332773,0.0624222098227073,8.68790437468706e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.129395246282686,0.00552775396083944,0.118560848519441,0.140229644045931,9.15365950699052e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.1627586917357,0.00699930666075475,0.149040050680621,0.176477332790779,1.12265452116679e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.200758695893747,0.00864935046699663,0.183805968978434,0.217711422809061,3.15623923859064e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOMO1,Nodal modulator 1,39858,0.0531849564638069,0.00229264101757315,0.0486913800693636,0.0576785328582503,4.04560866449225e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK1,Dickkopf-related protein 1,40009,0.133411282279909,0.00577127125629358,0.122099590617574,0.144722973942244,2.43099995206837e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.189186067593939,0.00818270397571739,0.173147967801533,0.205224167386345,5.78451489665817e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.111074241840523,0.00482356150288979,0.101620061294859,0.120528422386187,1.99446955633102e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYY,Peptide YY,37021,0.204855528679562,0.00890547635665765,0.187400795020513,0.222310262338611,7.8277773074812e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLUL1,Clusterin-like protein 1,39840,-0.100219045531819,0.0043669155255905,-0.108778199961977,-0.0916598911016621,1.05560658032831e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJAP1,Tight junction-associated protein 1,39913,0.183721141245367,0.00802979030581051,0.167982752245979,0.199459530244756,4.87497146695514e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.108160116423401,0.0047259146442214,0.0988973237207267,0.117422909126075,9.9397499579495e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0868068304855383,0.00380805673962103,0.0793430392758811,0.0942706216951955,3.19119163212645e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0906060625095008,0.00397550202621752,0.0828140785381145,0.0983980464808872,7.40277207773732e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHBP1,EH domain-binding protein 1,37437,0.164694100310836,0.0072417795417475,0.150500212409011,0.178887988212661,2.13012966353623e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0649335484849901,0.00285626498014523,0.0593352691239055,0.0705318278460748,2.61572808207644e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXLNA,Alpha-taxilin,39749,0.195377136736423,0.00862304858043652,0.178475961518768,0.212278311954079,6.91970126751872e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP20,Centrosomal protein 20,39477,0.161807804693733,0.00714284749994185,0.147807823593847,0.175807785793619,8.17500387591941e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL17,C-C motif chemokine 17,39836,0.197587274095099,0.00872659225930583,0.18048315326686,0.214691394923339,9.53605598470131e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0566317987120642,0.00250066190176657,0.0517305013846018,0.0615330960395267,1.75831966591688e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.103098346012919,0.00457802736919022,0.094125412369306,0.112071279656532,3.03828042802336e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.17800943673885,0.00791516588283593,0.162495711608491,0.193523161869208,5.41759119358879e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRN,Agrin,39931,0.0708518095641309,0.00315620325240903,0.0646656511894092,0.0770379679388526,6.45265625703892e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.112033688922005,0.00499036630952514,0.102252570955335,0.121814806888674,6.94499098968523e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.211714579651922,0.00943428136935206,0.193223388167992,0.230205771135852,7.85332178413934e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.115860334407874,0.00517828964546644,0.10571088670276,0.126009782112989,3.33137744537357e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCXR,L-xylulose reductase,39913,0.116495397601088,0.00521322045950426,0.10627748550046,0.126713309701716,6.00151714051915e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSO,Cathepsin O,40058,0.0645791793374239,0.00289558957342822,0.0589038237735046,0.0702545349013432,1.49323808859045e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.207639992368517,0.00931978278532257,0.189373218109285,0.22590676662775,2.49166049262405e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,HJV,Hemojuvelin,37411,0.095029413625517,0.00428174436210375,0.0866371946757936,0.10342163257524,3.15410213430731e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.210116042105645,0.00949202472092035,0.191511673652641,0.228720410558649,5.69416339781774e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2AP,CD2-associated protein,39868,0.135598199240679,0.00612757887160131,0.12358814465234,0.147608253829017,6.60225133693472e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.117204828135079,0.00529832184856648,0.106820117311888,0.127589538958269,8.37145838458678e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.169650893287335,0.00770903119831267,0.154541192138643,0.184760594436028,9.94492278918525e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0424008539528615,0.00192736526792983,0.038623218027719,0.046178489878004,1.08151352446515e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0435784147695744,0.00198268548550044,0.0396923512179936,0.0474644783211553,1.66545721606059e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.134659986269961,0.00612817650918857,-0.146671212227971,-0.122648760311952,1.87731587790644e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.0998979786468455,0.00454695402824481,0.0909859487514857,0.108810008542205,3.78182604938781e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.225606393818502,0.0102880040842865,0.205441905813301,0.245770881823704,4.80468637131746e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.206645593876255,0.00943659390157517,0.188149869829167,0.225141317923342,1.73072859354773e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.239391853693377,0.0109327739086987,0.217963616832327,0.260820090554426,1.92805321795922e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.171578715242318,0.00786529986477366,0.156162727507362,0.186994702977275,5.57861583160519e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS2,Protein MTSS 2,37368,0.209955478492408,0.00963217824155895,0.191076409138953,0.228834547845864,1.48465028244215e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0590591691242311,0.00271529464055056,0.053737191628752,0.0643811466197102,2.13639370188416e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD63,CD63 antigen,39720,0.108270675012703,0.00498213822079492,0.0985056840999454,0.118035665925462,3.27669822257824e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.112343286880598,0.00517251176962596,0.102205163812131,0.122481409949065,4.23957460178252e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.149190255145728,0.00686984428578165,0.135725360345596,0.16265514994586,4.75099607595956e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB2,Carboxypeptidase B2,37424,0.0474139716123438,0.00218110065220151,0.0431390143340288,0.0516889288906587,5.03731115782468e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES3,Carboxylesterase 3,39788,0.144285729986072,0.00665886503251168,0.131234354522349,0.157337105449795,1.23622887520949e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,THOP1,Thimet oligopeptidase,39798,0.0637977649418834,0.00294538882687755,0.0580248028412034,0.0695707270425633,1.46030630495447e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNA4,Plexin-A4,39866,0.169954362068795,0.00786159018129996,0.154545645313447,0.185363078824143,3.48076326325125e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0576320793577907,0.00266797487416906,0.0524028486044193,0.0628613101111621,9.29089638713104e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.171936224664002,0.00797256032189878,0.156310006433081,0.187562442894924,1.01594117642371e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.172570671644676,0.00799247644889809,0.156905417804835,0.188235925484516,1.1991245864037e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.14009921178287,0.00651145151004058,0.12733676682319,0.152861656742549,3.2479722431757e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXIN1,Axin-1,39866,0.198392943972187,0.0092411538993406,0.180280282329479,0.216505605614894,8.08319264727804e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN1,Perilipin-1,39489,0.0719898443333222,0.00335459516550527,0.0654148378089318,0.0785648508577125,1.03975214695547e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0722911944299433,0.00337397622898501,0.0656782010211327,0.0789041878387539,1.93818857605701e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.113117444168221,0.00528435400419857,0.102760110319992,0.123474778016451,3.25301690621471e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN1,Dynactin subunit 1,40030,0.134424217829963,0.00629899935437381,0.12207817909539,0.146770256564536,1.12638385164618e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE4,Ribonuclease 4,37051,0.0535893770269435,0.00250984808861754,0.0486700747732531,0.0585086792806339,1.8004494999825e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.131899454723094,0.00618729517217038,0.11977235618564,0.144026553260548,2.01768860106984e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELP,P-selectin,39931,0.118298458630913,0.00555368565844335,0.107413234740364,0.129183682521462,2.61839527482215e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZN,Kazrin,37382,0.214433298713287,0.0100682006594697,0.194699625420727,0.234166972005848,4.96778897230641e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARF6,ADP-ribosylation factor 6,37382,0.218766196752383,0.0102822109591203,0.198613063272507,0.238919330232259,7.80602190527707e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUOM,Fucose mutarotase,37124,0.130672894646698,0.00614266770623567,0.118633265942476,0.14271252335092,8.94926840572413e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,BECN1,Beclin-1,37043,0.12411992410303,0.00585316947949248,0.112647711923225,0.135592136282836,3.66523117576678e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.233609006989698,0.0110335220747859,0.211983303723118,0.255234710256279,3.81387573169164e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0653295626628035,0.00308443401260158,0.0592840719981044,0.0713750533275026,6.51508608611393e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.221781001701359,0.0104970742491309,0.201206736173063,0.242355267229656,1.6452447932015e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0795387724389204,0.00380021534200491,0.0720903503685908,0.08698719450925,5.30631855724416e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.147392207734205,0.00703360571871202,0.133606340525529,0.16117807494288,6.09085013340176e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.124056752904998,0.00593436390514804,0.112425399650908,0.135688106159089,1.71203421743319e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUCB2,Nucleobindin-2,39995,0.0755785720454505,0.0036336315486498,0.0684566542100969,0.0827004898808041,7.61787572997505e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANG,Angiogenin,39843,0.0679779330028162,0.00327195056767598,0.0615649098901713,0.0743909561154611,1.26726255941307e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.183214690202477,0.00883895843750204,0.165890331664973,0.200539048739981,3.49928009901978e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.174631155651351,0.00842934829840964,0.158109632986468,0.191152678316234,4.16064349881568e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,EZR,Ezrin,40009,0.0482136811533652,0.00232974689964584,0.0436473772300594,0.0527799850766711,6.36399898875031e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAB2,Disabled homolog 2,40030,0.223642901858872,0.0108137846035329,0.202447884035948,0.244837919681797,8.33544083402062e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.218490940737103,0.0105587247970775,0.197795840134831,0.239186041339375,1.13340731879755e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCR,Breakpoint cluster region protein,39866,0.1841542669365,0.00891046262119386,0.16668976019896,0.201618773674039,1.13919584740289e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPL,N-acetylneuraminate lyase,37437,0.0880216114203554,0.004257686234615,0.07967654640051,0.0963666764402008,1.64063759851693e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0868961465003302,0.00421054705931174,0.0786434742640792,0.0951488187365813,2.06342879703749e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL5,C-C motif chemokine 5,39931,0.201670745569203,0.00978181139216511,0.18249839524056,0.220843095897847,3.10382189698643e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,F13B,Coagulation factor XIII B chain,37380,0.0509103446751153,0.00246717813796346,0.0460746755247069,0.0557460138255237,3.60381207100645e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0582311098323507,0.00282769665836884,0.0526888243819477,0.0637733952827536,5.4203601033733e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5E,5'-nucleotidase,39913,0.110399087554596,0.00536275448116741,0.0998880887715082,0.120910086337684,5.76750829948216e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.148636629968658,0.00721556245697443,0.134494127552988,0.162779132384328,7.98248560659709e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.110740075829839,0.00538949367452605,0.100176668227768,0.12130348343191,1.25901548126195e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.175607778710953,0.00853885068186348,0.158871631374501,0.192343926047406,1.44071684817323e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBIN,Erbin,39788,0.204163723762804,0.00995396665754831,0.184653949114009,0.223673498411598,2.67878770989504e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0730315507760432,0.00356625226484471,0.0660416963369476,0.0800214052151388,5.04456169747339e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.250521618457604,0.0122533471958172,0.226505057953802,0.274538178961406,9.72135124720175e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD6,T-cell differentiation antigen CD6,40040,0.103860569108558,0.00508345411380965,0.0938969990454912,0.113824139171625,1.26449633644345e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.170211908684813,0.0083229040518476,0.153899016743192,0.186524800626434,1.42053302904838e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.205605004453988,0.0100744161601631,0.185859148780069,0.225350860127908,2.0369216632385e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.205990830779709,0.0101152693921081,0.186164902771177,0.225816758788241,5.0046239935698e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSD,Cathepsin D,38721,0.0774380514691732,0.00380105556857631,0.0699879825547636,0.0848881203835828,5.08723871680994e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.140041147979078,0.00688050937083697,0.126555349612237,0.153526946345918,9.74996674227787e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.147534524837695,0.00724750949626207,0.133329406225021,0.161739643450369,1.00634742609737e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,FETUB,Fetuin-B,39908,0.0662676964950263,0.00326215612518048,0.0598738704896726,0.0726615225003801,1.32727343324964e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.211981624925942,0.0104260501503835,0.19154656663119,0.232416683220694,1.48878579824779e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN2,CCN family member 2,39880,0.114347255986206,0.00567451868065656,0.103225199372119,0.125469312600292,3.35364415512955e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,BACH1,Transcription regulator protein BACH1,39866,0.144555690856552,0.00719149512220623,0.130460360417028,0.158651021296076,9.00448782992411e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.128460442006501,0.00639636259143112,0.115923571327296,0.140997312685706,1.25888637758589e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.179326766572776,0.00893828612651543,0.161807725764806,0.196845807380746,1.90477604849505e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A4,Protein S100-A4,39913,0.110626695406028,0.00551731081050288,0.0998127662174426,0.121440624594614,2.38980978444443e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL13,C-C motif chemokine 13,40024,0.133689704564491,0.00667494258125129,0.120606817105238,0.146772592023743,3.6343629296213e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMIP,C-Maf-inducing protein,37368,0.160933708610924,0.00803282122244399,0.145189379014933,0.176678038206914,5.20352858061765e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGF,Hepatocyte growth factor,40058,0.0659149143959872,0.00329550564048299,0.0594557233406405,0.0723741054513338,6.15138465344066e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0659809820664094,0.00330750142415853,-0.0724636848577601,-0.0594982792750587,1.76926525068183e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.115002157595861,0.00576640530344913,0.103700003201101,0.126304311990621,3.05782957866676e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.129672107564077,0.00652320038591439,0.116886634807685,0.142457580320469,1.15929800177221e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.118383225524425,0.00597571855340871,0.106670817159744,0.130095633889106,2.74939913789082e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R9B,Neurabin-2,40058,0.18177574700203,0.00918993314704387,0.163763478033824,0.199788015970235,4.59336761550869e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0946387110787337,0.00478616445319491,0.0852578287504716,0.104019593406996,5.67206417970754e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.181387754619758,0.00918952751248944,0.163376280695279,0.199399228544237,1.04335378956105e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0929775033159917,0.0047109675836603,0.0837440068520175,0.102210999779966,1.06606248842031e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINH1,Serpin H1,37169,0.245152125448085,0.0124333076256278,0.220782842501854,0.269521408394316,2.51427205300205e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0735036491641928,0.0037353242743638,0.0661824135864398,0.0808248847419458,3.29574274351291e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0772129027182419,0.00392364960681451,0.0695225494888854,0.0849032559475983,3.32181176722645e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.128688536454935,0.00656910663185559,0.115813087456498,0.141563985453372,1.78744975494838e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.121763975907323,0.00621476716322392,0.109583032267404,0.133944919547242,2.60967686247528e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLA2,Src-like-adapter 2,37411,0.200000121457141,0.010209820824301,0.179988872641511,0.220011370272771,2.80029179881247e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.217230273265667,0.0110936961056884,0.195486628898518,0.238973917632817,3.26351419310052e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.133736098290003,0.00683786194308412,0.120333888881559,0.147138307698448,3.50858941363142e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0706282523188501,0.00360936150641112,0.0635539037662843,0.0777026008714159,4.4182675321734e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCTN3,Tectonic-3,37437,0.0559178832863052,0.00285865424381434,0.0503149209684291,0.0615208456041813,4.76214847662475e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.049249976308584,0.00252169658405934,0.0443074510038277,0.0541925016133403,5.58051125855082e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAXX,Protein PAXX,37124,0.0871413192436956,0.00445791791971489,0.0784038001210544,0.0958788383663368,6.53480946097097e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.195235332220536,0.00998920430388957,0.175656491784913,0.21481417265616,7.02046374335204e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.159970653848299,0.00819877498540356,0.143901054876908,0.17604025281969,8.32120016462608e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST3,Cystatin-C,39897,0.0502454219469673,0.0025775328210335,0.0451934576177416,0.055297386276193,1.1542448451686e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC1,Stanniocalcin-1,40009,0.0791413100459288,0.00407097775556286,0.0711621936450256,0.0871204264468319,3.13799764109095e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.133753677965,0.00688055210922199,0.120267795830925,0.147239560099075,3.38783129830554e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.109497244028087,0.0056347221128582,0.0984531886868848,0.120541299369289,3.76942227580888e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,AAMDC,Mth938 domain-containing protein,37043,0.100727337560219,0.00518400207255514,0.0905666934980107,0.110887981622427,6.14302693773268e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.259097475749062,0.0133528381870497,0.232925912902445,0.28526903859568,6.46721889310031e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0754912877381884,0.00389137326646485,0.0678641961359173,0.0831183793404595,1.03023389429639e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM1,Isthmin-1,39866,0.0747763409027721,0.00387123458077999,0.0671887211244433,0.0823639606811009,3.3986384697181e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.202750578851571,0.0104951348238176,0.182180114596888,0.223321043106253,4.76804309771088e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.158115980585303,0.00819257464308503,0.142058534284856,0.17417342688575,6.73539885457972e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.100888049285558,0.00523377263276762,-0.111146243645782,-0.0906298549253334,7.39274449259096e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP10,Stromelysin-2,39857,-0.109903821748497,0.00570332232690853,-0.121082333509238,-0.0987253099877561,8.08045488724289e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0620021485463372,0.00322191379132121,0.0556871975153476,0.0683170995773267,1.31548376530503e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.141471258726936,0.00736621599252945,0.127033475381578,0.155909042072294,2.66806133381648e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP5,Fatty acid-binding protein 5,39972,0.1269703879049,0.00662578198740685,0.113983855209582,0.139956920600217,5.9806369896393e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0421076211941123,0.00219831589222972,0.0377989220453421,0.0464163203428826,7.37723125667484e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.113890540275991,0.00595739626710983,0.102214043592456,0.125567036959527,1.49974145788792e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELE,E-selectin,40052,0.0924359925421156,0.00483615937516271,0.0829571201667967,0.101914864917435,1.50083290245456e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.19704342455144,0.0103213038589309,0.176813668987936,0.217273180114945,2.32533483871035e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.153938690860831,0.00806324411530865,0.138134732394826,0.169742649326836,2.44426834613465e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.184540598155084,0.00967484083689607,0.165577910114768,0.203503286195401,3.12655977631415e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINK1,Misshapen-like kinase 1,37388,0.172010374133689,0.00901496230652558,0.154341048012899,0.189679700254479,4.11936072321366e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0434188656602488,0.00228141486976295,0.0389472925155134,0.0478904388049842,7.12082646495067e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPK2,SRSF protein kinase 2,39866,0.155435924904232,0.00816757168662166,0.139427484398453,0.17144436541001,7.20597301471517e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0435179859154209,0.00228700024626902,0.0390354654327337,0.0480005063981082,7.68966140433475e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK2,Docking protein 2,39868,0.226625537580893,0.0119142405035095,0.203273626194014,0.249977448967771,8.59492940465628e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINC1,Antithrombin-III,37424,0.026857616969399,0.00141215966960491,0.0240897840169734,0.0296254499218246,1.29048625319081e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEXIM1,Protein HEXIM1,39866,0.150503500530246,0.00792949281049772,0.13496169462167,0.166045306438821,1.85184815460145e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD5,Programmed cell death protein 5,40009,0.10689630843111,0.00563357059106236,0.0958545100726277,0.117938106789592,2.00989043253201e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLK1,Protein delta homolog 1,40052,0.102740442965453,0.00541703648937555,0.0921230514462765,0.113357834484629,2.35108797119885e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPD52L2,Tumor protein D54,37124,0.201098231241347,0.0105976822874511,0.180326773957943,0.221869688524751,3.02848078385315e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.127736758513146,0.00673450108865965,0.114537136379373,0.140936380646919,3.36376868076546e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN1,Pantetheinase,37445,0.133247754061831,0.00702593020732487,0.119476930855474,0.147018577268188,3.4810444792945e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.116254344472435,0.00613975177931067,0.104220430984986,0.128288257959884,4.31679194105056e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO1,Forkhead box protein O1,39866,0.158050536354496,0.00835218139756073,0.141680260815277,0.174420811893715,5.33764745541684e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.113127596218905,0.00597950065185061,0.101407774941277,0.124847417496532,5.75177029216693e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.157336101158667,0.00832714431363918,0.141014898303934,0.173657304013399,9.05147833632409e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.178147304931608,0.00942866095276018,0.159667129464198,0.196627480399018,9.46857045854823e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXT,Oxytocin-neurophysin 1,40009,0.25442040443322,0.0134680621740285,0.228023002572124,0.280817806294315,9.60697726371554e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.20966433499387,0.0111116694629844,0.187885462846421,0.231443207141319,2.07568318482438e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.145409034600805,0.00771878645637584,0.130280213146309,0.160537856055302,3.86957148663264e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0491313306080911,0.00261314155372986,0.0440095731627806,0.0542530880534016,4.98141244134295e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.139276456441754,0.00740711930417244,0.124758502605576,0.153794410277932,6.93765963754034e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.165466429000099,0.0088048027451212,0.148209015619662,0.182723842380537,8.45196007063575e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.12182169862872,0.00649046405682641,0.10910038907734,0.1345430081801,9.03748979636074e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0976176149864898,0.00519874092846841,0.0874280827666917,0.107807147206288,1.1672023465124e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.118055638290166,0.00630009731346063,0.105707447555784,0.130403829024549,1.69245800214729e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.140833277439773,0.00751399827004664,0.126105840830481,0.155560714049064,2.1052859483396e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNST,Consortin,39868,0.196457338928796,0.0104937887793851,0.175889512921201,0.217025164936391,2.22326681209923e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0526409826683205,0.00281370148275738,0.047126127762116,0.0581558375745249,2.73800363015463e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.171876142410499,0.00919165012429534,0.15386050816688,0.189891776654118,3.38521605754547e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEC31A,Protein transport protein Sec31A,37043,0.139971176240255,0.00747778376525364,0.125314720060357,0.154627632420152,3.50710867851905e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.234259087965457,0.0125311146363647,0.209698103278182,0.258820072652732,3.58910994551839e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.116144160898714,0.00620895446352445,0.103974610150206,0.128313711647222,4.11733837841831e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.103236459836411,0.00553888766333204,0.0923802400162799,0.114092679656542,1.00040428314385e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.20484803320458,0.0110024497920707,0.183283231612121,0.226412834797038,1.46533655736595e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA5,Integrin alpha-5,39858,0.0448378542679279,0.00241022364189229,0.0401138159298191,0.0495618926060368,1.93645858944826e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.185025153348785,0.00993820697852762,0.165546267670871,0.2045040390267,2.08248799635637e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTBDN,Retbindin,39788,0.0528022308464014,0.00284686380361275,0.0472223777913204,0.0583820839014824,5.38831827448698e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH2,Cadherin-2,39868,0.0632043659858275,0.00340948227684068,0.0565217807232198,0.0698869512484352,6.36972388519152e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0790905940472504,0.00427707760702513,0.0707075219374811,0.0874736661570196,1.48538885947056e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0356813864481927,0.00192957226531788,0.0318994248081697,0.0394633480882158,2.0356121771866e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0466537168875112,0.00252278316408818,0.0417090618858984,0.0515983718891241,2.10897450055192e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,USO1,General vesicular transport factor p115,39788,0.160775951388491,0.0087154642062186,0.143693641544303,0.17785826123268,3.33098084229957e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0781585703599381,0.00423320730410726,0.0698614840438879,0.0864556566759883,3.60972928340283e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0909181964429282,0.00493837502449844,0.0812389813949112,0.100597411490945,9.39831968525886e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP43,Centrosomal protein 43,39476,0.125019350068004,0.00680343025605576,0.111684626766135,0.138354073369873,1.25153270947289e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0800135016711472,0.00436020913416398,-0.0885595115741086,-0.0714674917681858,2.57690240536569e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB3,Plexin-B3,39812,0.0848318865584421,0.00463029019930999,0.0757565177677945,0.0939072553490897,3.23940429621046e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.183574282709102,0.010023534938706,0.163928154229238,0.203220411188965,3.59355344200095e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.199053223322685,0.0108875926509487,0.177713541726825,0.220392904918544,6.54202226999934e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.128572763432388,0.00703918321189533,0.114775964337073,0.142369562527703,1.19349584390771e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNMBP,Dynamin-binding protein,39749,0.109963043688764,0.00602898236007055,0.098146238263026,0.121779849114503,1.42210110347985e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0896257551059386,0.00491374777709733,0.0799948094628278,0.0992567007490493,1.44414172440338e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.184347008092225,0.0101239234811443,0.164504118069182,0.204189898115267,2.38815813322805e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.129600158931082,0.00713118934088548,0.115623027822946,0.143577290039217,4.65927252355877e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.135500151215673,0.00745666273188942,0.12088509226117,0.150115210170176,4.72707573860555e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGF,Placenta growth factor,40058,0.0453649741973238,0.00250069172840151,0.0404636184096569,0.0502663299849908,7.95361519082378e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.123357583708854,0.00679890584810374,0.11003172824657,0.136683439171137,1.09983970734764e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.135059409363663,0.00745184006335327,0.120453802839491,0.149665015887835,1.47717717014683e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.137205682107195,0.00757393602108471,0.122360767505869,0.152050596708522,1.79313017698353e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREG1,Protein CREG1,39660,0.0661100581103851,0.00365997665283751,0.0589365038708236,0.0732836123499466,3.31908002306102e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.151532018689322,0.00839284344556203,0.13508204553602,0.167981991842623,3.74948832655909e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.118236683971588,0.00655115271161809,0.105396424656816,0.131076943286359,4.39006779493113e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,PENK,Proenkephalin-A,37124,0.0511238676549351,0.00283129211067285,0.0455745351180163,0.0566732001918539,5.0764698087671e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2B3,SH2B adapter protein 3,39477,0.172409180263777,0.00958518668896417,0.153622214353407,0.191196146174147,1.29853463625617e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.12623563884644,0.00701967294943792,0.112477079865541,0.139994197827338,1.77951983008871e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0342607081955632,0.0019076643885485,0.0305216859940081,0.0379997303971182,2.03728392246915e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.114546557227043,0.00638543593495806,0.102031102794525,0.127062011659561,3.90120356134493e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXN,Paxillin,39489,0.0901595337493414,0.00503136194263016,0.0802980643417862,0.100021003156896,4.27007269733079e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0729363069401732,0.00407051898314198,0.0649580897332149,0.0809145241471314,4.32712320573927e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0474169735492001,0.00264842497727225,0.0422260605937465,0.0526078865046537,5.62663752888541e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMN,Protein amnionless,39587,0.0829866436072768,0.00463818314780626,0.0738958046375765,0.092077482576977,6.85347780539456e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC13,Mucin-13,39489,0.0880429769697762,0.00492960994441888,0.0783809414787152,0.0977050124608372,1.21531857756195e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH2,Neutral ceramidase,39749,0.0909351052688968,0.00509422896077911,0.0809504165057697,0.100919794032024,1.39690918269361e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.157285161017507,0.00880425439048827,0.14002882241215,0.174541499622864,1.42490379847166e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.108481664915703,0.00608814555456254,0.0965488996287609,0.120414430202646,3.21571687981094e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0738955060624136,0.00415856615055779,0.0657447164073204,0.0820462957175069,7.95258184139867e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0956640527796156,0.00538468756061529,0.0851100651608097,0.106218040398422,8.0182138275246e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0561681998949513,0.00316833092224456,0.0499582712873519,0.0623781285025506,1.18569280644212e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.168164153251779,0.00948775817185763,0.149568147234938,0.18676015926862,1.73475426551236e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.182670970476097,0.0103161878169934,0.162451242354789,0.202890698597404,2.29907639483575e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRAP,BRCA1-associated protein,37249,0.189565299108877,0.0107102845785273,0.168573141334964,0.210557456882791,2.60618327724478e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.15619260974058,0.0088329000273011,0.138880125687069,0.17350509379409,3.39873338995385e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.131563631934708,0.00744206631110049,0.116977181964951,0.146150081904465,3.67181815988339e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.108368273540251,0.00613311853659112,0.0963473612085323,0.120389185871969,4.30555908164078e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0893599412507144,0.00506548554029964,0.0794315895917271,0.0992882929097017,5.34847055033388e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0960752570649263,0.00545043398188862,0.0853924064604246,0.106758107669428,6.71038509832392e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBPL,FK506-binding protein-like,37382,0.102055757019194,0.00578576091167604,0.0907156656323094,0.113395848406079,7.27244760582688e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD36,Platelet glycoprotein 4,37056,0.0783216477245187,0.00444204958936427,0.0696152305293647,0.0870280649196727,8.60730977684823e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.124569630474964,0.00707064725606458,0.110711161853077,0.13842809909685,1.05235067504864e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,BID,BH3-interacting domain death agonist,39866,0.11293929206904,0.00643418271195562,0.100328293953607,0.125550290184473,2.46185651816547e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGFR,Opioid growth factor receptor,39788,0.0557728147188849,0.00317761473902166,0.0495446898304024,0.0620009396073673,2.53255811109581e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGLN1,Egl nine homolog 1,39866,0.0910255959581107,0.00519018472436242,0.0808528338983603,0.101198358017861,3.18908720199934e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.172803283262876,0.00987254072912571,0.153453103433789,0.192153463091962,5.79200432090072e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,THPO,Thrombopoietin,39585,0.0649475428177912,0.00371143392432045,0.0576731323261231,0.0722219533094593,6.37905852739283e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0825014363617017,0.00473474269794698,0.0732213406737256,0.0917815320496777,2.29981583957014e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0625636176034354,0.00359575517602436,0.0555159374584277,0.0696112977484431,3.50527901902609e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.144850925271967,0.0083230878847939,0.128537673017771,0.161164177526163,4.37161870253938e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1A,Meprin A subunit alpha,37382,0.120926092868508,0.00695700608056107,0.107290360950608,0.134561824786408,6.03263830948202e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,EREG,Proepiregulin,39713,0.134907990353541,0.00776843056103839,0.119681866453906,0.150134114253176,6.19179082601008e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.103722670399157,0.00597444236147733,0.0920127633706616,0.115432577427653,6.68252697994898e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.107728897655512,0.00620670490257558,0.0955637560464639,0.11989403926456,7.41759158519776e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLM2,Protein GOLM2,40009,0.0373378351258323,0.0021549273521034,0.0331141775157097,0.041561492735955,1.18409170162027e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT2,Omega-amidase NIT2,37377,0.127099325743755,0.00733379341225712,0.112725090655731,0.141473560831778,1.44578327319275e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0287795361062395,0.00166074063426659,0.025524484463077,0.032034587749402,1.46471185433786e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAG1,Dystroglycan,39931,0.0818197543746876,0.00472568606710211,0.0725574096831674,0.0910820990662077,1.48514464098251e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.143810303096791,0.0083063622642846,0.127529833058793,0.160090773134789,1.55886155852648e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTDH,Protein LYRIC,37056,0.155821690457747,0.00899667124149027,0.138188214824426,0.173455166091068,1.80466040585399e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0361064032461736,0.00209065584381104,0.032008717792304,0.0402040887000433,3.0822786471882e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.158330555961207,0.00916900875895491,0.140359298793655,0.176301813128758,3.33959936038194e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0447162588893306,0.00259060528719913,0.0396386725264203,0.0497938452522409,4.68366765044451e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.141948606225684,0.00823255612611342,0.125812796218502,0.158084416232867,5.07490722830115e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,QDPR,Dihydropteridine reductase,39790,0.0729566394988208,0.00423168730477276,0.0646625323814662,0.0812507466161755,5.23096996516164e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.0948920880598327,0.00550547213956318,0.0841013626662888,0.105682813453377,5.61921664257061e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDUA,Alpha-L-iduronidase,40030,0.0769354505886202,0.00446637961887568,0.0681813465356239,0.0856895546416166,6.62370429057125e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.1346430910697,0.00780981367118861,0.11933585627417,0.14995032586523,6.67556155862136e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP2,Methionine aminopeptidase 2,40011,0.0967792845638922,0.00562045555823648,0.0857631916697487,0.107795377458036,7.38814945166986e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0550893273199715,0.00320025218326005,0.0488168330407818,0.0613618215991612,8.05553715457297e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.178573729161608,0.0103673745547917,0.158253675034216,0.198893783288999,8.70049189924658e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL11,Eotaxin,40058,0.0638034333697324,0.00371475228003565,0.0565225189008625,0.0710843478386022,1.53621975848514e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.157795791672856,0.00922723910800061,0.139710403021174,0.175881180324537,5.50447553737808e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.126345629663344,0.00739423268897498,0.111852933592953,0.140838325733735,7.13314799183342e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0608805984967059,0.00356426159594576,0.0538946457686522,0.0678665512247596,9.82278599551635e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.198623023297276,0.0116387097905048,0.175811152107887,0.221434894486666,1.2624691551175e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.15989062579746,0.00937445592667264,0.141516692181182,0.178264559413739,1.49108119075258e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,MITD1,MIT domain-containing protein 1,39749,0.16095433119274,0.00946026344162812,0.142412214847149,0.179496447538331,2.41178611825456e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,COCH,Cochlin,37437,0.075646361431415,0.004446931906639,0.0669303748944025,0.0843623479684274,3.15081310159035e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2,Prothrombin,37453,0.024275985408886,0.00142812831316509,0.0214768539150824,0.0270751169026896,3.87236579769744e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDHD2,Phospholipase DDHD2,37411,0.110233012036083,0.00648729989288022,0.0975179042460376,0.122948119826128,4.32469723171009e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.135510903330816,0.00797743965035773,0.119875121616115,0.151146685045517,4.71577918031778e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAMBP,STAM-binding protein,39713,0.106370613588206,0.00626897946281326,0.0940834138410918,0.11865781333532,5.22147872292368e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0440063879283495,0.00259934610120824,0.0389116695699813,0.0491011062867176,9.71387502580408e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.143328665148733,0.00846696122377713,0.12673342115013,0.159923909147336,9.99173226775269e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.152686352494566,0.00902391003603535,-0.170373216165195,-0.134999488823937,1.14152488866707e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC5,Glypican-5,39749,0.0920655985896384,0.00544363911879398,0.0813960659168022,0.102735131262475,1.30997777267111e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.1244856202202,0.00736483442683844,0.110050544743597,0.138920695696803,1.91723389090462e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D23,TBC1 domain family member 23,39788,0.147918233723606,0.00875948936827683,0.130749634561783,0.165086832885429,2.00992269747384e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR,GMP reductase 1,40058,0.0814898247186541,0.00483113161745284,0.0720208067484465,0.0909588426888617,2.69948290045314e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD1,COMM domain-containing protein 1,37043,0.101733107958158,0.00603216300072555,0.0899100684767362,0.11355614743958,3.7264906437567e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPHN1,Oligophrenin-1,37388,0.177142175129733,0.0105068970932496,0.156548656826964,0.197735693432502,3.92893931574792e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0539752632497328,0.00320229604424157,0.0476987630030193,0.0602517634964463,4.49407152707459e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASHC3,WASH complex subunit 3,37388,0.124280485896129,0.0073761298558703,0.109823271378623,0.138737700413635,4.68301829297906e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSNL1,Visinin-like protein 1,37388,0.0618954831527649,0.00367508067541477,0.0546923250289519,0.0690986412765778,5.26470386168797e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.145879425467264,0.00866806713034854,0.128890013891781,0.162868837042747,6.46977475640719e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0438584957760894,0.00260847908637561,0.0387458767667932,0.0489711147853856,6.7284494911187e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.12281655351435,0.00731626080044115,0.108476682345485,0.137156424683215,1.04792952230905e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0824016342079714,0.00490907213611795,0.0727798528211803,0.0920234155947626,1.06971019354784e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.135234710949674,0.00805969457350396,0.119437709585606,0.151031712313742,1.52924847511683e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.057447357356956,0.00342855529898016,0.0507273889709549,0.0641673257429571,1.75323793159681e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.144288976565304,0.00860595325240186,0.127421308190596,0.161156644940012,1.90752490230263e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0532433832490652,0.00318128006331151,-0.0594786921731558,-0.0470080743249747,2.39620551082728e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCC,Tubulin-specific chaperone C,39749,0.13243009614895,0.00791659245484328,0.116913574937457,0.147946617360443,2.78581646726e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC4,Syndecan-4,39868,0.0738327338815042,0.00441705837523948,0.0651752994660348,0.0824901682969736,3.41008823236381e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCG,Gamma-synuclein,39749,0.105545666726909,0.00632649085077175,0.0931457446593959,0.117945588794421,5.85090234334546e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,C19orf12,Protein C19orf12,39489,0.105564849291796,0.00632762523479863,0.0931627038315907,0.117966994752001,5.96481386869817e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.18983575343725,0.0113841108821088,0.167522896108316,0.212148610766183,6.61380402216579e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIAE,Sialate O-acetylesterase,39875,0.0766620217508803,0.0045981330498006,0.0676496809732711,0.0856743625284895,6.91220570976547e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG2,Secretogranin-2,39949,0.0505094694562565,0.00303049401517203,0.0445697011865193,0.0564492377259937,7.50668953719942e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYDGF,Myeloid-derived growth factor,37437,0.164376281054015,0.00985582314627041,0.145058867687325,0.183693694420705,7.79259461475941e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES2,Cocaine esterase,39788,0.087736720359945,0.0052676586290167,0.0774121094470722,0.0980613312728177,9.15319458451852e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0767907289427465,0.00461321417292267,0.067748829163818,0.0858326287216749,1.3297494345525e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1S,Complement C1s subcomponent,37453,0.0338778210026983,0.00203687992974204,0.0298855363404039,0.0378701056649927,1.64936469531886e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS8,Galectin-8,40009,0.0990068885288868,0.00595865799420731,0.0873279188602405,0.110685858197533,1.73919901269975e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTPBP2,GTP-binding protein 2,37039,0.130636825267272,0.00786948426256262,0.115212636112649,0.146061014421894,2.89463609579062e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0815344895309281,0.00491526131628765,0.0719005773510043,0.0911684017108519,3.41944250785014e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.147032222864649,0.00886542362879924,0.129655992552202,0.164408453177095,3.72202030232054e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGA,Protein O-GlcNAcase,37382,0.114815909593919,0.00692651691901781,0.101239936432644,0.128391882755194,4.14134935367676e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRKL,Crk-like protein,39881,0.172722623299985,0.0104299104076519,0.152279998900988,0.193165247698983,4.34092155035656e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0961874012065633,0.00580489577025755,0.0848098054968585,0.107564996916268,4.58448034278449e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.125145635634648,0.00755499463365874,0.110337846152677,0.139953425116619,4.99365209681505e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM13A,Protein FAM13A,37382,0.108905524883598,0.00659388490421183,0.0959815104713431,0.121829539295853,1.10227734622644e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0410285034232791,0.00248720833165857,-0.0459034317533299,-0.0361535750932283,1.23741717579695e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.176729650852876,0.01072690209464,0.155704922747382,0.19775437895837,1.72752507047714e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.104118396941138,0.00633138932888572,0.091708873856522,0.116527920025754,2.82348910473126e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.0954424465044436,0.00580660628953614,0.0840614981769527,0.106823394831934,3.2608702537875e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.134071749855685,0.00815475385859409,0.118088432292841,0.15005506741853,3.73638145140981e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX15,Sorting nexin-15,37124,0.0862747263572638,0.00524845945599298,0.0759877458235176,0.0965617068910101,4.00774329346648e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.115270429084634,0.00702777647119193,0.101495987201098,0.12904487096817,7.16688742450341e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSB,Arylsulfatase B,39788,0.0881478707725266,0.00537911082803834,0.0776048135495715,0.0986909279954817,7.30605645710669e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0604816622476956,0.00369907319173395,0.053231478791897,0.0677318457034941,1.30647128522385e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX2,Heme oxygenase 2,39489,0.0753494543300269,0.0046092985092074,0.0663152292519804,0.0843836794080735,1.41941884918256e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.118911562992414,0.00728474044468064,0.10463347172084,0.133189654263988,2.04729388621518e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBNL,Drebrin-like protein,39931,0.147920402282356,0.00906972952811144,0.130143732407258,0.165697072157455,2.54062374594746e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0445783468239432,0.00273470641687893,0.0392183222468605,0.0499383714010259,2.91522414287827e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,C3,Complement C3,36816,0.0731998324753496,0.00448930566500472,0.0644007933719403,0.0819988715787588,3.50608679945132e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0910784906390414,0.00560503316881184,0.0800926256281702,0.102064355649913,6.62593806086452e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.205174699093796,0.0126307000105941,0.180418527073032,0.229930871114561,7.23520002602429e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS1,Galectin-1,39868,0.0529811472516702,0.00326538555581123,0.0465809915622802,0.0593813029410602,9.86010364002298e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0813979213489117,0.00502946073821077,0.0715401783020186,0.0912556643958048,1.89728808772285e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.193979662400931,0.0119852464524468,0.170488579354136,0.217470745447727,1.94074763817288e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0587060633657932,0.0036303557987978,0.0515905660001496,0.0658215607314369,2.32183722254204e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS9,Galectin-9,39859,0.0496429876824858,0.00307009995324299,0.0436255917741295,0.0556603835908421,2.38780454503126e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0632911369244148,0.00392005645444561,0.0556078262737014,0.0709744475751281,3.47876860868274e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0761003003652851,0.00470980994106202,0.0668690728808036,0.0853315278497667,3.50871673225065e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0439972100235606,0.00272710200395395,0.0386520900958108,0.0493423299513103,4.29490507175965e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0982156672514503,0.00608558868540156,0.0862879134280632,0.110143421074837,4.88547751371137e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0859776209822051,0.00533344274251177,0.075524073206882,0.0964311687575281,6.5404151210886e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.145308894476752,0.00902305864816858,0.127623699526342,0.162994089427163,6.97412434694347e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0545168700268763,0.00338601247217332,-0.061153454472336,-0.0478802855814165,7.19261247288244e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.123570934094024,0.00766913303939917,0.108539433336801,0.138602434851246,7.39132928060233e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.130855291296225,0.00812925836683622,0.114921944897226,0.146788637695224,7.6373681861361e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0434848359432397,0.00270194956259889,0.0381890148005459,0.0487806570859336,9.90842860037001e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0857517146311208,0.00533420246285355,0.0752966778039278,0.0962067514583137,1.06648119970155e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0479998117195755,0.00298364227807949,0.0421518728545397,0.0538477505846112,1.06727112113482e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.113608931980794,0.00707385400556087,0.0997441781298944,0.127473685831693,1.69661423564758e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.23034388726372,0.0143612632142896,0.202195811363713,0.258491963163728,2.29698237380545e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0830915408628453,0.00518444480212615,0.072930029050678,0.0932530526750125,2.78354555229332e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TALDO1,Transaldolase,37415,0.069796160043245,0.00435676243212286,0.0612569056762842,0.0783354144102058,3.09464064554008e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD69,Early activation antigen CD69,39785,0.137076522248107,0.0085631076448344,0.120292831264231,0.153860213231982,3.15075887377831e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.142918070250842,0.00892176931998781,0.125431402383665,0.160404738118018,3.25985065027875e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK1,Docking protein 1,37388,0.214019052674039,0.0133675408989792,0.18781867251204,0.240219432836038,3.62281757485867e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0778146327878449,0.00486032487575735,0.0682883960313605,0.0873408695443293,3.7439569824337e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0536463134190773,0.00335520356506416,0.0470701144315516,0.0602225124066031,4.29676383073694e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GLB2,Endophilin-B2,37388,0.103102872394653,0.00644564721478362,0.0904694038536773,0.115736340935629,4.56178482851708e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.113233627633735,0.00708567714258092,0.0993457004342766,0.127121554833194,4.80115951012687e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT1,Deaminated glutathione amidase,37043,0.0734010206221318,0.00459042098684998,0.0644037954879058,0.0823982457563577,5.14753761238311e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0550784464403975,0.00344987372783968,0.0483166939338317,0.0618401989469633,6.15921732395591e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.132381240078607,0.0082953369023086,0.116122379750082,0.148640100407132,6.99928263114517e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0894351399414686,0.00560464655971958,0.0784500326844182,0.100420247198519,8.62635245616802e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0697102734042828,0.00437519453565524,0.0611348921143985,0.0782856546941671,1.02443141188698e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.121017229449572,0.00759837564035345,0.10612441319448,0.135910045704665,1.34786024027407e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOC1,Apolipoprotein C-I,37424,0.0580635543089896,0.00364598623299816,0.0509174212923132,0.0652096873256659,1.37600716696443e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOT,Angiomotin,37124,0.0641078839316218,0.00402649078359492,0.0562159619957758,0.0719998058674679,1.49971801978403e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0484948803445489,0.00304705265186047,0.0425226571469024,0.0544671035421954,1.66462503584749e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.090378201276378,0.00568553327421424,0.0792345560589181,0.101521846493838,2.23153769267275e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.13378733196007,0.00841989398691976,0.117284339745708,0.150290324174433,2.48779749227074e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.109778274951609,0.00692411825582283,0.0962070031701966,0.123349546733022,3.50364615563052e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0811878541167509,0.0051241801426727,0.0711444610371124,0.0912312471963894,4.12627192907864e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.143808112372512,0.00910095832425864,0.125970234056965,0.161645990688059,8.17450516641538e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA2,Apolipoprotein A-II,37445,-0.0731939460335979,0.00463587627472825,-0.0822802635320652,-0.0641076285351305,1.16436447637409e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.120356506751065,0.00762859900800886,0.105404452695368,0.135308560806763,1.20454425317376e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPP,Lipoma-preferred partner,37021,0.10326143755091,0.00654043632610354,0.090442182351747,0.116080692750073,1.21546603174003e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,YJU2,Splicing factor YJU2,37368,0.0499014123427339,0.00316305716396742,0.0437018203013577,0.05610100438411,1.41825438876251e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAX,Protein max,39489,0.162135058742741,0.0102857221711591,0.141975043287269,0.182295074198212,1.49465467171204e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0610364959065854,0.00387528559157767,0.0534409361470931,0.0686320556660776,1.81688090921923e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0714258580893203,0.00453963887803958,0.0625281658883627,0.0803235502902778,2.30618954513834e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLG,Plasminogen,37162,0.0347004868014415,0.0022043106545718,0.0303800379184807,0.0390209356844022,2.45566099809421e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0441213593208548,0.00281124912294942,0.0386113110398739,0.0496314076018356,4.19458753939427e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEFTY2,Left-right determination factor 2,40011,0.0815875704515493,0.00520094627379368,0.0713937157549137,0.0917814251481849,4.72588159488266e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.104807116382067,0.00668231849673041,0.0917097721284753,0.117904460635659,4.93764492504681e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.103369757213295,0.00660037154039269,0.0904330289941255,0.116306485432465,8.41595960604288e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0870123462997143,0.00555614754970899,0.0761222971022847,0.0979023954971439,8.53038118652587e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.109522119474255,0.00700262364597169,0.0957969771281504,0.123247261820359,9.75140945100272e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.11974033170869,0.00766569785474656,0.104715563913387,0.134765099503994,1.34912136843614e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0569309216154165,0.00364615763507826,0.0497844526506631,0.0640773905801699,1.47761981740642e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUS,RNA-binding protein FUS,39455,0.0596807013932524,0.00382795266199986,0.0521779141757327,0.0671834886107722,2.16466016379618e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL4,C-C motif chemokine 4,39882,0.0946817189312746,0.00608057498189461,0.0827637919667612,0.106599645895788,2.8551880103692e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPART,Spartin,37124,0.118517563908861,0.00760967420536462,0.103602602466347,0.133432525351376,3.27017979616835e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.103323345702958,0.0066354716702894,0.0903178212291904,0.116328870176725,3.43630630636406e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0687282324861361,0.00441958292716491,0.0600658499488928,0.0773906150233793,3.99704341158928e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,TWF2,Twinfilin-2,37437,0.128166389870105,0.00824050949845781,0.112014991253128,0.144317788487083,4.42790144969118e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0770411275194369,0.00495671567134274,0.0673259648036051,0.0867562902352687,4.52456016323839e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.122313421396922,0.00787071851654546,0.106886813104493,0.137740029689352,4.59455469605282e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASC3,Protein CASC3,37039,0.0633459931992072,0.00408464962792702,0.0553400799284702,0.0713519064699441,9.09454584528457e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,IST1,IST1 homolog,37287,0.150736560981582,0.00972857694153672,0.13166855017617,0.169804571786993,1.10600932507067e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICA1,Islet cell autoantigen 1,39587,0.12116892333129,0.00782634969286562,0.105829277933274,0.136508568729307,1.13906054054726e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.116475227508817,0.0075256801862623,-0.131225560673891,-0.101724894343743,1.21028622921554e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.036357813443748,0.00234963260485501,0.0317525335382322,0.0409630933492638,1.27471901652738e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0442201552124378,0.00286140102530118,0.0386118092028475,0.0498285012220281,1.72335526444231e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0565463581170789,0.0036639081096085,0.0493650982222462,0.0637276180119115,2.4157205728859e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD226,CD226 antigen,37056,0.0630102453208857,0.00408437815817761,0.0550048641308575,0.0710156265109138,3.13302694689409e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA11,Annexin A11,39829,0.100432170444847,0.0065168351213047,0.0876591736070898,0.113205167282604,3.32477651990768e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGF,Pro-epidermal growth factor,39808,0.155631405895573,0.0101135467083424,0.135808854347222,0.175453957443924,4.70972058754104e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.102805420184918,0.00668010659639353,0.0897124112559867,0.115898429113849,5.53438108732913e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPBP,Platelet basic protein,37371,0.127440611638242,0.00828321520726693,0.111205509831999,0.143675713444485,5.76490629949189e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.119396566884155,0.00776613809804212,0.104174936211992,0.134618197556318,5.88405169197515e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0479194538882097,0.00311730499168114,0.0418095361045146,0.0540293716719047,6.00465235320561e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0809266245760919,0.00526917212039208,0.0705990472201234,0.0912542019320603,7.44626850367324e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.127759264451398,0.00832041800508578,0.111451245161429,0.144067283741366,7.98420671227061e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL7,C-C motif chemokine 7,39866,0.0872369782361914,0.00568305151749093,0.0760981972619092,0.0983757592104736,8.3725381566501e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.127809206280094,0.00832436872448126,0.11149344358011,0.144124968980077,9.33822560119564e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.030161066007851,0.00196595730679533,-0.0340143423291698,-0.0263077896865321,9.52322990955389e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,RFC4,Replication factor C subunit 4,37368,0.0319645102272303,0.00208240327622086,0.0278829998058374,0.0360460206486232,9.89227182725332e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.109466146041393,0.00714073038901692,0.0954703144789203,0.123461977603867,1.14381826406072e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOA,Elongin-A,39788,0.0760944961678468,0.0049796391919437,0.0663344033516372,0.0858545889840565,2.40177415897838e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0579580816766784,0.00379284826334966,0.050524099080513,0.0653920642728437,2.85634532198152e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILPL2,RILP-like protein 2,37437,0.146852313940362,0.00962356631509413,0.127990123962778,0.165714503917947,3.84300809495254e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0633400435455263,0.00416363208564869,0.0551793246576549,0.0715007624333977,6.66949973464892e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON2,Spondin-2,39775,-0.0497173205628707,0.00327064547941873,-0.0561277857025314,-0.04330685542321,8.04123642753307e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT1,Angiopoietin-1,39794,0.125115044378134,0.00823117857004759,0.108981934380841,0.141248154375428,8.1471874518745e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,RWDD1,RWD domain-containing protein 1,40009,0.0945744613911378,0.0062271847647171,0.0823691792522923,0.106779743529983,9.76636593956898e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSTN,Growth/differentiation factor 8,39585,0.0767745294610282,0.00505992719629745,0.0668570721562852,0.0866919867657712,1.2377039966545e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.0920970208591853,0.00607400950287369,0.0801919622335529,0.104002079484818,1.45808826513517e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2,Microtubule-associated protein 2,37388,0.0680287350262022,0.00448897350008663,0.0592303469660324,0.076827123086372,1.86687215858808e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0870801778226611,0.00575178006812681,0.0758066888891326,0.0983536667561897,2.05415030830093e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSZ,Cathepsin Z,39865,0.0457107443184242,0.00302255336639817,0.0397865397202837,0.0516349489165646,2.57545977512386e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY4,Protein canopy homolog 4,39788,0.11147439113558,0.00737308436423523,0.0970231457816794,0.125925636489481,2.75017054559894e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.154389138213251,0.0102212366428746,0.134355514393217,0.174422762033285,3.39583211747404e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.113358168987243,0.0075001630991022,0.0986578493130031,0.128058488661484,3.50800446728251e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0342039178697296,0.00226668178024181,0.0297612215804557,0.0386466141590036,4.20659805219842e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0388424521596049,0.00257762960683165,0.0337902981302149,0.043894606188995,6.67300619125185e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0859961691439083,0.0057103784084556,0.0748038274633353,0.0971885108244813,7.88848161694418e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PF4,Platelet factor 4,37385,0.141677584904581,0.0094128239795433,0.123228449904676,0.160126719904485,8.68983641314887e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.0950024073388703,0.00631685919603912,0.0826213633146337,0.107383451363107,9.00988104343655e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.144336546778544,0.00959734278356826,0.12552575492275,0.163147338634338,9.20940065384989e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0729590337709413,0.00485040033549328,0.0634522491133745,0.0824658184285082,1.01894622867527e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11,Coagulation factor XI,37249,0.0458002555833796,0.003046700015155,0.0398287235536758,0.0517717876130834,1.16008791056731e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM17,Splicing factor 45,37411,0.112128300555155,0.00746389777573905,0.0974990609147066,0.126757540195604,1.33047084693516e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS2,Trypsin-2,39931,0.0751200802781144,0.00500488343622141,0.0653105087431204,0.0849296518131084,1.40373662235256e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0485665296426009,0.00323735753689644,0.0422213088702839,0.0549117504149179,1.57312741258894e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.115518177369831,0.00770163362360032,0.100422975467574,0.130613379272087,1.66792815402618e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.140846507328242,0.00940693274369307,0.122408919150604,0.159284095505881,2.42948155957235e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESYT2,Extended synaptotagmin-2,37388,0.120219272460643,0.00803087968748764,0.104478748273167,0.135959796648119,2.92776974692951e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRY2,Protein sprouty homolog 2,39587,0.135241464347178,0.00904245448147808,0.117518253563481,0.152964675130875,3.13858176598583e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0914581330567678,0.00611384751291882,0.0794749919314469,0.103441274182089,3.41161824366488e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.0987837704975107,0.00660484706947406,0.0858382702413415,0.11172927075368,3.65976161610634e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0824840781912733,0.00552580099214259,0.0716535082466738,0.0933146481358728,4.77299964098953e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST13,Hsc70-interacting protein,37124,0.0805461231899559,0.00539325716243719,0.069975339151579,0.0911169072283328,5.00200391073788e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.111774408125768,0.00749126033429794,0.0970915378705445,0.126457278380992,5.23520337853064e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL18,C-C motif chemokine 18,39715,0.102740025595539,0.00688978050068459,0.089236055814197,0.116243995376881,6.00871466270738e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0505989746968768,0.00339503742321374,0.0439447013473779,0.0572532480463758,6.72647534064124e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARC,SPARC,39913,0.102547909503294,0.00688204568540576,0.0890590999598991,0.11603671904669,7.01772666435606e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0669250518022678,0.00448966225739706,0.0581253137777696,0.0757247898267661,7.43631802243108e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.111676030289759,0.00750256136454578,0.0969710100152493,0.126381050564269,9.0409030099487e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLB1,Beta-galactosidase,39749,0.0611514876306049,0.00411280584084947,0.05309038818254,0.0692125870786699,1.13767307464957e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGLL,Monoglyceride lipase,39908,0.126720977755133,0.00852557185283366,0.110010856923579,0.143431098586687,1.21404015159399e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLG4,Disks large homolog 4,37388,0.10388670753748,0.00699212843101759,0.0901821358126853,0.117591279262274,1.52457326051995e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.185961432267799,0.0125289337175348,0.161404722181431,0.210518142354167,1.65864375826512e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.04226609591089,0.00284809579851973,0.0366838281457914,0.0478483636759887,1.7078630604081e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGLAP,Osteocalcin,37437,0.125177303194663,0.00843259425197209,0.108649418460798,0.141705187928528,1.84479057566897e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0426569251735451,0.00287714755307178,0.0370177159695245,0.0482961343775658,2.11209712704266e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.106328753593669,0.00717213836718203,0.0922713623939925,0.120386144793346,2.51000091794362e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.086687081836367,0.00585338846514566,0.0752144404446815,0.0981597232280525,2.67010741737588e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0859891431875605,0.00581565308644371,0.0745904631381308,0.0973878232369901,3.86619304117994e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRAS,Ras-related protein R-Ras,37039,0.189718843902831,0.0128388746244937,0.164554649638823,0.214883038166839,5.09165605863976e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIN2,Bridging integrator 2,39858,0.129138597009482,0.00875459993491985,0.111979581137039,0.146297612881925,6.35883638168698e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.134636369420191,0.00912958811671676,0.116742376711426,0.152530362128956,7.65849373737907e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0867518269322794,0.00588309076950637,0.0752209690240469,0.0982826848405119,7.80442248188522e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.080253665565309,0.00544886833389268,0.0695738836308794,0.0909334474997387,8.82250554030026e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0803900639844432,0.00546148932303223,0.0696855449113,0.0910945830575864,1.00052575092443e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0801763381130266,0.00545430524415303,0.0694858998344866,0.0908667763915665,1.36128096150795e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD2,Polycystin-2,37021,0.0854935913187677,0.00581227235060289,0.074101537511586,0.0968856451259493,1.36807543070375e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBKS,Ribokinase,39504,0.0710128757472523,0.00483279257836764,0.0615406022936518,0.0804851492008529,1.48444538263614e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM2,Paralemmin-2,37388,0.0542020448691783,0.00369068755623762,0.0469682972589526,0.0614357924794041,1.86569921073832e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK10,Kallikrein-10,39856,0.0563854104658975,0.00384512828862834,0.048848959020186,0.0639218619116091,2.25482131958921e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,OCLN,Occludin,37411,0.0613815025498839,0.0041836042787215,0.0531816381635898,0.069581366936178,2.29098250309832e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0641855761605832,0.00437571760959323,0.0556091696457805,0.0727619826753859,2.41560541439371e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDC,Nuclear migration protein nudC,40058,0.0919983883672863,0.00627995133373052,0.0796896837531745,0.104307092981398,2.76207726460395e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN3,Centrin-3,37382,0.112820610283221,0.00770224277475246,0.0977242144447066,0.127917006121736,3.2576683880259e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.12660110305261,0.00865106929368818,0.109645007236981,0.143557198868239,3.49448376491329e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX8,Syntaxin-8,39866,0.0695516017094836,0.00475964873679061,0.060222690185374,0.0788805132335932,4.74890564267131e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53,Cellular tumor antigen p53,39477,0.0629521636117757,0.00431066116067337,0.0545032677368559,0.0714010594866955,5.50018422660453e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN2,Centrin-2,39489,0.0966000207301494,0.00661526104636603,0.083634109079272,0.109565932381027,5.59577188154676e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOM,Apolipoprotein M,39908,0.0379064519307045,0.00259654251095582,0.0328172286092311,0.0429956752521779,5.8005362119458e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,F12,Coagulation factor XII,37453,0.0590275099362708,0.00404319435146987,0.0511028490073899,0.0669521708651517,6.54436655999234e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.119051621090772,0.00816789448833973,0.103042547893626,0.135060694287918,9.24824548102368e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN3,Ataxin-3,37388,0.0871705965017926,0.00598113278548661,0.0754475762422388,0.0988936167613463,9.41923022257616e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHD3,EH domain-containing protein 3,37043,0.166881044171315,0.0114695028767641,0.144400818532857,0.189361269809773,1.36527116280141e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0695728803063067,0.00478389547753247,0.060196445170343,0.0789493154422703,1.50673491385673e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK13,Kallikrein-13,39490,0.0598196789971171,0.00411651298104573,0.0517513135542675,0.0678880444399668,1.55896082155439e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP7,Caspase-7,37388,0.119396816163566,0.00823101451721225,0.10326402770983,0.135529604617302,2.52436498714696e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEPR,Leptin receptor,39868,-0.0436985723803548,0.00301527842983053,-0.0496085181028227,-0.037788626657887,2.69724045678147e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR2,GMP reductase 2,37124,0.09487202993153,0.00654295503766007,0.0820478380577162,0.107696221805344,2.78980881398041e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADD1,Alpha-adducin,37124,0.0975508742596137,0.00673361231596186,0.0843529941203285,0.110748754398899,3.34790654223446e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEXN,Nexilin,37445,0.0970192743026221,0.00671041058242214,0.0838668695610747,0.110171679044169,4.98324678299369e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.159478940453278,0.0110353721225382,0.137849611093103,0.181108269813453,5.56762947224138e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.118578988628521,0.00822336845528285,0.102461186456167,0.134696790800875,7.64132052507919e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPSE,Heparanase,37306,0.132481047730918,0.00918273360431329,0.114482889866464,0.150479205595372,7.80599666236904e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0768981120009467,0.00533532590952224,0.0664408732182831,0.0873553507836103,8.44294544484229e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE2,Glia-derived nexin,37437,0.0908202049223452,0.00629894902684334,0.0784742648297323,0.103166145014958,8.79287865639635e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.178167267334611,0.0123559050601354,0.153949693416746,0.202384841252477,8.79391744635227e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.112246789260071,0.00778865337185787,0.0969810286512292,0.127512549868912,9.91953912990987e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0433148365367664,0.00300873078256615,-0.0492119488705961,-0.0374177242029368,1.05910876168812e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPACT,Protein IMPACT,37388,0.0777440326043834,0.00540332485722522,0.0671535158842219,0.0883345493245448,1.3547521573304e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD22,B-cell receptor CD22,40058,0.0562592318052019,0.00391434215122724,0.0485871211887965,0.0639313424216073,1.4869487865792e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0502501518914252,0.00349549687049727,0.0433989780252506,0.0571013257575999,1.62047134234156e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0866227601921962,0.00603949814601897,-0.0984601765583933,-0.074785343825999,2.57776566401091e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D5,TBC1 domain family member 5,39866,0.108974998312477,0.00760578749256004,0.0940676548270595,0.123882341797895,2.83120409014577e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXJ3,Forkhead box protein J3,37056,0.0627218535964692,0.0043768558562174,0.0541432161182831,0.0713004910746553,3.14246924256981e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.137039969027703,0.00956403042162884,0.11829446940131,0.155785468654095,3.15555774866792e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED8,Protein TMED8,37382,0.144653209517875,0.0100973989730249,0.124862307530747,0.164444111505004,3.28891353969176e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM3,Junctional adhesion molecule C,37124,0.0705791191670661,0.00494032431686287,0.0608960835060149,0.0802621548281173,5.83642314586342e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0474023949640319,0.00332062132122406,0.0408939771744327,0.053910812753631,5.97305997562417e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4D,Semaphorin-4D,40009,0.0417314085897145,0.0029235303693057,0.0360012890658753,0.0474615281135536,6.02136254833044e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRADD,Death domain-containing protein CRADD,39713,0.106171108854007,0.0074522501798449,0.0915646985015109,0.120777519206503,8.98770084700859e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB1,Carboxypeptidase B,40052,0.0798475262198135,0.00560599357938913,0.0688597788042108,0.0908352736354162,9.33139496963547e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0667627549889563,0.00468501052044844,0.0575801343688774,0.0759453756090353,9.55246946466352e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0802875183292224,0.00563746010949596,0.0692380965146103,0.0913369401438344,9.74885146667855e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.108791090611805,0.00764093393391715,0.0938148601013274,0.123767321122283,1.01372158499284e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.119742073809091,0.00840506127997425,0.103268153700341,0.13621599391784,1.02531956260938e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.120616547636559,0.00847908768386698,0.103997535776179,0.137235559496938,1.23502547152703e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATOX1,Copper transport protein ATOX1,39913,0.101087311408577,0.00710878199567303,0.0871540986970581,0.115020524120096,1.30168844613604e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFB,Complement factor B,37220,0.0456890076553467,0.00322007481460653,0.0393776610187179,0.0520003542919755,2.29439342851116e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0411820798621304,0.00290465475025102,0.0354889565516384,0.0468752031726224,2.37589682810485e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.101535911080514,0.00715809925682876,0.0875060365371293,0.115565785623898,2.4354849358196e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0420552417985933,0.00296558541733923,0.0362426943806084,0.0478677892165782,2.54455388566863e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0862429853703983,0.00608228860792197,0.0743216996988712,0.0981642710419253,2.59207102670706e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0687356054622421,0.00485205314273573,-0.0782456296220041,-0.0592255813024801,2.78118141529394e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.090065820859117,0.00635447574501576,0.0776110483988861,0.102520593319348,2.85379948692273e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0850378424184298,0.00600595440271508,0.0732661717891082,0.0968095130477513,3.07914153084764e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0536400794920699,0.00378889544447038,-0.0610663145632319,-0.046213844420908,3.16117448491656e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0391595632101468,0.00276665165424882,0.0337369259678191,0.0445822004524745,3.31283308154882e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0658508211378489,0.00465239496612076,0.0567321270042523,0.0749695152714456,3.69066878779907e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.144139411761451,0.0102181729107346,0.124111792856411,0.164167030666491,7.33823105282776e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.136886826136409,0.00970797973570265,0.117859185854432,0.155914466418386,8.01007894617441e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0642011701631899,0.00455726216958927,0.0552689363107949,0.0731334040155849,9.34323071445642e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBXN1,UBX domain-containing protein 1,37124,0.0954971791021851,0.0067785650512944,0.082211191601648,0.108783166602722,9.44362060977085e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOD,Apolipoprotein D,36780,-0.0596953815128315,0.00423738010829426,-0.0680006465250882,-0.0513901165005747,9.6715886322946e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0601356867581171,0.00426956113815771,0.051767346927328,0.0685040265889063,9.87500790129541e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMT,Catechol O-methyltransferase,39403,0.116960511568759,0.00831025045458238,0.100672420677777,0.13324860245974,1.02894277705214e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF19,Fibroblast growth factor 19,39931,0.105152086257024,0.00747358793671679,0.0905038539010595,0.119800318612989,1.07216173086479e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18,Interleukin-18,39795,0.0625316412244762,0.00444749388070988,0.0538145532182849,0.0712487292306676,1.23668033872716e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP10,Caspase-10,39489,0.0980797925847373,0.00698192432585613,0.0843952209060592,0.111764364263415,1.485725036837e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,APP,Amyloid-beta precursor protein,39829,0.0913171846371487,0.00650175590680987,0.0785737430598014,0.104060626214496,1.52189425082443e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTNB,Dystrobrevin beta,37348,0.0602860477163344,0.00429046157599306,0.051876743027388,0.0686953524052808,1.56079984366228e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0919718140216151,0.00654621007535785,0.0791412422739137,0.104802385769316,1.61030640655287e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0928278717264489,0.00661123277208296,0.0798698554931663,0.105785887959732,1.7940146211609e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0774226647480996,0.00551950639927299,0.0666044322055245,0.0882408972906746,1.95618210622852e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.109303691691112,0.00778890894983922,0.0940374301494274,0.124569953232797,2.03666771182559e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL32,Interleukin-32,39866,-0.0586094581417642,0.00418024664859157,-0.0668027415730036,-0.0504161747105247,2.13593535055154e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIFBP,KIF-binding protein,39788,0.113526018754967,0.00809895836618343,0.0976520603572477,0.129399977152687,2.24021067146354e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.116890654926967,0.00833829725079596,0.100547592315406,0.133233717538527,2.44938648904412e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6AP2,Renin receptor,39477,0.0556604001758628,0.00397867683134619,0.0478621935864242,0.0634586067653013,3.33130470875335e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCB,Tubulin-folding cofactor B,39749,0.138002618174082,0.00989460024124437,0.118609201701243,0.157396034646921,5.93652932550588e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.097283835488538,0.00697742948381274,0.083608073700265,0.110959597276811,6.29255852043022e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.069452999258329,0.00497941429334782,0.0596933472433672,0.0792126512732907,6.51945911610946e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0768602239282989,0.0055171281230032,0.0660466528072126,0.0876737950493852,7.4911875451402e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMNL1,Formin-like protein 1,39489,0.0829377291980883,0.00595468318806723,0.0712665501494765,0.0946089082467,7.810332779163e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TADA3,Transcriptional adapter 3,37368,0.053852378062346,0.00386629257593587,0.0462744446135117,0.0614303115111803,8.51542307053653e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0835151396886155,0.00599649302020044,0.0717620133690227,0.0952682660082084,8.65997145090994e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.149296987514736,0.0107283912883829,0.128269340589506,0.170324634439967,9.11766244670489e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0546916589793663,0.00393103377876081,0.0469868327729951,0.0623964851857375,9.58123995284024e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMA,Granzyme A,40058,0.0459050309330917,0.00330066677568915,0.039435724052741,0.0523743378134425,1.01318697841045e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.12556249512771,0.00904328468021221,0.107837657154494,0.143287333100926,1.40506563177858e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.0433929928919635,0.00312408508119539,0.0372697861328205,0.0495161996511064,1.4785759091366e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0441693570742727,0.003188188625683,0.037920507367934,0.0504182067806114,2.14012142483374e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0359310736340222,0.00259757179732474,0.0308398329112657,0.0410223143567787,2.87720251370051e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0614781733115621,0.00444482370965152,0.0527663188406452,0.0701900277824791,2.9156237821438e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.0937616251917795,0.00677728848084513,0.0804781397693231,0.107045110614236,3.14203130335495e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0906748100650274,0.00655750919833636,0.0778220920362881,0.103527528093767,3.47937741838423e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA1,Carboxypeptidase A1,40052,0.0797843422294702,0.00577517603661131,0.068464997197712,0.0911036872612284,3.63464054882045e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.135773793281199,0.00983552422799897,0.116496165794321,0.155051420768077,4.23212856152854e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0774700136993679,0.00561198920526946,0.0664705148570398,0.0884695125416961,4.25277214117464e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSS,Cathepsin S,36543,0.0330092674309315,0.00239030383604067,0.0283242719122918,0.0376942629495712,4.56665761595013e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2,Complement C2,39908,0.0318036414767445,0.00230667948656308,0.0272825496830809,0.0363247332704081,5.31998031468323e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNMT,Histamine N-methyltransferase,39669,0.062208581538929,0.00451413788761436,0.0533608712792049,0.0710562917986532,5.88838427316883e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.0783348465667628,0.00569313787918821,0.0671762963235539,0.0894933968099717,8.66878058443853e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0886998140035769,0.00645877510013638,0.0760406148073096,0.101359013199844,1.13189518366282e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.090854397793549,0.00661887289511059,0.0778814069191322,0.103827388667966,1.21943309600354e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.144779503400082,0.0105436126471544,0.124114022611659,0.165444984188504,1.27099713792423e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMVK,Phosphomevalonate kinase,39480,0.148902592047188,0.0108546541445387,0.127627469923892,0.170177714170484,1.40111390662359e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.103984227716099,0.00758639878553647,0.0891148860964476,0.118853569335751,1.61030757121079e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0596376527747326,0.00435416451262077,-0.0681718152194693,-0.0511034903299959,1.83505668883323e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACYBP,Calcyclin-binding protein,37088,0.138897488960974,0.010138570741507,0.119025890307621,0.158769087614328,1.9796988945085e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0421556385579782,0.00307995855610777,0.0361189197880069,0.0481923573279494,2.10722186164184e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM106A,Transmembrane protein 106A,37368,0.0951485852365917,0.00695408675344273,0.0815185751998439,0.108778595273339,2.47676137110113e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.071498197589762,0.00522664312821855,0.0612539770584536,0.0817424181210703,2.63744055318774e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX4,Syntaxin-4,39788,0.0789834389745483,0.00578382727185593,0.0676471375217107,0.090319740427386,3.21800580338423e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.117133450224987,0.00857670487202686,0.100323108675814,0.13394379177416,3.475612566601e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB6,Serpin B6,39970,0.0802478983682747,0.00587970796390493,0.0687236707590211,0.0917721259775284,3.54729084483221e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0823641663076038,0.00604023952923537,0.0705252968303025,0.0942030357849051,4.72212353712549e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP7,Matrilysin,39563,0.0657552837404572,0.00483144698884925,0.0562856476423127,0.0752249198386017,6.0522187874293e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.14993696995601,0.0110197669710098,0.128338226692831,0.171535713219189,6.37647378224317e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7,Interleukin-7,39866,0.0865635049441868,0.00636898671691629,0.0740802909790309,0.0990467189093428,7.68631945037439e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0398725562137936,0.00293444019439407,-0.045624058994806,-0.0341210534327812,8.05864209916624e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0423517071755036,0.00311695601643747,0.0362424733832861,0.048460940967721,8.06460624499472e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB1,Heat shock protein beta-1,39617,0.092299043689671,0.00680753742773582,0.0789562703313088,0.105641817048033,1.21054853542576e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0859869915088336,0.00634189042812573,0.0735568862697071,0.09841709674796,1.3182340502335e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.0964912510623925,0.00712209122091023,0.0825319522694085,0.110450549855377,1.51193811162912e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.158110882603812,0.0116698809204208,0.135237915999788,0.180983849207837,1.52505373367484e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0473381812127019,0.00349853174302671,0.0404810589963695,0.0541953034290342,1.74015938571306e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRL,Appetite-regulating hormone,39868,0.101267639209952,0.00749207744482637,0.0865831674180919,0.115952111001811,2.1048523332354e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.127083842452866,0.00940304797210806,0.108653868427534,0.145513816478198,2.14855772057083e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0587426449300321,0.00434973333000418,0.050217167603224,0.0672681222568403,2.75126474386276e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0316317142047904,0.00234270335482214,0.027040015629339,0.0362234127802418,2.80131990540072e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,LARP1,La-related protein 1,37368,0.0844789640752391,0.00625865510701072,0.0722120000654981,0.0967459280849801,2.97603468366079e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREH,Trehalase,37437,0.0992913021383219,0.00735992911787393,0.0848658410672889,0.113716763209355,3.26468618969101e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTF1,Cardiotrophin-1,39585,0.11175178139544,0.00829208257657453,0.0954992995453535,0.128004263245526,3.61902893085409e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,YWHAQ,14-3-3 protein theta,37124,0.0976791818294055,0.00725552595312685,0.0834583509612769,0.111900012697534,4.81929091491723e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0295502590620414,0.00219566912844192,0.0252467475702952,0.0338537705537875,5.10403247926072e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.124108925351843,0.00924575798667586,0.105987239697958,0.142230611005727,8.06022260514654e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.133970849958437,0.0100021881881608,0.114366561109642,0.153575138807232,1.20590881187374e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM3,Dynamin-3,37411,0.0717178358152499,0.00535744518349845,0.061217243255593,0.0822184283749069,1.31192743702484e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0488270664660361,0.00365094190764391,0.0416712203270541,0.0559829126050182,1.43272866331047e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MENT,Protein MENT,37124,-0.0290429550299212,0.00217165331711192,-0.0332993955314606,-0.0247865145283819,1.57719879371817e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL3,C-C motif chemokine 3,39866,0.0819590453344212,0.00613265928855956,0.0699390331288445,0.093979057539998,1.61058203396826e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0812546104660504,0.00608583096312288,0.0693263817783295,0.0931828391537712,2.08867512721958e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0490570787226083,0.00367964559298169,0.0418449733603642,0.0562691840848524,2.70949605784233e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDT,D-dopachrome decarboxylase,37437,0.0522504042788122,0.00392184066967078,0.0445635965662574,0.0599372119913669,3.04641329229868e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.088484306455362,0.0066500594186788,0.0754501899947515,0.101518422915972,3.50157751410741e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0534129978910836,0.0040158352129192,0.045541960873762,0.0612840349084053,3.74366302747352e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0865156613396078,0.00650644665613634,0.0737630258935806,0.099268296785635,3.93796307831432e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0545759882671968,0.00410394052214136,0.0465322648437997,0.0626197116905938,4.22284507813998e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,THTPA,Thiamine-triphosphatase,37345,0.114672069857865,0.00862570828554248,0.0977656816182015,0.131578458097528,4.46877962118633e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0965824464586608,0.00727594813647539,0.082321588111169,0.110843304806153,5.37860292860813e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0611686767152404,0.00461393898776751,0.0521253562992161,0.0702119971312648,6.61107204639742e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP2,Caspase-2,39866,0.0883504280621174,0.00667620533049531,0.0752650656143466,0.101435790509888,9.07702608164432e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0467082011019869,0.00353334066539532,0.0397828533978121,0.0536335488061618,1.09487571301618e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.066737484703066,0.00504865562640134,0.0568421196753193,0.0766328497308126,1.21962062409878e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0607184802191971,0.00459468959223504,0.0517128886184164,0.0697240718199778,1.26508627498167e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0861173180219003,0.00651811404436769,0.0733418144949396,0.0988928215488609,1.3365458423243e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0551784316299112,0.00417949382387513,0.0469866237351159,0.0633702395247064,1.36513948684197e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0765590525536184,0.00579975565362117,0.0651915314725209,0.0879265736347159,1.40033130963242e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.115457359571109,0.00874703218823174,0.0983131764821744,0.132601542660043,1.42213510546677e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,POSTN,Periostin,37437,-0.0479271052733931,0.00363091905003061,-0.0550437066114531,-0.0408105039353331,1.5426512122364e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.14450442180994,0.0109760873669412,0.122991290570735,0.166017553049145,2.21972773248882e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0818677123607076,0.00621949053736541,0.0696775109074714,0.0940579138139438,2.28104145565788e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL8,C-C motif chemokine 8,40003,0.0776330566707352,0.00589775859143725,0.0660734498315182,0.0891926635099523,2.28113168566646e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0826717233350718,0.00627985108067733,0.0703632152169442,0.0949802314531994,2.47480632967126e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.11871114602599,0.00903726198241097,0.100998112540464,0.136424179511515,3.61944530842796e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2R,Proteinase-activated receptor 1,39908,0.0749518329916903,0.00571027588456252,0.0637596922579478,0.0861439737254329,3.72885504012076e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0605422220858535,0.00460994154725201,0.0515067366532396,0.0695777075184674,3.75270355941572e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0608087572238005,0.00463506267655596,0.0517240343777508,0.0698934800698502,4.41113175763939e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL2,C-C motif chemokine 2,39720,0.0659143729235987,0.00504788437757455,0.0560205195435526,0.0758082263036448,9.08704478505276e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.127672856354646,0.00977948929830877,0.108505057329961,0.146840655379331,1.017551757816e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.076921127736216,0.00590079790638519,0.0653555638397011,0.088486691632731,1.21935665786106e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB9,Serpin B9,39749,0.0425710281344765,0.0032668798562891,0.0361679436161498,0.0489741126528031,1.28447101889631e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICALL2,MICAL-like protein 2,37039,0.0865930364238655,0.00664274381742675,0.0735732585417091,0.0996128143060219,1.32746648840415e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0779678887184778,0.00598139755206299,0.0662443495164344,0.0896914279205213,1.33904860427011e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIAPIN1,Anamorsin,39913,0.0803797995804011,0.00617203281901884,0.0682826152551242,0.0924769839056781,1.41585377755739e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164,Sialomucin core protein 24,39858,0.0333457567492196,0.00256184700542933,0.0283245366185781,0.0383669768798611,1.551351610839e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0431356160432049,0.00331595837004039,0.0366363376379257,0.049634894448484,1.73029453721432e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0568952561756692,0.00437697736191952,0.0483163805463069,0.0654741318050315,1.96810374067951e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0654202851827832,0.00504806495119278,0.0555260778784453,0.075314492487121,3.23339921801222e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.109246118473651,0.00843022338946004,0.0927228806303094,0.125769356316993,3.26576251709796e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.069648385035122,0.00537430381892418,0.0591147495500306,0.0801820205202134,3.50471534032002e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,UMOD,Uromodulin,40012,-0.0666817513496002,0.00515024841106433,-0.0767762382352863,-0.0565872644639141,3.76836042598902e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRB1,Chymotrypsinogen B,39858,0.0675758085333071,0.00522376776858007,0.0573372237068901,0.077814393359724,4.36411914977274e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH9,Protocadherin-9,37382,0.0420112276659547,0.00324690285613908,0.0356472980679221,0.0483751572639873,4.56914906591858e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.12291345197648,0.00950178756172703,0.104289948355495,0.141536955597465,4.81447674836132e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.112541092388887,0.00870413856864682,0.0954809807943391,0.129601203983435,5.13552308910773e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0467061288849126,0.00361401997855899,0.039622649726937,0.0537896080428882,5.17314094642285e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MESD,LRP chaperone MESD,39858,0.153771547794181,0.0119361989380134,0.130376597875675,0.177166497712687,8.67202853203064e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.07739625201972,0.00600769201420071,0.0656211756718866,0.0891713283675534,9.35341741377689e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3C,Protein FAM3C,39846,0.0363800013027822,0.00282851172638489,0.0308361183190678,0.0419238842864966,1.13397392203596e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA2,Carboxypeptidase A2,39933,0.0810045870795246,0.00629847212165746,0.068659581721076,0.0933495924379732,1.14444150603962e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0626985395955329,0.0048750090033893,0.0531435219488898,0.0722535572421759,1.14677497132908e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.100924975191512,0.00784755576215914,0.0855437658976806,0.116306184485344,1.26017403162562e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0857294173031931,0.00667005606091858,0.0726561074237927,0.0988027271825936,1.28548827763559e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMTN,Smoothelin,37342,0.121047203295059,0.00941552170594973,0.102592780751398,0.139501625838721,1.32117222891799e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0856458861541958,0.00666556436371138,0.0725813800013215,0.0987103923070701,1.33794306165008e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP3,Caspase-3,40052,0.111667009948813,0.00869452193038736,0.0946257469652536,0.128708272932372,1.4293699605877e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO3,Forkhead box protein O3,39477,0.122598536954636,0.00954613150703218,0.103888119200853,0.141308954708419,1.4633528369547e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.118868919104021,0.0092703416299137,0.10069904950939,0.137038788698652,1.87945048393427e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN4,Cerebellin-4,40030,0.0388508235067729,0.00303036839110506,0.032911301460207,0.0447903455533388,1.91589932488664e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL1,Growth-regulated alpha protein,39839,0.118946141669485,0.00927827466940974,0.100760723317442,0.137131560021528,1.94126087719825e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0661147268464245,0.00515718313091662,0.0560066479098279,0.0762228057830211,1.95847698604712e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0714217628006842,0.00557244507638967,0.0604997704509604,0.0823437551504079,2.20268673664179e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.124515753449853,0.00972191926829248,0.105460791684,0.143570715215707,2.44302836350754e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.123547020227391,0.00964801596106733,0.104636908943699,0.142457131511083,2.51326345624532e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0499676384715318,0.00390383706598494,0.0423161178222013,0.0576191591208623,2.70616370497166e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CERT,Ceramide transfer protein,39489,0.0770944662919691,0.00602712298821307,0.0652813052350715,0.0889076273488667,2.82191220493056e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0356748368531301,0.00278971387727736,0.0302069976536664,0.0411426760525937,3.13756353905651e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.0972482855441644,0.00760894671334604,0.0823347499860062,0.112161821102323,3.19201455935956e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1R,Complement C1r subcomponent,37453,0.0241490503666109,0.00188927950416824,0.0204460625384412,0.0278520381947807,3.3774939845703e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRGN,Neurogranin,37445,0.114430411333195,0.00895636284183132,0.0968759401632051,0.131984882503184,3.63266548210264e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0574206136277714,0.00449580985838875,0.0486088263053294,0.0662324009502133,3.89941393894512e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.110153034607946,0.00862595114979678,0.0932461703543446,0.127059898861548,3.95316229928733e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.068731729937319,0.00538532248792774,0.0581764978609806,0.0792869620136573,4.05470919200797e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.113713473023802,0.00890657420905611,0.0962565875740519,0.131170358473552,4.13518965608408e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0817761709713105,0.0064106390359702,0.0692113184608089,0.0943410234818121,4.34094879113105e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID1,Nidogen-1,39892,0.0468040653574652,0.00366938983984989,0.0396120612713594,0.053996069443571,4.41236722853861e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMFG,Glia maturation factor gamma,37437,0.0896854740635256,0.0070390324671897,0.0758889704278338,0.103481977699217,5.68401638742363e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0962598423332321,0.00756107778450589,0.0814401298756006,0.111079554790864,6.47867986792412e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0716399010421589,0.00563564807225192,0.0605940308205451,0.0826857712637726,7.65316341943793e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0551293604951469,0.00434223823989167,0.0466185735449592,0.0636401474453346,9.37882921069682e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.11774226451734,0.00927611009510596,0.0995610887309322,0.135923440303748,9.74208735278626e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12A_IL12B,Interleukin-12,39788,0.0912609218735953,0.00719294948845086,0.0771627408762316,0.105359102870959,1.04346845774122e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0666848145472912,0.00525370632012139,0.0563875501598533,0.0769820789347291,1.04807612265143e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0955686197621797,0.00754209044358141,0.0807861224927602,0.110351117031599,1.3923364867534e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.065992595019439,0.00521193891147931,0.0557771947529396,0.0762079952859385,1.56573744026399e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0802857083075018,0.00634694834770815,0.0678456895459938,0.0927257270690098,1.83504065569555e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0367590210504769,0.00290708234322302,0.0310611396577598,0.042456902443194,1.93319804365134e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP5,Platelet glycoprotein V,37124,0.0446591954361127,0.00353814308849023,0.0377244349826718,0.0515939558895535,2.57558392889195e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.100980980566321,0.00801344832393637,0.085274621851406,0.116687339281237,3.0811982725109e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,WDR46,WD repeat-containing protein 46,37368,0.0444053570776959,0.00352471643556225,0.0374969128639939,0.0513138012913979,3.44743624454822e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD72,B-cell differentiation antigen CD72,37124,0.051056054127364,0.00405997231766368,0.0430985083847432,0.0590135998699848,4.62584061595988e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3,Galectin-3,39901,0.0362095875895073,0.00288261845988075,0.030559655408141,0.0418595197708736,5.08852437348572e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0344084630385967,0.00274087579094808,0.0290363464883385,0.039780579588855,5.58742132524328e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.155818087475165,0.0124169873194298,0.131480792329082,0.180155382621247,6.39258740169397e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTF2,Transcription termination factor 2,37039,0.0602585433545564,0.00480642695950988,0.0508379465139171,0.0696791401951958,7.49347038060645e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGT1,Protein SGT1 homolog,39477,0.0992688790323244,0.00792716727802442,0.0837316311673965,0.114806126897252,8.3437798651665e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0860404777247989,0.00687654205268433,0.0725624553015377,0.0995185001480602,1.02252252552035e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0588228089102325,0.00470851421463318,0.0495941210495515,0.0680514967709135,1.28208603070522e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSL,Cathepsin L1,39868,0.029132058134831,0.00233440151764166,0.0245566311602533,0.0337074851094086,1.41489051823171e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0514705501512499,0.00412256486670722,0.0433903230125037,0.059550777289996,1.42684025047291e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0416825187213053,0.00334345266743248,0.0351293514931376,0.0482356859494729,1.66939832762213e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0792779925260061,0.00636109476033459,0.0668102467957503,0.0917457382562619,1.86154951102355e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0604337789342626,0.00484953826824899,0.0509286839284946,0.0699388739400306,1.92984661950938e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.100432161555545,0.00806773598612368,0.0846193990227421,0.116244924088347,2.21933140825445e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0411217500491628,0.00331076794824112,0.0346326448706102,0.0476108552277154,2.92720965050939e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRD2,Protein ZNRD2,37382,0.0821552394566982,0.00663755678220362,0.0691456281635791,0.0951648507498173,5.36294733250004e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0694119775868058,0.00560995643642758,0.0584164629714078,0.0804074922022039,5.71769833610263e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0711792259836563,0.00575613971080122,0.0598971921504859,0.0824612598168266,5.83370270039052e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.135742999287311,0.0109918261430038,0.114199020047024,0.157286978527599,7.11630089335834e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0363522456010411,0.00294993517694901,0.030570372654221,0.0421341185478611,9.75172929828924e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF2,Growth/differentiation factor 2,39868,0.0424353390042868,0.00344914648401425,0.0356750118956189,0.0491956661129547,1.24903072656953e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.145141900086115,0.0118007494297558,0.122012431203794,0.168271368968437,1.30618493961808e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0908826823380384,0.00739688052434748,0.0763847965103173,0.105380568165759,1.62999458120503e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP6,Platelet glycoprotein VI,39836,0.106455138819813,0.00867472393135658,0.089452679914354,0.123457597725272,1.83336716369506e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTD,Deoxycytidylate deaminase,37124,0.115002999519585,0.0093675611506683,0.0966425796642751,0.133363419374895,1.85783069189289e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF23,Fibroblast growth factor 23,40008,0.0699942207631658,0.0057096568463521,0.0588032933443157,0.0811851481820159,2.1401234059835e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0472363645978643,0.00385528079985968,0.0396800142301394,0.0547927149655893,2.34587858744232e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0521338349604366,0.00425585923120974,0.0437923508672655,0.0604753190536077,2.58475507349349e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0565678076698429,0.00461948095263377,0.0475136250026808,0.0656219903370051,2.73163466238303e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMMT,MICOS complex subunit MIC60,37368,0.0524797598637024,0.00428910892020408,0.0440731063801024,0.0608864133473024,3.04550083778723e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0689945138461565,0.00564263524883571,0.0579349487584385,0.0800540789338744,3.1641933386705e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.103217160276614,0.0084421097539443,0.086670625158883,0.119763695394345,3.43662202303269e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARK7,Parkinson disease protein 7,39858,0.0626810434551824,0.00513127857351408,0.0526237374510948,0.07273834945927,3.64817612693049e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB1,Beta-crystallin B1,37437,0.0795179577755152,0.00650728591856947,0.066763677375119,0.0922722381759113,3.68149741022082e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0388606243215214,0.0031836138270614,0.0326207412204811,0.0451005074225617,4.07857762288431e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGR1,Prostaglandin reductase 1,37437,0.0950149268865727,0.00778434900195956,0.079757602842732,0.110272250930413,4.36167988435835e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.0931363264255719,0.00764058391507183,0.0781607819520311,0.108111870899113,5.31461982359201e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0317892337032413,0.00261106534712308,0.02667154562288,0.0369069217836025,5.95743156571786e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAP,Prolyl endopeptidase FAP,40052,0.032478556788613,0.00266772706373276,0.0272498117436967,0.0377073018335292,5.97237709328704e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAP3,Cytosol aminopeptidase,39587,0.0579233090585832,0.00475915839177327,0.0485953586107076,0.0672512595064588,6.31002953426068e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBI,Acyl-CoA-binding protein,39793,0.0951643803078511,0.00782089458723131,0.0798354269168777,0.110493333698824,6.51046382120745e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0780083644926039,0.0064192959338047,0.0654265444623467,0.0905901845228611,7.94027549990819e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0994797085161943,0.00818898629524598,0.0834292953775121,0.115530121654876,8.27400511212517e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA3,Annexin A3,39985,0.0828422074806637,0.00682867527681171,0.0694580039381127,0.0962264110232147,1.00849403832226e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.104741568314669,0.00863168714143582,0.0878234615174553,0.121659675111884,1.04538846418177e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0568533310464199,0.00468786108141514,0.0476651233268462,0.0660415387659936,1.1367832727959e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.071948761504331,0.00593531014103581,0.0603155536279008,0.0835819693807612,1.21402867440888e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC3B,Tetranectin,37138,0.0250298469465989,0.00206965939041392,0.0209733145413876,0.0290863793518102,1.71011467558818e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB2,Calretinin,39489,0.0344867745465656,0.0028546883714829,0.0288915853384591,0.040081963754672,1.881649499628e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOF,Apolipoprotein F,37445,-0.0305617460087479,0.00252973052436601,-0.0355200178365052,-0.0256034741809905,1.97401502175719e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0475037466408787,0.00393348845942291,0.0397941092604098,0.0552133840213476,2.0812342923542e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLMH,Bleomycin hydrolase,40052,0.0377496234386758,0.00312877063381817,0.0316172329963922,0.0438820138809594,2.23923459293158e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,RP2,Protein XRP2,39788,0.0492244272479229,0.00408038634424242,0.0412268700132078,0.057221984482638,2.29667861055755e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0817793620479272,0.0067910890194911,0.0684688275697246,0.0950898965261297,3.18850635830992e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0453548471497075,0.00376793463597161,0.0379696952632032,0.0527399990362119,3.35088054399198e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSNAX,Translin-associated protein X,37021,0.0461325201524674,0.00383583642241393,0.0386142807645361,0.0536507595403987,3.83662762723834e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0487808620636095,0.00406065707375767,0.0408219741990445,0.0567397499281746,4.22190917129038e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0538757478674653,0.00448567427719928,0.0450838262841547,0.0626676694507759,4.64856740540173e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMSB10,Thymosin beta-10,39858,0.0907310627954481,0.00755829070611473,0.0759168130114632,0.105545312579433,4.68481318013079e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0869403348715802,0.00724478688021812,0.0727405525863527,0.101140117156808,5.19351478845077e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPPK1,Epiplakin,37043,0.0873740060933604,0.00729607205425973,0.0730737048670113,0.101674307319709,7.07302318538631e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0682835805571877,0.00570693486430879,0.0570979882231425,0.0794691728912329,7.55566723140051e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0754015196526428,0.00630265069317359,0.0630483242940225,0.087754715011263,7.68145857001666e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0575911006143739,0.00481928850122844,0.0481452951519662,0.0670369060767817,9.46860588822879e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.115685675206966,0.00968069289372905,0.0967115171352574,0.134659833278675,9.47410631650364e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.034961975324104,0.00293038018031637,0.0292184301706839,0.0407055204775241,1.13089171254746e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.10295525270252,0.00863084759754926,0.0860387914113235,0.119871713993717,1.1514413401742e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB10,Ras-related protein Rab-10,37437,0.0623205849404782,0.00523505736020042,0.0520598725144854,0.072581297366471,1.62792173806662e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0859131098886071,0.00722719720040852,0.0717478033758064,0.100078416401408,2.00615589010204e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBN,Nibrin,39587,0.0598501617405165,0.00504165918107443,0.0499685097456106,0.0697318137354224,2.29863933883051e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0706115864028252,0.00595497345510974,0.0589398384308101,0.0822833343748403,2.68366789578536e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.126764002916641,0.0106918670711978,0.105807943457093,0.147720062376189,2.94603069708834e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBN1,Drebrin,37056,0.0606790141250639,0.00512489408701497,0.0506342217145146,0.0707238065356132,3.52535060113269e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0458435433292901,0.00387708867228646,0.0382444495316087,0.0534426371269716,4.00295656502091e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0734229577141689,0.00621398758859125,0.06124354204053,0.0856023733878077,4.39906588034454e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.141518585738689,0.0119863129150319,0.118025412425227,0.165011759052152,4.89602187291534e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0573438571969065,0.00486010602584639,0.0478180493862476,0.0668696650075654,5.36684901103019e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPH,Hephaestin,37437,0.0303614551222165,0.00257451775264631,0.0253154003270297,0.0354075099174032,6.06774302743151e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0884822473166548,0.00750511426938206,0.073772223348666,0.103192271284644,6.32961147661672e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0347358614828361,0.00294639317620651,0.0289609308574714,0.0405107921082009,6.34094993841818e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.101696884637573,0.00863256642896282,0.0847770544368056,0.11861671483834,7.03726885224042e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.068269960399734,0.00579713435385237,0.0569075770661833,0.0796323437332846,7.03742247189154e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.117961279376803,0.0100178618463409,0.0983262701579751,0.137596288595631,7.50467630714291e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0359693521626724,0.0030575159372986,0.0299766209255671,0.0419620833997776,8.03967950423573e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0678927293169143,0.00578279633977212,-0.0792270101428676,-0.0565584484909609,1.06312373343443e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0316637793731133,0.00269915959718956,0.0263734265626218,0.0369541321836049,1.19552805730663e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ING1,Inhibitor of growth protein 1,39453,0.0516795405463027,0.00440614015518742,0.0430435058421353,0.06031557525047,1.22956019831637e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0612258975431727,0.00522138972918955,0.0509919736739612,0.0714598214123842,1.27299744387443e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0412255926881089,0.00353020243496659,0.0343063959155744,0.0481447894606434,2.20689350795272e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPT,Dermatopontin,40052,0.0306091843373646,0.00262149568891818,0.0254710527870849,0.0357473158876442,2.25236067889329e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0685191199805136,0.00586774231631844,0.0570183450405294,0.0800198949204977,2.37803363501799e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASS1,Argininosuccinate synthase,37021,0.0912929725354686,0.00782044854170326,0.0759648933937303,0.106621051677207,2.48068448390497e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,GET3,ATPase GET3,37437,0.0638746782971464,0.00547694150111379,0.0531398729549634,0.0746094836393294,2.79398815330609e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF6,SLAM family member 6,39477,0.0430462180441356,0.00369312932839878,0.035807684560474,0.0502847515277972,2.88942580070502e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0498644008715967,0.00427805453545677,0.0414794139821014,0.0582493877610919,3.0225518839441e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0437356893108917,0.00375892049812953,0.0363682051345578,0.0511031734872256,3.84141746522535e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0326785953179772,0.00281447670084463,0.0271622209843217,0.0381949696516327,4.86497100306244e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPLAH,5-oxoprolinase,37043,0.0788099545509804,0.00678640494453211,0.0655086008596975,0.0921113082422633,5.0161629882987e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD83,CD83 antigen,39866,0.037234342376007,0.00320931459267299,0.0309440857743679,0.043524598977646,5.35870169381169e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADM,Pro-adrenomedullin,40030,0.0298520960139498,0.00257490750108865,0.024805277311816,0.0348989147160836,5.8961226198243e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCA,Calcitonin,39713,0.0691069745904913,0.00596191528086194,0.0574216206400019,0.0807923285409807,6.0722893934495e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFASC,Neurofascin,40058,0.0313751202595449,0.00270876632196317,0.0260659382684971,0.0366843022505927,6.66700380285565e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.100520133304997,0.00867787188850101,0.0835115044035346,0.117528762206459,6.6695027251475e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMD,Dystrophin,37043,0.0587059965857755,0.00506798374474192,0.0487727484460814,0.0686392447254697,7.03275271462229e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,C4BPB,C4b-binding protein beta chain,39913,0.044924568166358,0.00388035149296331,0.0373190792401499,0.0525300570925661,7.11137355252705e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0693948345530989,0.00599520567256636,0.0576442314348689,0.081145437671329,7.32706709109903e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0865974774736537,0.00748447713122635,0.0719279022964501,0.101267052650857,7.78993098552532e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0768281496954057,0.00664388492024866,0.0638061352517183,0.0898501641390931,8.33252758323228e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0514323859028147,0.00444940572271043,0.0427115506863023,0.0601532211193272,9.23054211774637e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0300442586830492,0.00260756510886627,-0.0351550862964271,-0.0249334310696713,1.34917203776595e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,XCL1,Lymphotactin,40030,0.0617731552640732,0.00536523678959932,0.0512572911564585,0.0722890193716879,1.48244281037239e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.033819039889491,0.00293776034571451,0.0280610296118906,0.0395770501670915,1.51701407737004e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0416969236005022,0.00362152541616841,0.0345987337848121,0.0487951134161923,1.57287491102224e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0211750897920701,0.00183971634101835,0.0175692457636741,0.0247809338204661,1.62840824036092e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0979664082184977,0.00851570355509937,0.081275629250503,0.114657187186492,1.74141786307416e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0409437923798932,0.00356401105703397,0.0339583307081066,0.0479292540516798,2.11282774815916e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0760384297262162,0.00663262568560405,0.0630384833824323,0.0890383760700002,2.77553382937943e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF2,Fibroblast growth factor 2,39866,0.0747193046733553,0.00652131224789716,0.0619375326674769,0.0875010766792337,2.82314587508461e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.050743137936851,0.00442895267118812,0.0420623907013222,0.0594238851723797,3.00971418430867e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.044219303894859,0.00386780877851044,0.0366383986889785,0.0518002091007394,3.76951701769834e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH7,Protocadherin-7,37382,0.0375344812899375,0.00328515761656513,0.0310955723614698,0.0439733902184051,4.28666880474451e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL26,C-C motif chemokine 26,39866,0.0953760033694777,0.00837091937874128,0.0789690013871448,0.111783005351811,5.86156221660575e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL25,C-C motif chemokine 25,40058,0.0555503662652318,0.00487573160537355,0.0459939323186997,0.065106800211764,5.87617620565689e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0844923526466792,0.00742288919050126,0.0699434898332967,0.0990412154600616,6.97667552231841e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0794552928395097,0.00698449600736893,0.0657656806650666,0.0931449050139528,7.52095378229847e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC79,Protein unc-79 homolog,36962,0.0627872365137192,0.00552037742822204,0.051967296754404,0.0736071762730344,7.80071486859381e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0588972519861893,0.00518667701980098,0.0487313650273793,0.0690631389449992,9.09629250297773e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.134176768101768,0.0118224220602874,0.111004820863605,0.157348715339932,9.70752244247284e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCA,Tubulin-specific chaperone A,37124,0.0959760521998373,0.00846445548235661,0.0793857194544183,0.112566384945256,1.15539087613019e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL24,C-C motif chemokine 24,39908,0.0913429893768662,0.00806902365029504,0.0755277030222879,0.107158275731444,1.34966524232315e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0693305844343588,0.00613590498947522,0.0573042106549874,0.0813569582137302,1.79625149035439e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0595710036446585,0.00527609658121319,0.0492298543454807,0.0699121529438364,1.88674359391042e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0721222981257706,0.0064045229970063,0.0595694330516382,0.0846751631999029,2.64216201265001e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0614111424866209,0.00545436787010691,0.0507205814612114,0.0721017035120305,2.83032053683105e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0492820265629947,0.00438241927627463,0.0406924847814965,0.057871568344493,3.31290962151073e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0741247595711154,0.00659161193821549,0.061205200172213,0.0870443189700177,3.31706797169919e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0477925882067462,0.00425799424268181,0.0394469194910899,0.0561382569224026,4.20292893572508e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.131584240387952,0.0117499173607836,0.108554402360816,0.154614078415087,5.29965316674798e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0987710089341531,0.00882167158206749,0.0814805326333009,0.116061485235005,5.73493309155867e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAP,Prosaposin,37347,0.0306248748890462,0.00273818451744617,0.0252580332348518,0.0359917165432407,6.51817032338254e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFP,Alpha-fetoprotein,39699,0.0738864128056044,0.00661038150004093,0.0609300650655241,0.0868427605456846,6.75357903949558e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0524089655663815,0.0046918123639097,0.0432130133331184,0.0616049177996445,7.62083108915382e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0570024456789973,0.00512027587444583,0.0469667049650835,0.0670381863929111,1.10523955200449e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40LG,CD40 ligand,40058,0.0846497686235323,0.00761145664771979,0.0697313135940015,0.0995682236530631,1.25375786604762e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0455150535495154,0.00409283672156771,0.0374930935752427,0.0535370135237881,1.2729595382796e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0773906227589637,0.00695721859722467,0.0637544743084033,0.0910267712095241,1.2796388195007e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1B,Meprin A subunit beta,39868,0.125055554658776,0.0112693218811654,0.102967683771692,0.14714342554586,1.64837783877988e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA13,Carbonic anhydrase 13,39657,0.114494669852043,0.0103239970053638,0.09425963572153,0.134729703982556,1.78403433567143e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3B,Protein FAM3B,39788,0.0389156405742408,0.00351029159257878,0.0320354690527864,0.0457958120956952,1.86113859286628e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP1,Guanylate-binding protein 1,37376,0.0687318539173474,0.00622218415381171,0.0565363729758765,0.0809273348588184,3.01854874653194e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0593461299547045,0.00537254712135872,0.0488159375968414,0.0698763223125676,3.04229107018849e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.119336039499878,0.0108143546473547,-0.140532174608693,-0.0981399043910629,3.2810233810367e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0298430653231969,0.00270480109257199,0.0245416551817558,0.035144475464638,3.50565466842423e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0729789721769672,0.00662697467791598,0.0599901018082519,0.0859678425456826,4.22397657510867e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,FADD,FAS-associated death domain protein,39868,0.0828336236436331,0.00752302235196183,0.0680884998337879,0.0975787474534783,4.28106967418645e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSB,Cathepsin B,39847,-0.0553028043629569,0.00502465349378874,-0.0651511252107829,-0.045454483515131,4.49462547609595e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0743748190130473,0.00677158855800324,0.0611025054393609,0.0876471325867336,5.76692746915781e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0643820831219509,0.00586192263357629,0.0528927147601413,0.0758714514837604,6.09017219203744e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0587671645159651,0.00535475386411235,0.0482718469423048,0.0692624820896253,6.39167232281051e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAL,Integrin alpha-L,37056,0.0459173143109716,0.004182919400039,0.0377187922868951,0.054115836335048,6.48587366834734e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF22,Kinesin-like protein KIF22,37021,0.130220634123841,0.0118693823223303,0.106956644772074,0.153484623475608,6.94705465935956e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGRN,Neugrin,37388,0.0228982679893242,0.00208750632128545,0.0188067555996047,0.0269897803790436,7.04345641730072e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL14,C-C motif chemokine 14,39843,0.0417113244766251,0.00380412859207868,0.0342552324361509,0.0491674165170993,7.09620087061607e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSA,Arylsulfatase A,39858,0.0482104180379551,0.0044024655960799,0.0395815854696385,0.0568392506062717,8.2695648624644e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0211909382590872,0.00193601336680238,-0.0249855244580199,-0.0173963520601545,8.75536343739364e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0413274571457419,0.00377724247799554,0.0339240618888706,0.0487308524026131,9.63127453355919e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,TF,Serotransferrin,37453,0.023358216936677,0.0021365677763774,0.0191705440949773,0.0275458897783767,1.05008891159113e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLNK,B-cell linker protein,37056,0.0418288288530569,0.00382764600776854,0.0343266426778305,0.0493310150282832,1.11186534777061e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0898877128297767,0.00822667565068913,0.073763428554426,0.106011997105127,1.12544068692757e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0517119867749109,0.00473500392158909,0.0424313790885963,0.0609925944612255,1.14896185777921e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0332790318630022,0.00304875926598624,0.0273034637016692,0.0392546000243352,1.26572040589217e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0453347800669553,0.00415856670775058,0.0371839893197642,0.0534855708141464,1.4201422447155e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2,Brorin,39684,0.0410645038922084,0.00376903294872538,0.0336771993127067,0.0484518084717102,1.52132228309712e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0430756091732853,0.00396009360206031,0.0353138257132471,0.0508373926333235,1.9182794195213e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN1,Ficolin-1,37430,0.0597801954962451,0.00550352293133303,0.0489932905508323,0.0705671004416578,2.26224816338397e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA6,Integrin alpha-6,39866,0.0562871466380388,0.00519255670272427,0.0461097355006992,0.0664645577753783,2.76829940401685e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLB,Beta-klotho,39489,-0.0781188805327987,0.00721088371641819,-0.0922522126169783,-0.063985548448619,2.98608425916336e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0300129188427432,0.0027726069563541,0.0245786092082891,0.0354472284771972,3.41382259872849e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0640925002718897,0.00592541148552891,-0.0757063067835264,-0.0524786937602531,3.73652934829421e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTC,Probetacellulin,39477,0.0782149534872808,0.00724708220677542,0.064010672362001,0.0924192346125606,4.64740755092318e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN4,CCN family member 4,40030,0.0423086145537937,0.00392109689286365,0.034623264643781,0.0499939644638065,4.7451236689453e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA4,Ephrin-A4,39720,0.0291993949178936,0.00270872567960651,0.0238902925858648,0.0345084972499223,5.32182985622006e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRBP,Acrosin-binding protein,37368,0.0405003607198435,0.00375743002099875,0.0331357978786859,0.0478649235610011,5.58476583178821e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDHB,Succinate dehydrogenase,37382,0.0739987712474402,0.00686621239147839,0.0605409949601425,0.0874565475347378,5.6747158123635e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.0820770066232915,0.00761872045522527,0.06714431453105,0.097009698715533,5.69789886730354e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID2,Nidogen-2,39858,0.0765754041702437,0.00711462449645729,0.0626307401571875,0.0905200681833,6.35716692831761e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO1A,Coronin-1A,39520,0.0941417772969803,0.00875227880242672,0.0769873108442239,0.111296243749737,6.87446741833804e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.0919652051974615,0.0085542249460947,0.0751989243031159,0.108731486091807,7.58636790490204e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.068505678446862,0.00637324040624638,0.0560141272506191,0.0809972296431049,7.6924484029615e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0511236136114983,0.00476224496178685,0.0417896134863961,0.0604576137366005,8.92141296706561e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0385950651200202,0.00359782854808087,0.0315433211657817,0.0456468090742587,9.7709056633115e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0400123455839656,0.00373569944467151,0.0326903746724094,0.0473343164955217,1.11641928940565e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD46,Membrane cofactor protein,39777,0.0297069798098749,0.00277367861381331,0.0242705697268008,0.0351433898929489,1.12241920874485e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB6,Heat shock protein beta-6,40030,0.0392019984019441,0.00366898969261108,0.0320107786044264,0.0463932181994618,1.47233596590789e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0350485977179514,0.00328401103265925,0.0286119360939393,0.0414852593419636,1.68333625959058e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0528551304666306,0.00495353611674665,0.0431461996778071,0.062564061255454,1.73141630782958e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0477012926519021,0.00447211676600546,0.0389359437905313,0.0564666415132728,1.79112193360696e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0624795475829075,0.00586237288244642,0.0509892967333125,0.0739697984325025,2.04183284001341e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0523170746633597,0.00491077957131627,0.0426919467035798,0.0619422026231396,2.05398848768721e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0296274370627049,0.00278137062712116,0.0241759506335474,0.0350789234918623,2.09101195088586e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN2,Dynactin subunit 2,39788,0.0986657074808169,0.00927589654538514,0.080484950251862,0.116846464709772,2.46295506150437e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACYP1,Acylphosphatase-1,37073,0.0683955175917161,0.00643315400622882,0.0557865357395076,0.0810044994439246,2.70947935038289e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD84,SLAM family member 5,39866,0.0324015954265347,0.00304921074295727,0.0264251423703385,0.038378048482731,2.75337794340425e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0552885518572999,0.00520280595111964,0.0450910521931054,0.0654860515214944,2.86032266214222e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,APLP1,Amyloid-like protein 1,39868,-0.0531808172836369,0.00501093738333376,-0.063002254554971,-0.0433593800123027,3.17091709214073e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX9,Sorting nexin-9,39868,0.0719420510975046,0.00678621546864709,0.0586410687789563,0.0852430334160529,3.59234685867891e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.049637100746958,0.00468673454099793,0.040451101046602,0.0588231004473139,4.15263466865456e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0263081897272492,0.00248742125580072,-0.0311835353886186,-0.0214328440658798,4.83518086345073e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0343037317221518,0.00324450342493528,0.0279445050092787,0.040662958435025,4.85185551549299e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0316401935818087,0.00300137422311041,-0.0375228870591051,-0.0257575001045123,6.90456604139193e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0599390756700403,0.00570640945220688,0.0487545131437148,0.0711236381963658,1.04138561115286e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL19,C-C motif chemokine 19,40009,0.118852301725961,0.0113251469819997,0.0966550136412415,0.14104958981068,1.10698552880819e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX,Glutaredoxin-1,39771,0.0574675750473895,0.00549114261237303,0.0467049355271383,0.0682302145676406,1.50602892810888e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVR,Poliovirus receptor,40009,0.0380702273612124,0.00364256390924284,0.0309308020990965,0.0452096526233284,1.73939959918088e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.10119314169669,0.00969295495822305,0.0821949499785724,0.120191333414807,1.96672882080663e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0683850736107224,0.00654972790483912,0.0555476069172378,0.0812225403042071,2.02333102024596e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABHD14B,Protein ABHD14B,39687,0.0587053540843019,0.00562894105036805,0.0476726296255806,0.0697380785430233,2.20461985021921e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOE,Apolipoprotein E,37453,0.0739461793533631,0.00709743514744775,0.0600352064643655,0.0878571522423606,2.53678835118128e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.077480256926266,0.00743738980344434,0.0629029729115151,0.0920575409410169,2.57671151287408e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0516040421417044,0.00496123178681209,0.0418800278395527,0.0613280564438561,2.93894199544099e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0899875127897514,0.00865614131602696,0.0730214758103385,0.106953549769164,3.11878984260907e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0448461692923899,0.00432788123907278,0.0363635220638073,0.0533288165209726,4.44415680265601e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAST,Gastrin,37388,0.11785630241432,0.0113710398189564,0.0955690643691657,0.140143540459475,4.45902180899327e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0499924644126088,0.00482595745313047,0.0405335878044731,0.0594513410207446,4.58842361731857e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0194959360562888,0.00188331693219003,0.0158046348691963,0.0231872372433813,5.08255876605817e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0458063280775208,0.00442832969892823,-0.0544858542874201,-0.0371268018676215,5.34269233303212e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0546530811642935,0.00529244519502856,0.0442798885820375,0.0650262737465495,6.38341522983055e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARFIP1,Arfaptin-1,37411,0.0699389987704414,0.00677880929445407,0.0566525325533115,0.0832254649875714,7.27435534411391e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0388193014544274,0.00376563479656795,0.0314386572531542,0.0461999456557006,7.94175136952778e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN2,Nectin-2,39846,0.0284289994860286,0.00276086466960113,0.0230177047336104,0.0338402942384468,8.67617885223276e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0475186543559214,0.00461781316269344,0.0384677405570422,0.0565695681548005,9.3500599248362e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSTB,Cystatin-B,39619,0.0427197963367581,0.00415260909514499,0.0345806825102739,0.0508589101632423,9.61178290386871e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0244216889710937,0.00237650500199332,0.0197637391671868,0.0290796387750006,1.07558342883216e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0836646640470472,0.00814198848873471,0.0677063666091272,0.0996229614849673,1.08200805835895e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0348066107925363,0.0033914312444676,0.0281594055533798,0.0414538160316928,1.23349855607338e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NADK,NAD kinase,39868,0.0535368452841261,0.00522563917811307,0.0432945924950245,0.0637790980732277,1.48342465712976e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA14,Carbonic anhydrase 14,40030,-0.0352118766757606,0.0034371184945685,-0.0419486289251148,-0.0284751244264063,1.48756668596157e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0878635135478473,0.00857404651021418,0.0710583823878275,0.104668644707867,1.49152490482497e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.106998716268693,0.0104446816155111,0.0865271403022913,0.127470292235095,1.54257052194065e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.040585868586084,0.0039624152604068,0.0328195346756867,0.0483522024964814,1.57735219892338e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGMN,Legumain,39931,0.035998213228309,0.00351759360883838,0.0291037297549858,0.0428926967016322,1.66431274937497e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0350935075840096,0.00342964623059978,-0.0418156141959852,-0.028371400972034,1.75260278948384e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL15,C-C motif chemokine 15,40052,0.043369444318164,0.00424444087305182,0.0350503402069825,0.0516885484293456,1.95497172524954e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,FEN1,Flap endonuclease 1,39477,0.0623525950010416,0.00610867381840568,0.0503795943169664,0.0743255956851167,2.19545221877457e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA2,Annexin A2,36879,0.0696644551481435,0.00682464814441439,0.0562881447850913,0.0830407655111957,2.26091186500573e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0471615242530646,0.00462295349580163,0.0381005354012934,0.0562225131048358,2.3184999699263e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGN,Biglycan,39448,-0.119154917121867,0.0116841966481576,-0.142055942552256,-0.0962538916914779,2.41457756762528e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLF4,Krueppel-like factor 4,36991,0.0393763575857523,0.00386162526691531,0.0318075720625983,0.0469451431089063,2.52369274531832e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.094638787126708,0.00929175797028314,0.076426941504953,0.112850632748463,2.74113730024367e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX16,Syntaxin-16,39477,0.0581263352341856,0.00570726622100806,0.0469400934410098,0.0693125770273614,2.76623423341939e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0590844350433544,0.00580529556308965,0.0477060557396987,0.0704628143470102,3.04892242361502e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS27,Serine protease 27,39818,0.0400042220999102,0.00393271039888312,0.0322961097180992,0.0477123344817211,3.12926980599435e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0235204054436165,0.00231478298535732,0.0189834307923162,0.0280573800949169,3.50606727124364e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0231300539775173,0.00228196747193874,0.0186573977325174,0.0276027102225172,4.52411838853292e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0896907457038724,0.00884734460040672,0.0723499502870753,0.10703154112067,4.58491844850748e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0669340884156721,0.00660563090037884,0.0539870518509296,0.0798811249804146,4.68039543154448e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0693066966796226,0.00684438422457455,0.0558917035994564,0.0827216897597887,5.00532307511727e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0559372544282898,0.00552646446305581,0.0451053840807004,0.0667691247758792,5.24864301584405e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA2,Integrin alpha-2,37124,0.033367233109336,0.0032958143295586,0.0269074370234011,0.0398270291952708,5.27874197473221e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0662941916220523,0.00654880773172163,0.0534585284678779,0.0791298547762267,5.33061476427415e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRN1,Secernin-1,39866,0.0557315668589541,0.00550817646635765,0.0449355409848931,0.0665275927330151,5.42982034470156e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLO1,Lactoylglutathione lyase,39585,0.0573460286799996,0.00566877788787082,0.0462352240197728,0.0684568333402265,5.54921710634829e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1F,Protein phosphatase 1F,37437,0.0527676383355781,0.00521536343349686,0.0425455260059243,0.062989750665232,5.60650065675933e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP1,Interstitial collagenase,39314,0.0908645350026817,0.00898990883997947,0.073244313676322,0.108484756329042,6.08061669889939e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0410036875229677,0.00405850951758163,0.0330490088685077,0.0489583661774277,6.30705831581552e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOL1,Apolipoprotein L1,37445,0.0605450771509681,0.00600637984202647,0.0487725726605962,0.07231758164134,8.20175110400507e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0263332203830063,0.00261684096638635,-0.0314622286771236,-0.0212042120888891,9.47507628148545e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.021368019794346,0.00212404651361527,0.0172048886276601,0.025531150961032,9.76628259527282e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0712695204640448,0.00708812105571549,0.0573768031948425,0.0851622377332472,1.03210201299295e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO2,Roundabout homolog 2,40009,0.0223731661162983,0.00222667720587105,0.018008878792791,0.0267374534398055,1.10287629640207e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSE,Cathepsin E,37124,0.0520051292622877,0.00517643110921306,0.0418593242882301,0.0621509342363453,1.15636287059338e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,POMC,Pro-opiomelanocortin,37043,0.0697620190698842,0.00695319034259582,0.0561337659983964,0.083390272141372,1.32518870108114e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0498062195985913,0.00496589175956936,-0.0595393674473472,-0.0400730717498353,1.36401725534199e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO2,Gamma-enolase,40009,0.0648148755740189,0.00648272204159189,0.0521087403724988,0.0775210107755391,1.8178837050787e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX7,Syntaxin-7,37056,0.0482909638466598,0.00483459064071117,0.0388151661908659,0.0577667615024537,2.06971249283757e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0717179069576053,0.00718613911641585,0.0576330742894302,0.0858027396257803,2.18508829542287e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PER3,Period circadian protein homolog 3,37056,0.114853777589535,0.0115052029398487,0.0923035798274319,0.137403975351639,2.19488259467963e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0273283826413776,0.00274135789680962,0.0219553211636307,0.0327014441191244,2.52170799638074e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN9,Septin-9,39788,0.0275948975835298,0.00277165264171475,0.0221624584057689,0.0330273367612907,2.77367015990395e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7,Complement component C7,37149,-0.031242143104875,0.0031390152798653,-0.037394613053411,-0.025089673156339,2.95572984733361e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,COLEC12,Collectin-12,39862,0.0241515537083015,0.00243304843436875,0.0193827787769388,0.0289203286396642,3.72621254023032e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,VGF,Neurosecretory protein VGF,37411,0.0284089756772828,0.00286216288578443,0.0227991364211453,0.0340188149334203,3.85998005103743e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.088646435661651,0.008933918615142,0.0711359551759727,0.106156916147329,3.98659354097888e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA1,Apolipoprotein A-I,37453,-0.0265075466068053,0.0026745841932157,-0.031749731625508,-0.0212653615881025,4.46948521529158e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDK,Midkine,39843,0.0490651541998528,0.00495616706482863,0.0393510667527887,0.058779241646917,4.85817933341768e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0433902942165591,0.00438972609965244,0.0347864310612403,0.0519941573718778,5.65873185834102e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0703584231596282,0.00711985868339741,0.0564035001401692,0.0843133461790871,5.79723085073764e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.068238336705765,0.00691243828339282,0.0546899576703151,0.081786715741215,6.62117874143561e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0420205139647635,0.00425948963695597,0.0336719142763298,0.0503691136531972,6.87645564262544e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENAH,Protein enabled homolog,39587,0.0463500043738071,0.00470227359586784,0.0371335481259062,0.0555664606217081,7.4512125163702e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFA,Protransforming growth factor alpha,39866,0.0441973572687519,0.0044937025303146,0.0353897003093352,0.0530050142281685,9.19471748060865e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0369438281214262,0.0037563665843948,0.0295813496160124,0.04430630662684,9.26492317318546e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.030824182037454,0.00313443164593255,0.0246806960114262,0.0369676680634818,9.5669431309063e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNF,Tumor necrosis factor,39555,0.0365875449255145,0.00372321545233507,0.0292900426389378,0.0438850472120912,1.00318723752159e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0265410879189656,0.00270172373265312,0.0212457094029655,0.0318364664349657,1.05891078796017e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM1,Dynamin-1,37382,0.110171451300158,0.0112261115999306,0.0881682725642941,0.132174630036022,1.16822543334957e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.034879389861332,0.00356161131306988,0.027898631687715,0.0418601480349489,1.39675287238054e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0475702217478256,0.00486413851126174,0.0380365102657526,0.0571039332298986,1.63171913093508e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLTA,Clathrin light chain A,39585,0.0445863763980947,0.0045609703086949,0.0356468745930527,0.0535258782031367,1.66045329065794e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0436467888015385,0.00447334999198751,0.0348790228172429,0.052414554785834,1.98355407968094e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIT2,Slit homolog 2 protein,39489,0.0493326922437853,0.0050576429055997,0.0394197121488099,0.0592456723387608,2.05292158916169e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.092206025283293,0.00945892612195958,0.0736665300842522,0.110745520482334,2.17358773893206e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0733506865858687,0.00753315185821153,0.0585857089437741,0.0881156642279633,2.42566063539961e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0257335132667909,0.00264678898886849,-0.0309212196849731,-0.0205458068486086,2.78419097092061e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0367448353675019,0.00378059777861251,0.0293348637214213,0.0441548070135824,2.87024008508672e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN6,Dynactin subunit 6,39489,0.0675839319782934,0.00696084983241934,0.0539406663067515,0.0812271976498353,3.18498547265561e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0334748068914307,0.0034524346979135,0.0267080348835202,0.0402415788993412,3.70075819851246e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSHB,Follitropin subunit beta,37043,0.0620934010124551,0.00641107314566632,0.0495276976469491,0.0746591043779611,4.1239785037508e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0335956426661035,0.00349668059327732,0.02674214870328,0.0404491366289271,8.69314763391778e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0455618764518207,0.00474232245228279,0.0362669244453464,0.054856828458295,8.72942275704159e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENR,Density-regulated protein,37056,0.0544002555167687,0.00566330361752437,0.0433001804264209,0.0655003306071164,8.9084247452148e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH1,Acid ceramidase,37340,0.0444604118484347,0.00463269278146751,0.0353803339967584,0.053540489700111,9.64935304823527e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0259139944403627,0.00270288985712135,0.0206163303204049,0.0312116585603206,1.03239841778157e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0576287358409296,0.00601166934599095,0.0458458639227873,0.0694116077590719,1.07615068380844e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0300388974736662,0.0031353803653361,0.0238935519576075,0.036184242989725,1.10117177730982e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0389179481435785,0.00406905810404944,0.0309425942596416,0.0468933020275154,1.32538655760941e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0498144232405566,0.00521458949172229,0.039593827836781,0.0600350186443323,1.43810427685362e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPA1,Inositol monophosphatase 1,39749,0.057336309121344,0.00600759099383901,0.0455614307734195,0.0691111874692684,1.5699417835312e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0312505149430731,0.00327729022676398,0.0248270260986157,0.0376740037875305,1.7473782054281e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0259477158835511,0.00272281958770031,0.0206109894916585,0.0312844422754437,1.79672492982893e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOB,Elongin-B,37021,0.0366648045605865,0.00384743153609146,0.0291238387498473,0.0442057703713258,1.85020000946201e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0626844847434366,0.00658620925027146,0.0497755146129045,0.0755934548739687,2.06862553154255e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIT,Vitrin,37437,0.0342785094561205,0.00360278411757344,0.0272170525856766,0.0413399663265645,2.12990885032827e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0326210403565753,0.00342889414625955,0.0259004078299066,0.039341672883244,2.15441393267605e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA9,Serpin A9,39715,0.0676118346385969,0.00711284549055,0.053670657477119,0.0815530118000749,2.2676300949401e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0833910946709644,0.00878087186958107,0.0661805858065855,0.100601603535343,2.52727487512391e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRIB,Protein scribble homolog,37043,0.0837821826002271,0.00884421386211449,0.0664475234304827,0.101116841769972,3.17313029373721e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0509634689296528,0.00538857806238667,0.0404018559273749,0.0615250819319307,3.5870310363246e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAEP,Glycodelin,39749,-0.133841116060165,0.0141843477620031,-0.161642437673691,-0.106039794446639,4.40453204223535e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR2,Folate receptor beta,40009,-0.0265167018623139,0.00282383070704281,-0.0320514100481179,-0.02098199367651,6.76169615120205e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0342128273252888,0.00364342353735729,0.0270717171920686,0.0413539374585091,6.79137964662063e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,KITLG,Kit ligand,39868,-0.0340617773018751,0.00362935497929904,-0.0411753130613012,-0.026948241542449,7.11306673554384e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0333407702616102,0.0035540475647722,0.0263748370346566,0.0403067034885637,7.37651354694011e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0648269536559087,0.00691441141444073,0.0512747072836049,0.0783792000282125,7.78328950776205e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRG,Histidine-rich glycoprotein,37380,0.0289785934689164,0.00309960576072012,0.022903366177905,0.0350538207599279,1.02052906108703e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0304555627986127,0.00326280247264371,0.0240604699522311,0.0368506556449944,1.14692021914646e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN2,Matrilin-2,39885,0.0272166442816641,0.00291626944865246,0.0215007561623053,0.0329325324010229,1.16447255434751e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0428990454473676,0.00461550849923155,0.0338526487888738,0.0519454421058615,1.66317691662403e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA4,Annexin A4,39783,0.0659380012425738,0.00710141195654224,0.052019233807751,0.0798567686773966,1.8180156655646e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0269759888718516,0.00291336386081121,0.0212657957046616,0.0326861820390416,2.3085116173223e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0600794813710781,0.00648872356406093,0.0473615831855187,0.0727973795566375,2.3256540773732e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0789350657691135,0.00854482024334352,0.0621872180921602,0.0956829134460667,2.82641704450401e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA,Adenosine deaminase,40058,0.0314156555669279,0.00340559781954286,0.0247406838406239,0.0380906272932319,3.18652292262671e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXN,"Frataxin, mitochondrial",40030,0.0663025102780549,0.00719215628454054,0.0522058839603554,0.0803991365957543,3.36918639780259e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0501131356412024,0.0054446522673944,0.0394416171971094,0.0607846540852954,3.96143367326268e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCOF1,Treacle protein,37437,0.027433563913919,0.00298396443663529,0.0215849936181138,0.0332821342097242,4.34170734550147e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.043564114222607,0.00473915455561585,0.0342753712936,0.0528528571516141,4.39558550440955e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0219178355557198,0.00238837023873993,0.0172366298877895,0.02659904122365,4.96783606493378e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100P,Protein S100-P,39585,0.0472549487295376,0.00516326186521103,0.037134955473724,0.0573749419853512,6.25375692739974e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0327234475255845,0.00357556868460255,0.0257153329037635,0.0397315621474055,6.39805674664802e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGT,Angiotensinogen,37445,0.0200959160112041,0.00219608422848968,0.0157915909233643,0.0244002410990439,6.44631003428338e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0301330697866458,0.00329829070237709,0.0236684200099867,0.0365977195633049,7.24681639789374e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0553860390218727,0.00606644396201957,0.0434958088563143,0.0672762691874311,7.84369794119711e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0284066403928263,0.00311442942386586,0.0223023587220492,0.0345109220636034,8.30393326358198e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0235325364173159,0.00258222385108638,0.0184713776691866,0.0285936951654452,8.93197237123769e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0200652438752603,0.00220674065068829,0.0157400321999112,0.0243904555506093,1.09872406620146e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM,Paralemmin-1,37299,0.025342686790651,0.0027875694713703,0.0198790506267652,0.0308063229545368,1.11383759912502e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0463303623265628,0.0051004348730707,0.0363335099753442,0.0563272146777814,1.17166010945982e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0301329681456569,0.00331987854793594,0.0236260061917025,0.0366399300996113,1.2523893671644e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0203121822182072,0.00224929211989954,-0.0247207947732103,-0.0159035696632041,1.89915337612549e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0264580249799104,0.00293320211494593,0.0207089488346164,0.0322071011252044,2.12642985104134e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA9,Carbonic anhydrase 9,40030,-0.0381942614885551,0.00424065868599794,-0.0465059525131111,-0.0298825704639991,2.35637398624807e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0289574052398656,0.00322003423645968,-0.0352686723433266,-0.0226461381364046,2.72312843517186e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0518980579834976,0.00577355362806307,0.040581892872494,0.0632142230945013,2.82242485007428e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0559155298330419,0.00622559916262353,0.0437133554742997,0.068117704191784,3.02810091938532e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPL,Periplakin,37056,0.0281885693592854,0.00314496404323746,0.02202443983454,0.0343526988840308,3.57694411211547e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0850380396535428,0.00949319736681513,0.0664313728145851,0.1036447064925,3.74060615948754e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0638728668707693,0.00713231656840699,0.0498935263966916,0.077852207344847,3.75985353892729e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMB1,Laminin subunit beta-1,37043,0.0266896171072598,0.00298095005961201,0.0208469549904202,0.0325322792240993,3.90379641882357e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0603978599838444,0.00674674232924501,0.0471742450185242,0.0736214749491646,3.93443508859054e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD248,Endosialin,37437,-0.0347709237315465,0.0038874530823438,-0.0423903317729404,-0.0271515156901526,4.21799900001473e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.032340310015944,0.00362144781143022,0.0252422723055408,0.0394383477263472,4.7059041988209e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.018645175091592,0.00208929423804715,-0.0227401917981644,-0.0145501583850196,4.96526252896799e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0732547043458385,0.00820801875799347,0.0571669875801714,0.0893424211115057,5.04396395039877e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0218513082303223,0.00245145354657915,0.0170464592790271,0.0266561571816174,5.56208292534342e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0646694842183758,0.00726693380631883,0.0504262939579909,0.0789126744787607,6.21306328808461e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0409654246106618,0.00460647094087102,0.0319367415665546,0.049994107654769,6.57068246622331e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD302,CD302 antigen,39788,0.0252799438926805,0.00284411832668597,0.019705471972376,0.030854415812985,6.84613215262071e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0442222738554065,0.00497557056291113,0.0344701555521007,0.0539743921587123,6.87924172724742e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0244189882611005,0.00274883270934653,-0.0298067003714197,-0.0190312761507813,7.16212976949043e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARCO,Macrophage receptor MARCO,39868,0.022759261355074,0.00256870367039243,0.0177246021611048,0.0277939205490432,8.81166169856225e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0219723855973498,0.00248147676150551,0.017108691144799,0.0268360800499006,9.43052792798812e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.047074082788403,0.00531778521282614,-0.0574969418055422,-0.0366512237712637,9.46509283791564e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0784743673786037,0.00889573846095527,-0.095910014762076,-0.0610387199951314,1.24658823363534e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.027426237748797,0.00311390437252219,0.0213229851786536,0.0335294903189405,1.43093343006864e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0568179065057052,0.0064567114580696,0.0441627520478888,0.0694730609635216,1.5080338440203e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0350480118307483,0.00398430113210971,0.0272387816118132,0.0428572420496833,1.55315752850992e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0355971938502515,0.00404681221411566,0.0276654419105848,0.0435289457899182,1.58410678151487e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0590691029111033,0.00672117375343045,0.0458956023543796,0.072242603467827,1.66725807474658e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0475606533108235,0.00541749080198319,0.0369423713389365,0.0581789352827106,1.84552690428328e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA1,BolA-like protein 1,36991,0.0472634393855263,0.00538448304112903,0.0367098526249134,0.0578170261461392,1.87258981659277e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR3,Toll-like receptor 3,40058,0.0522569254760623,0.00597083669264528,0.0405540855584776,0.0639597653936471,2.29888854897615e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK4,Dickkopf-related protein 4,39718,0.0388465190937872,0.0044418327270992,0.0301405269486728,0.0475525112389016,2.43762887398485e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0566976026950227,0.00648555955494811,0.0439859059673244,0.069409299422721,2.5539358604961e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0450296751492208,0.00515321982123416,0.0349293642996018,0.0551299859988397,2.65097800109505e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPR,Nucleoprotein TPR,37021,0.0403114385888413,0.00461499312858242,0.0312660520568197,0.0493568251208628,2.73088366026513e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0397934803294408,0.00456082400496603,0.0308542652797074,0.0487326953791743,2.92006362653127e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_E,,39866,0.0233746040081254,0.00268322965711269,0.0181154738801845,0.0286337341360662,3.29163413970038e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0286929039590374,0.00329690571853035,0.022230968750718,0.0351548391673569,3.54186128078352e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDA,Cytidine deaminase,37422,0.0395125708121196,0.00454746999787455,0.0305995296162854,0.0484256120079537,4.07428808384402e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0289299644013372,0.00333293989839273,0.0223974022004875,0.035462526602187,4.33490775811127e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASET2,Ribonuclease T2,39974,0.0216689980703947,0.00249652230714329,0.0167758143483938,0.0265621817923955,4.34328575952558e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0310264446577659,0.00357565910520046,0.024018152811573,0.0380347365039588,4.53010492769646e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0651691418233781,0.00751641027432009,0.0504369776857107,0.0799013059610454,4.81324971794246e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR3,Small proline-rich protein 3,37388,0.05565520267374,0.00642213646419005,0.0430678152039275,0.0682425901435525,4.9725580217345e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0523583243632811,0.00605193033127452,0.040496540913983,0.0642201078125791,5.64789093495734e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0318598006826759,0.0036865744134212,0.0246341148323704,0.0390854865329815,6.03308920703891e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTN,Pleiotrophin,39585,0.042568229333285,0.00493888681574841,0.0328880111744181,0.0522484474921519,7.38921272935049e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.044447579026732,0.00515604459904583,0.0343417316126022,0.0545534264408618,7.42156684897692e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0242352421809273,0.00281487917458579,-0.0297524053631155,-0.0187180789987392,7.99040828615303e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0446744176485043,0.00519481468999698,0.0344925808561102,0.0548562544408984,8.85103199988306e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0515960080856265,0.00600072388164394,0.0398345892776044,0.0633574268936487,8.96778711116284e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX6,Syntaxin-6,39477,0.0574702079600259,0.00668612776406866,0.0443653975424513,0.0705750183776004,9.07082316272681e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0395158068183732,0.00459921520653953,0.0305013450135557,0.0485302686231907,9.35673868130206e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,C5,Complement C5,37453,0.0127900289631925,0.00149128986124089,0.00986710083516039,0.0157129570912247,1.08299810392904e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0439954182095021,0.00513416738403605,0.0339324501367915,0.0540583862822128,1.15430189565732e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP3,Stromelysin-1,39858,-0.0400299963478499,0.00467277562071415,-0.0491886365644496,-0.0308713561312501,1.16135833669366e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.021402281387091,0.00249934906370542,0.0165035572222284,0.0263010055519536,1.21594897264881e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0311657756665049,0.00364293898328829,0.0240256152592599,0.03830593607375,1.28554228785303e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CX3CL1,Fractalkine,39749,-0.0277724964131387,0.0032511022347211,-0.034144656793192,-0.0214003360330853,1.43134243907832e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK6,Kallikrein-6,39889,0.0247502579517617,0.00289952185240298,0.0190671951210519,0.0304333207824716,1.5127355639667e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0277885732104874,0.0032575616340192,-0.034173394013165,-0.0214037524078098,1.58861807448814e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0246250547943265,0.00288818313579883,0.0189642158481608,0.0302858937404922,1.67657449172149e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL8,Interleukin-8,39750,0.0551994618458609,0.0064770728859168,0.042504398989464,0.0678945247022579,1.70315379615803e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSF,Cathepsin F,39913,0.0337328805382253,0.00396464512067227,0.0259621761017076,0.0415035849747429,1.91688904526148e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.0403407830209782,0.00474674966825091,0.0310371536712064,0.0496444123707499,2.09007503767498e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMS,Spermine synthase,36991,0.0533125446491719,0.00628683431701543,0.0409903493878216,0.0656347399105221,2.49014718660356e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBD,Thrombomodulin,39868,0.0225749334968881,0.00266458568678322,0.017352345550793,0.0277975214429833,2.61469620295189e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMM2,Phosphomannomutase 2,37021,0.0499527485145608,0.00590138873567238,0.0383860265926429,0.0615194704364786,2.84086541349327e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0363788147397344,0.00430139444216123,0.0279480816330984,0.0448095478463704,2.96614271291432e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0337216904824184,0.00398633132354598,0.0259084810882683,0.0415348998765685,2.97009358672617e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPB,Natriuretic peptides B,39585,-0.104935493367633,0.0124144970670871,-0.129267907619124,-0.0806030791161423,3.09438793753399e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SWAP70,Switch-associated protein 70,37382,0.0296953339347348,0.00351850001404137,0.0227990739072137,0.0365915939622559,3.50027911993537e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0320902411685762,0.00380305173948514,0.0246362597591854,0.0395442225779671,3.50240210825737e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMB,RGM domain family member B,40009,0.0210782778909532,0.00249840509442894,0.0161814039058725,0.0259751518760339,3.53765873779144e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0273224484958751,0.00323860553342723,-0.0336701153413925,-0.0209747816503578,3.59950848803452e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP2,Retinol-binding protein 2,39788,-0.063065833134416,0.0074835805619448,-0.0777336510358278,-0.0483980152330042,3.83868641961367e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH5,Cadherin-5,40052,-0.0251754181421263,0.00298833054513405,-0.0310325460105891,-0.0193182902736636,3.92103544878006e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX1,Heme oxygenase 1,39691,-0.039279242159782,0.00467233690891546,-0.0484370225012562,-0.0301214618183077,4.56965360986147e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0492220809782499,0.00586028084510706,0.0377359305218401,0.0607082314346597,4.87217737920689e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.038671434180138,0.00460869783833419,0.029638386417003,0.047704481943273,5.29528168651178e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0346379587060438,0.00412963943397475,0.0265438654154533,0.0427320519966343,5.44725090439547e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0661299896676576,0.00789051291583404,0.0506645843526229,0.0815953949826923,5.77850887543636e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0479484446111271,0.00572710430981043,0.0367233201638987,0.0591735690583556,6.22214389157406e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0970908016703906,0.0116229061369795,0.0743099056419108,0.11987169769887,7.27358169826599e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0323994975979146,0.00388257930820929,0.0247896421538244,0.0400093530420048,7.70897084350658e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0299260367295527,0.00358596642481047,0.0228975425369242,0.0369545309221813,7.80550395305552e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0388624103769011,0.00466274425075679,0.0297234316454177,0.0480013891083844,8.41360403480761e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0340193437328867,0.00408462872690089,0.026013471428161,0.0420252160376125,8.84606390273341e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPG,Macrophage-capping protein,39739,0.0473710282757507,0.00569072127763256,0.0362172145715909,0.0585248419799105,9.17008747730483e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA4,Carbonic anhydrase 4,40052,-0.0190934388732859,0.00229537772264321,-0.0235923792096666,-0.0145944985369052,9.63348466235399e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0461567531619356,0.00555737936049633,0.0352642896153628,0.0570492167085084,1.07430968135556e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0188818243164995,0.00227529207385315,0.0144222518517473,0.0233413967812517,1.13706883070726e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0329500517515298,0.00397916587868354,-0.0407492168737495,-0.02515088662931,1.32148772438992e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.0228727957185628,0.00276231206844705,-0.028286927372719,-0.0174586640644066,1.32475214100953e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0329260427139204,0.0039768486785391,0.0251314193039837,0.040720666123857,1.33625234263682e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0407068505496912,0.00493046484131559,0.0310431394607127,0.0503705616386698,1.646221011087e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK7,Kallikrein-7,36818,0.0315525876206642,0.00382950230531879,0.0240467631022394,0.039058412139089,1.89691675805719e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0785754296967636,0.00954905524212942,0.0598592814221899,0.0972915779713372,2.03871446495741e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0344949635870382,0.00419326827523914,-0.042713769406507,-0.0262761577675695,2.07918889850327e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0756750395175589,0.00920115101833382,0.0576407835216246,0.0937092955134931,2.10752004512436e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM2,Junctional adhesion molecule B,40009,0.0201810698879968,0.00245816045882306,0.0153630753887036,0.02499906438729,2.38093985505106e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.044927025436292,0.00547244100975368,0.0342010410571748,0.0556530098154092,2.42058002706101e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.033998153651231,0.00414867287875944,0.0258667548088625,0.0421295524935995,2.73101225078582e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.0239253665001594,0.00292136974576975,0.0181994817984507,0.0296512512018681,2.81231100834947e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0176039244484125,0.00214941358141083,0.0133910738288473,0.0218167750679778,2.84246394607979e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0419778671215202,0.00513093165157437,0.0319212410844344,0.0520344931586059,3.06292534666887e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0313558970302385,0.00383412236801352,0.023841017188932,0.038870776871545,3.1015476634438e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0426891421974692,0.00522060101546588,0.0324567642071561,0.0529215201877823,3.17280046117141e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPL14,60S ribosomal protein L14,37043,0.0324435658881333,0.003968499403436,0.0246653070573987,0.0402218247188678,3.22008710534297e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0208874722374285,0.00256015949829469,0.0158695596207709,0.0259053848540861,3.68316619621989e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBS,Cystathionine beta-synthase,37043,0.0407222235803533,0.00500097737805869,0.0309203079193583,0.0505241392413483,4.20568969170756e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.0868718995499866,0.010674498406936,-0.107793916427581,-0.0659498826723919,4.38044701972593e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0523350710342993,0.00643360664862252,0.0397252020029992,0.0649449400655994,4.49996230204162e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0477270746390111,0.00587210429570482,0.0362177502194296,0.0592363990585925,4.76061324845188e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0330238291841652,0.00406459692408611,0.0250572192129565,0.040990439155374,4.8798301716562e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0402634341683773,0.00495983513058386,0.0305421573124329,0.0499847110243217,5.16254842594215e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0416967116219637,0.00513934959365681,-0.051769836825531,-0.0316235864183963,5.28419409322184e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIT,Citron Rho-interacting kinase,37039,0.0359909798032712,0.00444012880543116,0.0272883273446262,0.0446936322619163,5.69771487614437e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0453149226701075,0.00560151669693186,0.0343359499441211,0.056293895396094,6.4146136630751e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBI3_IL27,Interleukin-27,40011,-0.0243927459257704,0.00301751863683678,-0.0303070824539705,-0.0184784093975703,6.72412408450735e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0209347716924483,0.00259424029441239,0.0158500607154001,0.0260194826694966,7.54129655559713e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFR,Epidermal growth factor receptor,40052,0.0126740518630432,0.00157196429713808,0.00959300184065257,0.0157551018854338,7.98968765845375e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR2,Complement factor H-related protein 2,37364,0.044522009987128,0.00552490407601334,0.0336931979981419,0.0553508219761141,8.37392076401742e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCT,Secretin,37039,0.0347839782680406,0.00432829632929959,0.0263005174626134,0.0432674390734678,1.00340629823575e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA11,Integrin alpha-11,39866,-0.0267220971474623,0.0033334810406297,-0.0332557199870965,-0.0201884743078281,1.16474816340845e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0718832698419887,0.0089823982997538,0.0542777691744713,0.0894887705095062,1.31869585481395e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN3,CCN family member 3,40042,0.0253634742675872,0.00317305473349725,0.0191442869899325,0.0315826615452418,1.40071568353585e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL20,C-C motif chemokine 20,40058,0.0659712811592081,0.0082562923729246,0.0497889481082759,0.0821536142101403,1.43463583833293e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0893694505294859,0.0111973468673919,0.0674226506693977,0.111316250389574,1.56401733602036e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0608412517860048,0.00762815745829788,-0.0757924404042687,-0.045890063167741,1.6146319700501e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0335485430438321,0.00421828948578467,-0.04181639043597,-0.0252806956516941,1.93904259450775e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0325143233582835,0.00410302072668164,0.0244724027339875,0.0405562439825795,2.4408267163093e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0485346724915397,0.00613880898948868,0.0365026068721419,0.0605667381109376,2.82555403955355e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0501387841347839,0.00634046502658463,0.0377114726826781,0.0625660955868898,2.82842416101188e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0573422188806351,0.00725442346603366,0.0431235488872091,0.0715608888740611,2.9020577571556e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0253546195847793,0.00320851960462831,0.0190659211597078,0.0316433180098508,2.95468122350248e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0447753474437479,0.00567512390417912,-0.055898590295939,-0.0336521045915569,3.22155425339523e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMD,Osteomodulin,39931,-0.0336074482931945,0.00426481829471104,-0.0419664921508281,-0.0252484044355609,3.4778803139991e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0313165657266315,0.0039813534549583,0.0235131129549133,0.0391200184983498,3.9446501868304e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB2,Plexin-B2,39984,0.0181649691890005,0.00231451791717785,0.0136285140713319,0.0227014243066691,4.48141847999027e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA,Lymphotoxin-alpha,39866,0.0303637026401974,0.00387098255336826,0.0227765768355956,0.0379508284447992,4.64083825237581e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP2,Neuropilin-2,39858,-0.0218800737628151,0.00279665308422911,-0.0273615138079042,-0.0163986337177261,5.44964492072574e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPOCK1,Testican-1,39749,0.0194634666849069,0.00248842728208211,0.014586149212026,0.0243407841577879,5.54198295186898e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP8,Caspase-8,39984,0.0472893456084056,0.00604704606887172,0.035437135313417,0.0591415559033942,5.59677957559698e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0558642376162881,0.00714633377924396,0.0418574234089699,0.0698710518236063,5.73771961969952e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FST,Follistatin,39908,0.039425698703146,0.00504489673443003,0.0295377011036631,0.0493136963026289,5.83682746394921e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0326551884723794,0.00418438347063946,0.024453796869926,0.0408565800748327,6.44475424663003e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,XG,Glycoprotein Xg,39985,0.0229063421712778,0.00294735373239808,0.0171295288557775,0.028683155486778,8.20003983494566e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0492138284322967,0.00634800666320991,0.0367717353724053,0.0616559214921881,9.55209224947944e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0318659416157775,0.00411010448596706,0.0238101368232821,0.039921746408273,9.60919612523816e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0414432349900116,0.00534728587030241,0.0309625546842189,0.0519239152958043,9.71612401851333e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP12,Macrophage metalloelastase,39900,0.0381369567834105,0.00492771310733337,0.0284786390930371,0.0477952744737839,1.05911393935728e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0375453135953452,0.00485533227564356,0.0280288623350838,0.0470617648556066,1.12866300975337e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0270978111579262,0.00350627555433987,0.02022551107142,0.0339701112444323,1.16583732946282e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ULBP2,UL16-binding protein 2,39749,0.0276588993306789,0.00358014446134659,0.0206418161864396,0.0346759824749182,1.17913698898481e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA2,Carbonic anhydrase 2,39821,0.0513917763539903,0.00665775653675939,0.0383425735419419,0.0644409791660387,1.24081809813563e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0254275242406672,0.00329885365460525,0.0189617710776409,0.0318932774036935,1.36934419035514e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0176835691865604,0.00230072812826144,0.013174142055168,0.0221929963179528,1.6046250800326e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH1,Cadherin-1,39315,0.0302637869086907,0.00395052903674365,0.0225207499966732,0.0380068238207083,1.95869456511939e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0362220568502161,0.00472914422965563,0.0269529341600911,0.0454911795403412,1.99624664739835e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRSF1,G-rich sequence factor 1,36874,0.0606350786638694,0.00792169895444649,0.0451085487131542,0.0761616086145845,2.08035284925451e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0403574244912932,0.00527373691268401,0.0300209001424325,0.0506939488401538,2.10320884650129e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0622740231071693,0.00814098890021872,0.0463176848627406,0.078230361351598,2.13316857253072e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0329150150109666,0.00431214670912772,0.0244632074610763,0.041366822560857,2.42073295939379e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A13,Protein S100-A13,37056,0.0259615508736208,0.0034088090734169,0.0192802850897237,0.0326428166575179,2.79395515395913e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0217477488024938,0.0028601992893027,0.0161417581954605,0.0273537394095271,3.04116726029963e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0277278971342174,0.00365028461965212,0.0205733392796992,0.0348824549887355,3.25744822771024e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0182423397548244,0.00240235775319885,-0.0229509609510941,-0.0135337185585546,3.3213119422751e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFC1,Cryptic protein,39477,0.0347301638047558,0.00457822376920753,0.0257568452171091,0.0437034823924026,3.48627192748838e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP6,Gastrotropin,39564,0.0401821118257033,0.00530398091490185,0.0297863092324957,0.0505779144189109,3.76654043469558e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0362442244259253,0.00478807221537934,0.0268596028837818,0.0456288459680688,3.94448791751078e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAM,Integrin alpha-M,39858,-0.0233866205321102,0.00309279680430937,-0.0294485022685566,-0.0173247387956638,4.19568531419316e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS1,Nephrin,37056,0.0254029986955257,0.0033592300635078,0.0188189077710504,0.031987089620001,4.22633888261936e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0385417236969325,0.00510555513811067,-0.0485486117676294,-0.0285348356262356,4.6228362646242e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXN,Thioredoxin,37289,0.0319547361765104,0.00423597938048354,0.0236522165907627,0.0402572557622582,4.86340277855623e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX5,Sorting nexin-5,37043,0.0225468455062278,0.00298879774039499,0.0166888019350536,0.0284048890774019,4.86395818395958e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB8,Serpin B8,40058,0.040604400524545,0.00539820571435753,0.0300239173244043,0.0511848837246858,5.68409654766122e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0524383748502819,0.00697518873561094,0.0387670049284845,0.0661097447720793,5.92453056545809e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0254783391280099,0.00339496669505482,0.0188242044057025,0.0321324738503174,6.47945633460415e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0294491123346303,0.00394030310520267,0.0217261182484331,0.0371721064208275,8.28249012198755e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD93,Complement component C1q receptor,39238,-0.0224417160450331,0.00301729588331578,-0.028355615976332,-0.0165278161137342,1.07865421379196e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SBSN,Suprabasin,37420,-0.0247199904347032,0.00333161310562804,-0.0312499521217342,-0.0181900287476722,1.24244635383408e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0349890182915667,0.00471790283339043,0.0257419287381215,0.044236107845012,1.26589445968592e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0173025570463343,0.00233487469409682,-0.0218789114467641,-0.0127262026459045,1.32097424947797e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.02301805311081,0.00310840948487378,0.0169255705204574,0.0291105357011626,1.37630971424448e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP9,Caspase-9,37056,0.0459800818768496,0.00621226052780588,0.0338040512423501,0.0581561125113491,1.42797090899372e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A12,Protein S100-A12,39615,0.0540556281728203,0.00732359793127131,0.0397013762275285,0.068409880118112,1.64919732371494e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0161063274181018,0.00218730128584307,0.0118192168978493,0.0203934379383542,1.89375368022317e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRH,Corticoliberin,39455,0.0626738917785512,0.00853014612659524,0.0459548053704245,0.0793929781866779,2.12199047854064e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0857731833297433,0.0117557587049023,0.0627318962681349,0.108814470391352,3.12800005483446e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGCR6,Protein DGCR6,36991,0.0309073117794126,0.00424985755365862,0.0225775909742417,0.0392370325845835,3.72743556457641e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0233713534958607,0.00322381486112527,0.0170526763680551,0.0296900306236662,4.37114101959465e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0258614819693658,0.00357112339112424,0.0188620801227623,0.0328608838159693,4.66608676622974e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0255729403659989,0.00353223647418771,-0.0324961238554068,-0.018649756876591,4.69669771961206e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0521435320624517,0.007234732937687,0.0379634555045852,0.0663236086203182,5.96431693197683e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB6,Integrin beta-6,39587,0.0208868882681783,0.00291063716139671,0.0151820394318408,0.0265917371045159,7.49562465417089e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GC,Vitamin D-binding protein,37453,0.0181903386446694,0.00253587427651933,0.0132200250626915,0.0231606522266473,7.70541560354779e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.023962931562016,0.00334753423524658,-0.0305240986630993,-0.0174017644609327,8.58280660901972e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0701012394309716,0.00983502135074525,0.0508245975835109,0.0893778812784323,1.06547860756097e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRK1,Protein BRICK1,39489,0.0311220417940478,0.0043691914406944,0.0225584265702868,0.0396856570178089,1.10156087856194e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MET,Hepatocyte growth factor receptor,39879,-0.0136299242388144,0.00191418567021523,-0.0173817281524362,-0.00987812032519249,1.12118935553999e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.032826226034137,0.00462088326046205,0.0237692948436314,0.0418831572246426,1.26535727258785e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0687046320806466,0.00967655698570058,0.0497385803886735,0.0876706837726198,1.31053719486469e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0593375417456897,0.00836764600127875,0.0429369555831834,0.0757381279081961,1.3841832088746e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0660917120540003,0.00932970654168292,-0.0843779368756988,-0.0478054872323017,1.45876425659746e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0424805240052939,0.00600680827496013,0.030707179786372,0.0542538682242157,1.60180462930664e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEK,Angiopoietin-1 receptor,39913,0.015010522557822,0.00212508078207579,0.0108453642249535,0.0191756808906906,1.69016051083097e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD59,CD59 glycoprotein,39173,0.0146262587398877,0.00207174598760056,0.0105656366041906,0.0186868808755848,1.73820240007783e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI2,Serpin I2,37382,0.0394900200675428,0.00561565186845975,0.0284833424053617,0.0504966977297239,2.13166236980118e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0219286837215003,0.00311971156221964,0.0158140490595498,0.0280433183834508,2.16292001304761e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.04502097685255,0.00640684705335607,0.0324635566279722,0.0575783970771279,2.19437504080276e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPQ,Carboxypeptidase Q,37430,0.0260131694657334,0.00370492978225066,0.0187515070925221,0.0332748318389447,2.30380247954767e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPE,Carboxypeptidase E,39906,-0.026498343758366,0.00378386219964338,-0.033914713669667,-0.0190819738470649,2.6050023748294e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH15,Cadherin-15,39973,0.036822716688656,0.0052587266237807,0.0265156125060458,0.0471298208712662,2.61902681146057e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFAP1,Actin filament-associated protein 1,37124,0.058327826042574,0.00833016964163124,0.0420006935449768,0.0746549585401712,2.6448791815009e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSG,Basigin,40040,0.013345841809507,0.0019070723927927,0.00960797991963331,0.0170837036993807,2.69677446751105e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHPS,Deoxyhypusine synthase,37368,0.0281194219264248,0.0040194880832224,0.0202412252833089,0.0359976185695407,2.76224841603802e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0196465458501851,0.00281831792153466,-0.025170448976393,-0.0141226427239772,3.26911311518944e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.022705779522295,0.00326331069252215,-0.0291018684796384,-0.0163096905649516,3.58761826555105e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0603760948323584,0.00867811670206354,0.0433669860963139,0.0773852035684029,3.60352089270643e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX2,Sorting nexin-2,37368,0.0549477499731294,0.00790790513259181,0.0394482559132495,0.0704472440330094,3.86223141215976e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE6,Ribonuclease K6,37386,0.0188097464508388,0.0027094837490431,0.0134991583027143,0.0241203345989633,4.03676728057149e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0300290714002003,0.00433918985222035,0.0215242592898484,0.0385338835105522,4.71115370140046e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0328623259801462,0.00475018740664523,-0.0421726932971708,-0.0235519586631215,4.78249655660067e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0223639586088218,0.00323715883668088,0.0160191272889273,0.0287087899287164,5.1154704536911e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD276,CD276 antigen,39862,-0.0238274876046753,0.00345227045460948,-0.0305939376957099,-0.0170610375136407,5.32095271392414e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0381606077162379,0.00553059739318237,0.0273206368256004,0.0490005786068753,5.44176110676562e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0191021697962811,0.00278228623734315,-0.0245554508214737,-0.0136488887710885,6.86350427897353e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0565205291305729,0.00825461086471643,0.0403414918357287,0.0726995664254171,7.81439888859526e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLU,Clusterin,37453,0.0213935583491032,0.00312510630012384,0.0152683500008605,0.0275187666973459,7.93643624316268e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPB2,Coatomer subunit beta',37021,0.028700207189655,0.00419606240536892,0.0204759248751319,0.0369244895041781,8.28104420630183e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0403016236474746,0.00589707425722855,0.0287433581033066,0.0518598891916425,8.55313029412839e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0268655530468738,0.00393568800194424,0.0191516045630631,0.0345795015306846,9.03642965214823e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0462410428433068,0.00677606155378967,0.0329599621978791,0.0595221234887346,9.22010359383084e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK4,Kallikrein-4,40030,-0.0401996010004983,0.00590146414649122,-0.0517664707276211,-0.0286327312733755,9.97817646323278e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0166866233650649,0.00245002907298508,0.0118845663820141,0.0214886803481156,1.00508033862198e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0244526721950204,0.00359068994471734,0.0174149199033744,0.0314904244866664,1.01821762952684e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0278788596898482,0.00410703584046148,0.0198290694425437,0.0359286499371527,1.1774014050372e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0208467802491871,0.00307429786277006,0.0148211564381578,0.0268724040602164,1.24441693675774e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0186121132571773,0.00274654979021337,0.013228875668359,0.0239953508459955,1.28316266538419e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRN,Progranulin,39787,0.0163900229212748,0.00242273955757522,0.0116414533884274,0.0211385924541222,1.37877550771632e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0251338433058826,0.00371495042565552,0.0178525404715978,0.0324151461401675,1.38215114258038e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM3,Myomesin-3,37124,-0.0622094142376393,0.00919569551890933,-0.0802329774547016,-0.044185851020577,1.38845722036887e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0354937722454843,0.00524747393843716,0.0252087233261474,0.0457788211648211,1.39783004992003e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0384681186986773,0.0056940144270247,0.0273078504217089,0.0496283869756458,1.46976868774598e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0148570993832437,0.0022022312634236,0.0105407261069335,0.019173472659554,1.56795345613645e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN3,Matrilin-3,39720,-0.0207110274219944,0.00307229078101413,-0.0267327173527821,-0.0146893374912067,1.6246489773773e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0227179869053637,0.00337138589610705,0.0161100705489939,0.0293259032617335,1.65549355685214e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0234641619943299,0.00348381316379432,-0.0302924357953667,-0.016635888193293,1.69228761178116e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0333495427266923,0.00495395161822199,0.0236397975549772,0.0430592878984074,1.74384603954795e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST5,Cystatin-D,39559,0.0358196858270053,0.00532231145257728,0.0253879553799539,0.0462514162740568,1.75416861466848e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0365553203509221,0.00543328341653645,0.0259060848545106,0.0472045558473335,1.78890333849514e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0223109591166923,0.00331772701497247,0.0158082141673462,0.0288137040660383,1.82938343466134e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF7,SLAM family member 7,39866,-0.0380380498814725,0.00566017108818811,-0.0491319852143212,-0.0269441145486238,1.87470959032241e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.030951306913694,0.00461053749951931,0.0219146534146361,0.0399879604127518,1.97017879150142e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNC,Tenascin,39931,-0.0309159956126118,0.00461393294653794,-0.0399593041878261,-0.0218726870373974,2.14500335320002e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0148985307673366,0.00222563160542153,0.0105362928207105,0.0192607687139628,2.24177881623239e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYGD,Gamma-crystallin D,37388,0.0632566448534641,0.00945251947185816,0.0447297066886221,0.0817835830183061,2.28744988796867e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0392053695180927,0.00587102674945434,0.0276981570891621,0.0507125819470232,2.50627970374206e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0191186302391184,0.00286862584255079,0.0134961235877189,0.024741136890518,2.73940716857804e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGA,Fibrinogen alpha chain,37149,0.0201291338110204,0.0030252462547163,0.0141996511517764,0.0260586164702643,2.96979782178901e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0235322794276776,0.00355031833337657,0.0165736554942595,0.0304909033610957,3.5076083691904e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVALB,Parvalbumin alpha,39971,0.0740700704578656,0.0111992098026094,0.0521196192447511,0.09602052167098,3.86192415387137e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPO,Myeloperoxidase,39858,0.0293885237882534,0.00444662930770588,0.0206731303451499,0.0381039172313569,3.9869739864998e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0309626948773072,0.00468737169963868,0.0217754463460154,0.0401499434085991,4.08517067351545e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0217322686441244,0.0032921810068124,0.0152795938707721,0.0281849434174767,4.23060459626773e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.019815571557106,0.00300317462418755,-0.0257017938205136,-0.0139293492936984,4.29451387039044e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.023284456642646,0.00353223007534097,0.0163612856949777,0.0302076275903143,4.47753568859733e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD209,CD209 antigen,39885,-0.0250962600913019,0.00381195884160362,-0.032567699420845,-0.0176248207617588,4.73583597582645e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0226672124758235,0.00344457381448641,0.0159158477994301,0.0294185771522168,4.86439433913987e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0325280236950936,0.00496253892039082,0.0228014474111276,0.0422545999790596,5.77705327157262e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0244055652734732,0.00372867237184875,0.0170973674246496,0.0317137631222967,6.15206339687874e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA12,Carbonic anhydrase 12,39788,-0.0203448191383871,0.00312299323782132,-0.0264658858845169,-0.0142237523922573,7.5105674370738e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.02037586952321,0.00312777738189905,0.0142454258546878,0.0265063131917321,7.51390298973975e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0233600467261376,0.00359015048855735,0.0163233517685652,0.03039674168371,7.9526202418204e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0385144958121499,0.00593109272420841,0.0268895540727014,0.0501394375515984,8.67769830142253e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0324957697540037,0.00502768969021529,0.0226414979611817,0.0423500415468257,1.05438336110265e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN2,Calsyntenin-2,40058,-0.0248490781601257,0.00386401337137117,-0.0324225443680132,-0.0172756119522382,1.30403578600443e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0268475548487509,0.00417556325911777,-0.0350316588366218,-0.0186634508608801,1.32277041744367e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.023187168322753,0.00361951738305146,0.0160929142519722,0.0302814223935339,1.53481096932514e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0374947789177166,0.00585704444415484,0.0260149718071731,0.04897458602826,1.57935516516069e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAX,Apoptosis regulator BAX,39456,0.0574911994801089,0.00898754997240652,0.0398756015341921,0.0751067974260256,1.63229711053575e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0227157872399031,0.00355110223771558,0.0157556268539806,0.0296759476258256,1.63870951591349e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1A,Protein phosphatase 1A,39477,0.019161923871236,0.00299650993896589,0.0132887643908629,0.0250350833516092,1.65382240966534e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA6,Carbonic anhydrase 6,39817,-0.0398672909932022,0.00623910987524621,-0.0520959463486848,-0.0276386356377196,1.70594616236564e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0160335946967934,0.00250895838438553,-0.020951153130189,-0.0111160362633977,1.70697881644997e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0160015634928769,0.00250577247147988,0.0110902494487764,0.0209128775369775,1.75110480680481e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0181766282752965,0.00285126836399978,0.0125881422818569,0.023765114268736,1.89000722113341e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0219569331545455,0.00345561384997289,0.0151839300085987,0.0287299363004924,2.15613620685169e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0346623280048173,0.00546839225358833,0.0239442791877842,0.0453803768218504,2.37896456068251e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0223862539748507,0.00353430536944653,0.0154590154507355,0.0293134924989659,2.46709966032951e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0379245426039387,0.00598864403605191,0.026186800293277,0.0496622849146005,2.48657615680257e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0390366196244315,0.00617864113761885,-0.0511467562541645,-0.0269264829946986,2.7205459524765e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0391831080802238,0.006212942884354,0.0270057400268899,0.0513604761335576,2.92554974172695e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0281847533154274,0.00447276514637221,0.0194181336285378,0.0369513730023169,3.04315746138092e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0153994980482534,0.0024473520187949,0.0106026880914154,0.0201963080050914,3.22421290570731e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A14,Protein S100-A14,37411,0.0314920647562075,0.00501061288385703,0.0216712635038477,0.0413128660085672,3.37739048888897e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLC,Galectin-10,39841,-0.0410216646760588,0.00653357632954633,-0.0538274742819696,-0.028215855070148,3.50471566741336e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0291299904070485,0.00464746122612302,0.0200209664038474,0.0382390144102497,3.75467987071583e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0362387376992583,0.00579934557253015,-0.0476054550214174,-0.0248720203770993,4.24180446907839e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL1,Chordin-like protein 1,39908,0.0187955180433725,0.0030085504077963,0.0128987592440917,0.0246922768426532,4.27951709910072e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17D,Interleukin-17D,39587,0.0207639204622499,0.00332525195734858,0.0142464266258467,0.0272814142986531,4.36591180332045e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0295238048660076,0.00473417138918756,0.0202448289432,0.0388027807888152,4.59432190279e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0155077155334637,0.00248847387382289,0.0106303067407709,0.0203851243261566,4.75008261432878e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0342541053044759,0.005511646420132,0.0234512783210172,0.0450569322879346,5.2921083178689e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCOR1,REST corepressor 1,39585,0.0273991422582409,0.00441166612494982,0.0187522766533393,0.0360460078631426,5.41056743106894e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB2,Lamin-B2,37388,0.016671103225785,0.0026846188030497,0.0114092503718076,0.0219329560797624,5.4583840746916e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE3,Eosinophil cationic protein,39791,0.065403402566191,0.0105498539599231,0.0447256888047418,0.0860811163276402,5.80526820412926e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0146053291883115,0.00236050932830897,0.00997873090482586,0.019231927471797,6.26776634151737e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0257601207764313,0.00416570043080679,0.01759534793205,0.0339248936208126,6.43974591520937e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0259475690265959,0.0041978260904711,0.0177198298892725,0.0341753081639192,6.51620181918287e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRL,Prolactin,40009,-0.0459534983303109,0.00743922307561665,-0.0605343755585195,-0.0313726211021023,6.6815393130377e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.048996077141462,0.00794274409001096,0.0334282987250405,0.0645638555578835,7.056902005643e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0253242098869551,0.00411484594594758,0.0172591118328979,0.0333893079410124,7.75100753108339e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0326116992765915,0.00530105349451172,0.0222216344273486,0.0430017641258345,7.86967856747268e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0267776055713721,0.0043541688838851,0.0182434345589573,0.0353117765837869,7.97292798703215e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300A,CMRF35-like molecule 8,37124,0.0174589144474198,0.00284078674744985,0.0118909724224181,0.0230268564724215,8.18393880715128e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PZP,Pregnancy zone protein,37453,0.0331646037575736,0.00540101551566616,0.022578613346868,0.0437505941682793,8.45858127144994e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0327540969304056,0.00533449261888041,0.0222984913974,0.0432097024634112,8.48608798750283e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0210788088716402,0.00343340581440695,0.0143493334754026,0.0278082842678778,8.48733207729946e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LXN,Latexin,39682,-0.040247835519039,0.00655769913709589,-0.0531009258277469,-0.027394745210331,8.58323154225492e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA12,Serpin A12,39405,0.0711278145867392,0.0115948404255878,0.0484019273525872,0.0938537018208913,8.75315273595934e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0358927681971096,0.00585765861861903,0.0244117573046163,0.0473737790896029,9.17552296873266e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0341738090953389,0.00559164202333443,0.0232141907296034,0.0451334274610744,1.00972196267847e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0361688433987714,0.00591970295966366,0.0245662255978306,0.0477714611997122,1.02497382445454e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.14311383322284,0.0234631210789172,0.097126115908162,0.189101550537517,1.0928542036354e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0464021725132181,0.00760761639532505,0.031491244378381,0.0613131006480552,1.09421815922272e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0318766969475908,0.00523652033874704,0.0216131170836466,0.042140276811535,1.17880573390349e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL3,Insulin-like 3,37388,0.0431618732499486,0.00711523657786379,0.0292160095573355,0.0571077369425616,1.345327821163e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPF,Centromere protein F,37169,0.0319727142235902,0.00529285549644551,0.021598717450557,0.0423467109966234,1.57509544468025e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0285927359009035,0.00473614658849787,0.0193098885874477,0.0378755832143593,1.61094390318523e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0270582103125469,0.0044888708966807,0.0182600233550527,0.0358563972700411,1.70606328221262e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDM1,Nuclear protein MDM1,37039,0.0184982216725911,0.00306897190813388,0.0124830367326487,0.0245134066125335,1.70964064419165e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0459819148982792,0.00764170238711143,0.0310041782195408,0.0609596515770176,1.82126654200779e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0289498984271545,0.00481505941187548,-0.0383874148744304,-0.0195123819798786,1.86796164988763e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LUZP2,Leucine zipper protein 2,37368,0.0257144997624495,0.00428921641094831,0.0173076355969908,0.0341213639279082,2.08480436490614e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.0141075943238906,0.0023544323359724,-0.0187222817023965,-0.00949290694538465,2.11832285453171e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0121497567288736,0.00203040821639585,0.0081701566247377,0.0161293568330094,2.22527860724304e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0355614001643741,0.00594448660179614,0.0239102064248536,0.0472125939038945,2.24765275988696e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0210805136733173,0.00352662084524916,0.0141683368166289,0.0279926905300056,2.31292142386322e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0606131566632289,0.0101418714071988,0.0407350887051194,0.0804912246213385,2.33681983625636e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0144601704773266,0.00242172782197359,0.00971358394625838,0.0192067570083948,2.40770524959297e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0690688380238585,0.0115732627225585,0.0463852430876439,0.0917524329600731,2.45361650766296e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1B,Interleukin-1 beta,39478,0.0326362371783804,0.00547497449687407,0.0219052871645072,0.0433671871922536,2.56121611284421e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO1,Roundabout homolog 1,39885,0.0137622684333926,0.00231693243023664,0.00922108087012882,0.0183034559966564,2.9115674678711e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0150550813937324,0.0025386937263619,-0.0200309210974017,-0.0100792416900631,3.09830138987594e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1,Programmed cell death protein 1,39998,0.02371579953504,0.00401608408024783,0.0158442747377543,0.0315873243323257,3.59279667978567e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAT,Catalase,37252,0.0305952669199818,0.00518595428719155,0.0204307965170864,0.0407597373228772,3.73090076523394e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0155395981184747,0.00263540031874997,-0.0207049827432246,-0.0103742134937247,3.80224768579091e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHCY,Adenosylhomocysteinase,39868,0.0391824666413589,0.0066488158340793,0.0261507876065635,0.0522141456761543,3.8651090316302e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA7,Carbonic anhydrase 7,37169,-0.0194462636238608,0.00330319060728839,-0.0259205172141461,-0.0129720100335756,4.02464069364617e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0305043922321455,0.00518610508416267,0.0203396262671867,0.0406691581971044,4.13696997607187e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0237802424907293,0.00404549650761803,0.015851069335798,0.0317094156456607,4.24768531336512e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0305222691010073,0.00519550064268793,0.0203390878413389,0.0407054503606756,4.33600859887794e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY75,Lymphocyte antigen 75,39866,0.0221502526535421,0.00379207010260381,0.0147177952524386,0.0295827100546455,5.28302397915579e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0308066633521859,0.00527704613287167,0.0204636529317575,0.0411496737726144,5.39034114024752e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR1,Cadherin-related family member 1,39489,0.024390343276265,0.00419312510622166,0.0161718180680706,0.0326088684844595,6.1176861374166e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN1,Contactin-1,40052,-0.0152011015529016,0.00261405570907694,-0.0203246507426924,-0.0100775523631108,6.17241256724393e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0172871876476411,0.0029865711259051,-0.0231408670544151,-0.0114335082408671,7.2728183829648e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0531670211752054,0.00919137485636052,0.0351519264567388,0.071182115893672,7.41095399007984e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN3,Calsyntenin-3,37388,0.0171705919773781,0.00296918403938914,0.0113509912601754,0.0229901926945809,7.50312843023337e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0214659740257323,0.0037162876424327,0.0141820502465642,0.0287498978049004,7.81400982336344e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH1,Protocadherin-1,40018,0.0117667211914538,0.00204046036308415,0.00776741887980882,0.0157660235030987,8.23158575128154e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSM,Oncostatin-M,39785,0.0403884716485754,0.00701241310981372,0.0266441419533405,0.0541328013438103,8.58850025437409e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0159990285684854,0.00277797008893887,0.0105542071941652,0.0214438499428055,8.63341931423855e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSC2,Desmocollin-2,39673,-0.0188006127819181,0.00326701805735037,-0.0252039681743248,-0.0123972573895114,8.84183593704205e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO3,R-spondin-3,40030,0.0151972522104878,0.00264417938747111,0.0100146606110444,0.0203798438099312,9.22391516025146e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAM,Basal cell adhesion molecule,39858,-0.0132789550539794,0.00231051238365839,-0.0178075593259498,-0.00875035078200893,9.23905895233046e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0260871827175061,0.00454063450504447,0.0171875390876189,0.0349868263473933,9.34281050715636e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0137638525535601,0.00239659191036981,-0.0184611726978849,-0.00906653240923528,9.46296510861594e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0249942107040163,0.00435706471812332,-0.033534057551538,-0.0164543638564945,9.8792348899243e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0228456485888855,0.00398349071552458,0.0150380067864574,0.0306532903913137,9.92680889719905e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0193130113510917,0.00336882233044366,0.0127101195834221,0.0259159031187613,1.00505223235506e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG3,Desmoglein-3,39964,0.0187487627334037,0.00327117713953292,0.0123372555399192,0.0251602699268882,1.01325674177612e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.0142369323805729,0.00248475667033432,-0.0191070554544282,-0.00936680930671768,1.02391317884175e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0183617149192027,0.00320433670281941,-0.0246422148567287,-0.0120812149816766,1.02450971398646e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0234136038935775,0.00409079307843397,0.0153956494598469,0.0314315583273081,1.06569378349249e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENSA,Alpha-endosulfine,37368,0.0294738746321811,0.00515695798698881,0.019366236977683,0.0395815122866792,1.11784659292079e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0157088576365403,0.00275269866348832,0.0103135682561032,0.0211041470169774,1.17203335718203e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS4,Thrombospondin-4,39892,0.0250123488756577,0.00438323287494683,0.0164212124407619,0.0336034853105535,1.17450068265335e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.022733392204201,0.00398384893490549,0.0149250482917863,0.0305417361166158,1.17489933459901e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA1,Carbonic anhydrase 1,39531,0.0332093010915629,0.00582479093146403,0.0217927108658934,0.0446258913172323,1.20988038402597e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAD,Chondroadherin,37124,0.0282124570245924,0.00495180559411489,0.0185069180601272,0.0379179959890576,1.24228342442307e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0153538588031844,0.00269555805573725,0.0100705650139394,0.0206371525924294,1.24817953775461e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.025846881425468,0.00454034185359425,0.0169478113924232,0.0347459514585127,1.27225605676785e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0273713098035917,0.00481531587249054,0.0179332906935102,0.0368093289136731,1.34115625234572e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALCAM,CD166 antigen,40052,0.0108156324268075,0.00190433224195623,0.00708314123257332,0.0145481236210417,1.37418312968705e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0212729010338859,0.00376954878929605,0.0138845854068657,0.0286612166609062,1.70200918301997e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB37,Ras-related protein Rab-37,39587,0.0461348406382563,0.00818245865718249,0.0300972216701786,0.062172459606334,1.747278051999e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0220321820903834,0.00391966946034311,0.0143496299481109,0.0297147342326558,1.93794847783564e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.0291116317256774,0.00518293965360807,0.0189530700046056,0.0392701934467492,1.98415465030149e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST1,Cystatin-SN,35640,0.0556014447504507,0.00990214181836308,0.0361932467864591,0.0750096427144424,2.00902925179951e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL34,Interleukin-34,39456,0.0196378921856408,0.00351284558811365,0.0127527148329381,0.0265230695383436,2.30465269309845e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0315710709160744,0.00565636388162493,0.0204845977080896,0.0426575441240593,2.42303546275171e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSH,Pro-cathepsin H,39546,0.0394916720970417,0.007099686421693,0.0255762867105234,0.05340705748356,2.70355938977401e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0165311568570422,0.00297539796676797,0.010699376842177,0.0223629368719075,2.80617038484818e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAN,Versican core protein,40009,-0.0160900887784005,0.00290157814204971,-0.0217771819368179,-0.0104029956199831,2.98071073294668e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0382247872765448,0.00689287819083952,0.0247147460224994,0.0517348285305903,2.98672826074563e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA1,Ephrin-A1,39826,0.0143310206166448,0.00258596007643874,0.00926253886682484,0.0193995023664647,3.04016391703959e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR1,Complement receptor type 1,37420,0.0193716067692139,0.00349738685741443,0.0125167285286816,0.0262264850097462,3.10077850514367e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD1,Leiomodin-1,37411,-0.0190818698439541,0.00345570151483397,-0.0258550448130287,-0.0123086948748796,3.41619412230982e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGA4,Pepsin A-4,37445,0.0336783801234011,0.00610352388135825,0.021715473315939,0.0456412869308633,3.49437075066072e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300E,CMRF35-like molecule 2,39991,0.0208101239429199,0.00377356375050578,0.0134139389919285,0.0282063088939112,3.54714908783593e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0159770722505368,0.00289728070042426,0.0102984020777053,0.0216557424233684,3.55153249320923e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0309966817219325,0.00564659674384393,0.0199293521039984,0.0420640113398666,4.09360899136952e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0173994953555622,0.00318775299642607,0.0111514994825671,0.0236474912285573,4.89594659440788e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0191731158243081,0.00351453757448966,0.0122846221783084,0.0260616094703079,4.97532993726866e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0150621034783752,0.00276165162477659,-0.0204749406629373,-0.00964926629381302,4.99673283604597e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALY,RNA-binding protein Raly,37368,0.0260469365500976,0.00477835433802597,0.0166813620475667,0.0354125110526285,5.09589249818955e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0348515273949936,0.00639804973761199,0.022311349909274,0.0473917048807131,5.19176737911216e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0330718026493427,0.00607691281490086,0.0211610535321371,0.0449825517665484,5.35417197978102e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0254585344563272,0.00468131373462412,0.0162831595364639,0.0346339093761905,5.47422454463705e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MILR1,Allergin-1,39587,-0.026417129101856,0.00486011627426099,-0.0359429569994075,-0.0168913012043044,5.54589413688431e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN5,CCN family member 5,39858,0.0204283994322144,0.00377713342698144,0.0130252179153308,0.027831580949098,6.4488906302341e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN8,Septin-8,37357,0.0169155121236895,0.0031300262895934,0.0107806605960864,0.0230503636512925,6.61776040513768e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0195898174321051,0.00363082718284811,0.0124733961537228,0.0267062387104874,6.95147749578491e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0333793558989087,0.00619494258046523,0.0212372684411969,0.0455214433566206,7.2384567842268e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.012801898057607,0.00237709269838019,0.00814279636878181,0.0174609997464322,7.34719393335995e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00928403850315061,0.00172462499877257,0.00590377350555637,0.0126643035007448,7.41952510506396e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0203352597957349,0.00378164892456829,0.0129232279035811,0.0277472916878888,7.66575388093818e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00826674201661511,0.00153761318007925,0.00525302018365977,0.0112804638495704,7.70657239264297e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.0177921673180208,0.00330951946877073,-0.0242788254768114,-0.0113055091592302,7.73939853292395e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.018899094830194,0.00351931691045254,0.012001233685707,0.025796955974681,7.98096071900112e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSR,Insulin receptor,37056,0.00877204637451019,0.00163368777703364,0.00557001833152425,0.0119740744174961,8.03039533947644e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH1,Neurexophilin-1,39489,0.0197650874099358,0.00368746714102957,0.0125376518135178,0.0269925230063538,8.43697373377393e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0205681205130025,0.00384026676270001,0.0130411976581105,0.0280950433678945,8.65221724479143e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0170342527448182,0.00318056895390256,0.0108003375951692,0.0232681678944672,8.66030823875435e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA4,Apolipoprotein A-IV,37453,0.0185996186444758,0.00347469235270768,0.0117892216331688,0.0254100156557829,8.79707192311151e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0145325063816093,0.00271611969433945,0.00920891178070398,0.0198561009825146,8.8934989525998e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCN,Decorin,39585,-0.0114086141486623,0.00213341666169421,-0.0155901108055829,-0.00722711749174162,9.03844978799333e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0133866662356966,0.00250443497879491,0.00847797367725859,0.0182953587941346,9.1791593980635e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,C8B,Complement component C8 beta chain,37453,0.0158996531584043,0.00297636783242148,0.0100659722068582,0.0217333341099504,9.34263980091794e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD1,Polycystin-1,37437,0.0137335778902108,0.00257224203396653,0.00869198350363639,0.0187751722767852,9.48889544275535e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D17,TBC1 domain family member 17,39489,0.0230589645263399,0.00431938312061265,0.0145929736099392,0.0315249554427407,9.50356563110633e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0136195018353672,0.00255271130173722,-0.0186228159867722,-0.0086161876839623,9.69602619199392e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0288627216073685,0.00542879275443424,0.0182222878086774,0.0395031554060596,1.07143158304422e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CABP2,Calcium-binding protein 2,37039,0.034281633399419,0.00645533700487775,0.0216291728698586,0.0469340939289793,1.11048071497347e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR15L,Protein GPR15L,37382,0.0317217243097291,0.00602559797345342,0.0199115522817604,0.0435318963376978,1.42727834422357e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG4,Desmoglein-4,39725,0.0252797113006487,0.0048135098924678,0.0158452319114118,0.0347141906898856,1.52544249869424e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0362300810337907,0.00690998090636597,-0.049773643610268,-0.0226865184573133,1.60234711038293e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0279835153025372,0.00534582738862326,-0.0384613369842387,-0.0175056936208356,1.67395233938971e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0216464258610682,0.00413904780099986,0.0135338921711085,0.0297589595510279,1.72207157953326e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0366975413018125,0.0070419331471029,0.0228953523334908,0.0504997302701342,1.9033786569364e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0160545258328964,0.00308453088316309,-0.0221002063638961,-0.0100088453018968,1.97073022936277e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0136959853227697,0.00263858301577014,0.00852436261186025,0.0188676080336792,2.12102929834918e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.021808707716064,0.00422918703619894,0.0135195011251141,0.0300979143070139,2.54370693424487e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MBL2,Mannose-binding protein C,37257,-0.0543549171728749,0.010547569532618,-0.0750281534568063,-0.0336816808889436,2.59564655254578e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0172459380316067,0.00334675246394088,0.0106863032022826,0.0238055728609309,2.59896980201678e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZU1,Azurocidin,39344,0.0387196386625771,0.0075238302274045,0.0239729314168643,0.0534663459082899,2.68970506066664e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN10,Ataxin-10,39489,0.0368467321671566,0.00718595970451329,0.0227622511463105,0.0509312131880026,2.96963143521077e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYT1,Synaptotagmin-1,37388,0.0186362573237638,0.00363600063195989,0.0115096960851224,0.0257628185624052,3.0086869084169e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0340833074603637,0.00665784120435949,0.0210339386998191,0.0471326762209083,3.11062148368242e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTB,Lymphotoxin-beta,37368,0.0171633462506919,0.00335394425773433,0.0105896155055326,0.0237370769958512,3.14090929297495e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0361116179289254,0.00706455750268613,0.0222650852236606,0.0499581506341902,3.23689907004274e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMPD3,AMP deaminase 3,37388,0.0354665440223503,0.00695410711641813,0.0218364940741707,0.0490965939705298,3.4409068155931e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS53,Serine protease 53,37388,0.0185819821732461,0.00366249236532507,0.011403497137209,0.0257604672092832,3.95554908841223e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTL1,Cytokine-like protein 1,37437,0.011371244368053,0.0022471993552419,0.00696673363177889,0.0157757551043272,4.24324462656073e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDN1,Endothelin-1,37043,0.0139229555709257,0.00275866583930167,0.00851597052589441,0.019329940615957,4.54809303015777e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0091873176757121,0.00182094867689474,0.0056182582689984,0.0127563770824258,4.58542301359322e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0276330508733055,0.00548485746411708,-0.038383371502975,-0.016882730243636,4.75394040374963e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN2,Prefoldin subunit 2,39489,0.0275749948150634,0.00548236416201524,0.0168295610575136,0.0383204285726133,4.9652861324883e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0190726006666232,0.00379478231110063,0.011634827336866,0.0265103739963805,5.07200600052443e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB1,Calbindin,39788,0.0206484103845543,0.00411024829429738,0.0125923237277314,0.0287044970413772,5.12498507692564e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0346755707655584,0.00690483057355899,0.0211421028413827,0.048209038689734,5.17198148436908e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0131622642953016,0.00262397014582167,0.00801928280949109,0.0183052457811121,5.33806643836859e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0138781437416357,0.00277389611718911,0.00844130735194508,0.0193149801313264,5.70231787045988e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOB,Apolipoprotein B-100,37445,0.011121698374851,0.00222380949557959,0.00676303176351503,0.015480364986187,5.76880828224436e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL21,C-C motif chemokine 21,39931,0.0191998719028843,0.00384295727196403,0.0116676756498348,0.0267320681559338,5.91098483411924e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300C,CMRF35-like molecule 6,40009,0.0163034284625323,0.00326463678967517,0.00990474035476896,0.0227021165702956,5.97743104390102e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0189122987102853,0.00380623768126006,0.0114520728550156,0.026372524565555,6.80797866530751e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0237712585865553,0.00478897726796049,0.0143848631413528,0.0331576540317579,6.99891806646192e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK14,Kallikrein-14,40030,-0.0219864244854402,0.00443004348735529,-0.0306693097206565,-0.0133035392502238,7.01089466674633e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0208573351473729,0.00420734064263252,-0.0291037228069327,-0.0126109474878132,7.218603677396e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH6,Cadherin-6,39868,-0.0184368350478426,0.00373243475162606,-0.0257524071610297,-0.0111212629346555,7.90618638618507e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0133879705080127,0.00271299393205875,-0.0187054386148479,-0.00807050240117759,8.1220783732704e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMBS,Porphobilinogen deaminase,40030,0.0208007693458667,0.00421819614789538,0.0125331048959918,0.0290684337957417,8.25367989489999e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.011342846162517,0.00230558785448208,-0.0158617983573019,-0.00682389396773212,8.75192003905688e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0191115728233758,0.00388690497526845,0.0114932390718496,0.0267299065749019,8.89786231293616e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0151165877277068,0.00307525626728896,0.00908908544382041,0.0211440900115931,8.95959290293763e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.017676330234182,0.00359668779714127,0.0106268221517852,0.0247258383165789,8.98537158309503e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0174032529262296,0.00354458004470632,0.0104558760386052,0.024350629813854,9.20586098423655e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.0118930708013309,0.00242955396399939,-0.0166549965707697,-0.00713114503189207,9.91685757264605e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0103156694787747,0.00210831691382146,-0.0144479706298648,-0.00618336832768466,1.00372221890381e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX18,Sorting nexin-18,37382,0.0216813317315109,0.00443889708583574,0.0129810934432729,0.030381570019749,1.04933517048364e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A11,Protein S100-A11,39703,0.0217827071917438,0.00446064300941991,0.0130398468932807,0.0305255674902068,1.05336442717453e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC16,Mucin-16,39788,0.089088642227077,0.0182478700250855,0.0533228169779094,0.124854467476245,1.05958070079392e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN1,Calsyntenin-1,39489,0.0240401239321121,0.00494589272556485,0.014346174190005,0.0337340736742192,1.18152625776145e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL3,Fc receptor-like protein 3,39587,0.024867251387803,0.00512001873411919,0.0148320146689294,0.0349024881066766,1.20404754520649e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRLB,Fc receptor-like B,39477,0.0274562500249432,0.00568200610867459,0.016319518051941,0.0385929819979454,1.36356149186659e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0148362804578173,0.00307595484408668,0.00880740896340739,0.0208651519522272,1.42773213989821e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0121498270751802,0.00252211229721666,0.00720648697263555,0.0170931671777248,1.47068728268469e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0169396919015671,0.00352513365519606,0.0100304299373828,0.0238489538657513,1.56139716914084e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC1,Glypican-1,40030,0.0136643128324247,0.00284595728175701,0.008086236560181,0.0192423891046685,1.5904455315242e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0198492498161948,0.00414262891482403,0.0117296971431397,0.0279688024892499,1.67081783116408e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0192740114072358,0.00402508025479048,0.0113848541078464,0.0271631687066251,1.69583091970575e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA1,Annexin A1,37072,0.0205467929573411,0.00429769266312832,0.0121233153376096,0.0289702705770726,1.7640317487583e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCP1,Plastin-2,37437,0.0220206812903706,0.00460970934683282,0.0129856509705783,0.0310557116101629,1.79771318185785e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0241558227024924,0.00506150161620513,0.0142352795347304,0.0340763658702545,1.83635433261773e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0161606213313002,0.00338705477762702,0.00952199396715127,0.0227992486954492,1.84958810602276e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0124304979077476,0.00260787781533199,0.00731905738969688,0.0175419384257983,1.89067066399748e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLMP,CXADR-like membrane protein,40030,0.00957472625114244,0.00201014462824953,0.00563484277977335,0.0135146097225115,1.92197857912388e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0124838714805434,0.00262678599504765,0.00733537093025,0.0176323720308368,2.02949619301263e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0238527276730835,0.00502906913894372,0.0139957521607538,0.0337097031854131,2.12471029903897e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0118176903717601,0.00249169624885145,0.00693396572401124,0.0167014150195089,2.1257627823015e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0137825731120812,0.00290805023550799,0.00808279465048554,0.0194823515736769,2.16546932791189e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GM2A,Ganglioside GM2 activator,37178,0.0168006696290709,0.00355012044375155,0.00984243355931782,0.0237589056988239,2.24137582751132e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0153338370232577,0.0032472711708125,0.00896918552846517,0.0216984885180502,2.35417320780271e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPA,Apolipoprotein(a),37186,-0.0815172367234402,0.0172695961912031,-0.115365645258198,-0.0476688281886822,2.37923165572871e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK8,Kallikrein-8,39315,0.0161045965379804,0.00341446386396081,0.00941224736461718,0.0227969457113435,2.41937442959267e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0164065242444537,0.00348714066986453,-0.0232413199573881,-0.00957172853151919,2.5613691305435e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0148942577050136,0.00317309929726198,-0.0211135323276471,-0.00867498308238016,2.70302036420291e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0168923514407666,0.00360121528693403,0.00983396947837594,0.0239507334031573,2.74446541584432e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0240573013256223,0.00513268992531954,0.013997229071996,0.0341173735792486,2.79396872172869e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0314637334957372,0.0067268689985158,0.0182790702586463,0.0446483967328282,2.93532611206047e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0120954756053779,0.00259729826594711,0.00700477100412152,0.0171861802066342,3.23515998290825e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0119802338968239,0.00257584929209065,-0.0170288985093215,-0.00693156928432619,3.33584881223134e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0343316348727566,0.00738583943903337,0.0198553895722512,0.048807880173262,3.37399256854699e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSHB,Thyrotropin subunit beta,39868,0.03415221850525,0.00734855603815312,0.0197490486704699,0.0485553883400301,3.38704790410301e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SATB1,DNA-binding protein SATB1,37411,0.013683181886743,0.0029442461738356,0.00791245938602527,0.0194539043874608,3.39261386943531e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLFM4,Olfactomedin-4,36654,0.0562222565231315,0.0121009019893595,0.032504488623987,0.079940024422276,3.41607727168587e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0127516828300122,0.00274569849234503,0.00737011378501594,0.0181332518750085,3.44538859738667e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR2,Complement receptor type 2,39931,0.0206209039729229,0.00444791019501441,0.0119029999906947,0.0293388079551512,3.57858030133058e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICOSLG,ICOS ligand,39788,0.00855763765628411,0.00184933744319958,0.00493293626761294,0.0121823390449553,3.73190089039937e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0127795495504089,0.0027621891748149,-0.0181934403330461,-0.00736565876777167,3.74649005732748e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00949111343854001,0.00205726530383325,-0.0135233534340532,-0.00545887344302684,3.99748334896843e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0144389293999102,0.00312993552525709,-0.0205736030294141,-0.00830425577040633,4.00282123990451e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0117685272062655,0.00256212540390591,0.00674676141460993,0.0167902929979211,4.3967200432277e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.021114567694355,0.00459872649178169,-0.0301280716182471,-0.0121010637704629,4.43616784045128e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0313800843131696,0.0068381520997436,-0.0447828624286671,-0.0179773061976722,4.4881829692588e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN4,Contactin-4,39858,-0.0106968482167896,0.00234270381147317,-0.015288547687277,-0.00610514874630217,5.0076056155401e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0151218699425732,0.00331530332588842,-0.0216198644613145,-0.00862387542383188,5.13144535790673e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN8,Tetraspanin-8,37382,0.0437320785167569,0.00962001100310197,0.0248768569506771,0.0625873000828368,5.51627521063087e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0189424938491841,0.00417031548160121,0.0107686755052458,0.0271163121931225,5.60695185267083e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLGN,Calmegin,37039,0.0194343742655523,0.00428442550028721,0.0110369002849893,0.0278318482461152,5.78232049550143e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0136948919348491,0.00302012884468232,-0.0196143444704265,-0.00777543939927174,5.8233428626811e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0159524611789135,0.00352163627463091,0.00905005408063687,0.02285486827719,5.94779009826318e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWF,von Willebrand factor,40052,-0.0322745289584148,0.00717245586359188,-0.0463325424510549,-0.0182165154657747,6.84949669101354e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0194043212405824,0.00433047091215568,0.0109165982527572,0.0278920442284075,7.49627982212709e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.062238294795215,0.0138956664122463,0.0350027886272122,0.0894738009632177,7.55350781491862e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM2,Myomesin-2,37021,-0.0225990572413975,0.00506030675926613,-0.0325172584895591,-0.0126808559932358,8.03794524635004e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0230407977137565,0.00516532054559502,0.0129167694443903,0.0331648259831228,8.23630732956873e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0231232601347278,0.0051845588045766,0.0129615248777576,0.0332849953916979,8.25181474798247e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0136269939501469,0.00305754849597594,-0.0196197890022597,-0.00763419889803403,8.37415034150736e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHISA5,Protein shisa-5,37437,0.0100156526258053,0.00225127028413309,0.0056031628689044,0.0144281423827061,8.70019128869204e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0222863406958345,0.0050138025782818,0.0124592876424021,0.0321133937492668,8.8498274484898e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE1,Ribonuclease pancreatic,37445,0.00976821060182051,0.00219818651244893,0.00545976503742062,0.0140766561662204,8.91002718870827e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS4,Galectin-4,39862,0.022973468781153,0.00517908565946693,0.0128224608885979,0.0331244766737082,9.23360898016332e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0118595995094953,0.00267819144029442,0.00661034428651824,0.0171088547324724,9.56620866557895e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00995856613827031,0.00225222978494555,-0.0143729365167636,-0.00554419575977703,9.87348853185827e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN2,Alpha-actinin-2,37021,-0.0255968751752516,0.00580180366583665,-0.0369684103602914,-0.0142253399902118,1.03290153220421e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0279568654106265,0.00634161125944102,0.0155273073421221,0.0403864234791309,1.04914318946798e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAP,Cartilage-associated protein,37039,0.0213737308379544,0.00484960218272511,0.0118685105598132,0.0308789511160956,1.05486569278033e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPO,Erythropoietin,39866,0.0332877680550772,0.00757693190371112,0.0184369815238034,0.048138554586351,1.12358070581501e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0169165502369521,0.00385085965073234,-0.0244642351523875,-0.00936886532151673,1.12681355821442e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0158833598779579,0.00361695858117597,0.00879412105885296,0.0229725986970628,1.13501448070666e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0123318270287023,0.00281042255376347,0.00682339882332594,0.0178402552340787,1.15200319749543e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0305796522166529,0.00698576532584039,0.0168875521780057,0.0442717522553001,1.21006347317211e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNU13,NHP2-like protein 1,37021,0.0265787744492043,0.0060807503330523,0.0146605037964218,0.0384970451019868,1.24644582484726e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.010763867849015,0.00247359796879926,0.00591561583016849,0.0156121198678616,1.36036892476133e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA4,Carboxypeptidase A4,36868,0.0186245768930972,0.00428562521429544,0.0102247514730781,0.0270244023131163,1.39806235649756e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOSB,Protein fosB,39489,0.0166362333169387,0.00383779692696345,0.00911415134009031,0.024158315293787,1.46778635267046e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP4,Guanylate-binding protein 4,39489,0.0207700872922398,0.00480239234286343,0.0113573983002275,0.0301827762842521,1.53514939736778e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.015541373566789,0.0036099326912999,-0.0226168416417368,-0.00846590549184121,1.68030152681785e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0203466310715952,0.00474335250699312,0.0110496601578887,0.0296436019853017,1.80147918925859e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.0108233258050439,0.00252529960424232,-0.0157729130293589,-0.00587373858072899,1.83017823335715e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2,Ataxin-2,36991,0.0466933831245492,0.0109303366065854,0.0252699233756419,0.0681168428734565,1.95172815703392e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,B2M,Beta-2-microglobulin,37453,0.0129027375655084,0.00302363920658662,0.00697640472059864,0.0188290704104182,1.99204241579833e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0110108016340128,0.00258109529578832,0.00595185485426769,0.0160697484137579,2.00199401596536e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTG,Protogenin,40030,0.0104134176357206,0.00244394211696313,0.00562329108647287,0.0152035441849684,2.04748217013235e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0126529712331578,0.00297147496469576,0.00682888030235406,0.0184770621639615,2.07295738065839e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.00939327378591137,0.00220619610331972,-0.013717418148418,-0.00506912942340472,2.07741094537173e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0157994111054963,0.003721447912471,-0.0230934490139394,-0.0085053731970531,2.1960514202795e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY2,Protein canopy homolog 2,39585,0.0250883189318588,0.00591881316139233,0.0134874451355298,0.0366891927281877,2.26058538104447e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15,Interleukin-15,39866,0.0134902948424346,0.00318645560825833,0.0072448418502483,0.019735747834621,2.31225200732371e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0273646590878557,0.00646695190569287,-0.0400398848230138,-0.0146894333526977,2.33707573875885e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANPEP,Aminopeptidase N,39891,0.0115915496759518,0.00274004219079767,0.00622106698198834,0.0169620323699152,2.34543042031769e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0105958042636505,0.00250665574333717,0.00568275900670968,0.0155088495205914,2.3806521893727e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0254394126006906,0.00602816941929809,0.0136242005388664,0.0372546246625149,2.45575515764907e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00961062614205395,0.00228682424851352,0.00512845061496745,0.0140928016691404,2.65275656664121e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.024306600996946,0.00578412893635144,0.0129697082816972,0.0356434937121948,2.65949369311049e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0369850386998543,0.00880466474124877,0.0197278958070067,0.0542421815927019,2.67624103998301e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0245690189575493,0.00587156896798432,0.0130607437803,0.0360772941347985,2.87722888789039e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.0171968580461766,0.00411463594156869,-0.0252615444916513,-0.009132171600702,2.94069817201559e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0172253025102499,0.00412147581801987,0.00914720990693095,0.0253033951135688,2.9416075731061e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.015747487004306,0.00377905556543443,0.00834053809605448,0.0231544359125574,3.10235918992116e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLVRB,Flavin reductase,39858,0.026308967284185,0.00633085716720962,0.0139004872364541,0.0387174473319158,3.26018913130629e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0158451498023364,0.00381907846468645,0.008359756011551,0.0233305435931219,3.35776640753353e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.0129899038503729,0.0031469084747999,-0.0191578444609807,-0.00682196323976506,3.68456237534945e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,F3,Tissue factor,39931,-0.0110016016935628,0.00266650458239227,-0.0162279506750517,-0.00577525271207399,3.71225818383392e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST7,Cystatin-F,39882,0.0373481534422702,0.00906385402704961,0.0195829995492529,0.0551133073352874,3.79852679490141e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROCR,Endothelial protein C receptor,37021,-0.0147841084837817,0.00359012633052733,-0.0218207560916153,-0.00774746087594819,3.84523564000346e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0185308878443443,0.00451091853559363,-0.0273722881741078,-0.00968948751458082,4.01090171619368e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC2,Mucin-2,37437,0.0363511414233533,0.00886087442012003,0.0189838275599181,0.0537184552867886,4.11214336500492e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0350021344887572,0.00855924853851358,0.0182260073532705,0.0517782616242438,4.35075167800421e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARCL1,SPARC-like protein 1,39871,-0.0109175775840447,0.00267271528783537,-0.016156099548202,-0.00567905561988738,4.43244656542309e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSPN,Persephin,39866,0.0377297254907171,0.00925081765870524,0.0195981228796549,0.0558613281017794,4.55409373682502e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0177115691359828,0.00434663900933674,0.00919215667768283,0.0262309815942829,4.62823810278367e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0746379866565697,0.0183352702606553,0.0387008569456853,0.110575116367454,4.70915547181858e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0203635274138672,0.00500775086709786,0.0105483357143554,0.030178719113379,4.80153725891847e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT2,Angiopoietin-2,40030,-0.0151912475124153,0.00373998466891446,-0.0225216174634876,-0.0078608775613429,4.89154885125935e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLASP1,CLIP-associating protein 1,36962,0.0291250386761513,0.00718677682493308,0.0150389560992824,0.0432111212530201,5.09467803433576e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRUNE2,Protein prune homolog 2,37169,0.0113263114572703,0.00279776929882808,0.00584268363156724,0.0168099392829733,5.18749245328169e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0162195735289759,0.00401113410745703,0.00835775067836017,0.0240813963795917,5.28748387004576e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF16,Fibroblast growth factor 16,37056,0.0191313586631295,0.00474296504830527,0.00983514716845112,0.0284275701578078,5.52313708791956e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0118562756277559,0.00294637863913701,0.00608137349504739,0.0176311777604645,5.74836163568273e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00754337284393297,0.00188163587555035,-0.0112313791600116,-0.00385536652785429,6.13165515915718e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00318013672518889,0.000794386104449728,-0.00473713348991035,-0.00162313996046742,6.28116317977466e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAN,Aggrecan core protein,39730,0.0110500293290047,0.00276514399208196,0.0056303471045241,0.0164697115534854,6.46619927024341e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0333824600216337,0.00835464624068423,-0.0497575666533748,-0.0170073533898926,6.48083066774203e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0129623688317241,0.00324807771953908,-0.0193286011620207,-0.00659613650142749,6.62129152005423e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD7,T-cell antigen CD7,37037,0.0167154251758853,0.00420175546703624,0.00847998446049426,0.0249508658912763,6.98103479486192e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH3,Cadherin-3,40009,0.0135057040091892,0.00340128551134875,0.00683918440694564,0.0201722236114327,7.19527843413742e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0160496869714929,0.0040498899124106,0.00811190274316815,0.0239874711998177,7.44059374707993e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0241517671413972,0.00610505201497137,-0.0361176690907411,-0.0121858651920534,7.66077555852455e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0236519640071722,0.00602702206300709,0.0118390007636783,0.0354649272506661,8.74194456071923e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00936140974456067,0.0023949005220879,-0.0140554147678529,-0.00466740472126838,9.31020063525859e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP1,Caspase-1,39489,0.0256141563156032,0.00656987683417555,0.0127371977206191,0.0384911149105873,9.71037014611131e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD9,COMM domain-containing protein 9,37368,0.0150202225763823,0.00385457885729512,0.00746524801608385,0.0225751971366807,9.79738911281758e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0151322902410932,0.00390001872956036,-0.0227763269510315,-0.00748825353115492,0.000104925814854241
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.01571640503853,0.00406395047424444,0.00775106210901087,0.0236817479680491,0.000110575364244625
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECM1,Extracellular matrix protein 1,37106,0.0137243325910672,0.00355326717965704,0.00675992891893939,0.020688736263195,0.000112787766353204
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPS10,40S ribosomal protein S10,37021,-0.0162544275724076,0.00421715638300813,-0.0245200540831036,-0.0079888010617117,0.000116585465042601
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST6,Cystatin-M,39524,0.0177294304287043,0.00460381687975761,0.00870594934437941,0.0267529115130293,0.000118090777455818
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0107139926821905,0.00278503357540949,0.00525532687438794,0.0161726584899931,0.000120141174345816
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.036393483905378,0.00949288929214099,0.0177874208927817,0.0549995469179743,0.000126784687909243
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMS1,PMS1 protein homolog 1,37039,0.0186644965589501,0.00488346448937337,0.00909290615977834,0.028236086958122,0.000132993789390465
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF4,Neurotrophin-4,39477,0.0148917614405101,0.00390529512155442,0.00723738300226339,0.0225461398787567,0.000137693617691712
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0113180797123186,0.00296844319559326,0.00549993104895582,0.0171362283756814,0.000137921612810643
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0137417696843451,0.00360454576939192,-0.0208066793923533,-0.00667685997633693,0.000138281729517164
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00695752603725071,0.00182956221472255,0.00337158409639451,0.0105434679781069,0.000143674331098381
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0124656017544906,0.0032876331620255,0.0060218407569206,0.0189093627520606,0.000150195267056641
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0111594009043933,0.00296723868670218,-0.0169751887303296,-0.00534361307845701,0.000169926238493965
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0123253567178671,0.00327922917999257,0.00589806752508164,0.0187526459106525,0.000171594423251473
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.012841753885632,0.00342299447952996,0.00613268470575328,0.0195508230655107,0.000176312619343734
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0178050696779642,0.00477258298826188,-0.0271593323349575,-0.0084508070209709,0.000191609887288635
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0256179017246779,0.0069025598657549,0.0120888843877983,0.0391469190615575,0.000206971731552827
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL,Podocalyxin,39788,0.00546798863492526,0.00147536594966681,0.00257627137357831,0.00835970589627221,0.000211111841638323
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0138524327380976,0.00374022206072793,-0.0211832679771243,-0.00652159749907088,0.000213244499933412
NMR metabolomics,X23501.Triglycerides in Large VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0167491194729984,0.00452319943865726,0.00788364857323015,0.0256145903727666,0.000213979516205075
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0364660880755541,0.0098482520794448,0.0171635139998423,0.0557686621512659,0.000214104645322778
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0160926707692589,0.00436273952620398,0.00754170129789905,0.0246436402406187,0.000226319830181317
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDS,Iduronate 2-sulfatase,40058,0.00325449515477185,0.000884019565904512,0.00152181680559901,0.00498717350394469,0.000232642369863823
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0306404154123572,0.00833623884543102,0.0143013872753125,0.046979443549402,0.000238114482706969
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0157700494064742,0.00429709132010032,0.00734775041907761,0.0241923483938709,0.000243559224932552
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00952938131819274,0.00259958427780799,-0.0146245665026964,-0.00443419613368908,0.000247432850944455
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.015598972259594,0.00426352334116567,0.00724246651090928,0.0239554780082787,0.000254480806618663
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP1,Dipeptidase 1,39713,-0.016997720022089,0.00465051681505814,-0.026112732979603,-0.00788270706457503,0.000257995019557149
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0202428312305203,0.00555427159761456,0.00935645889919579,0.0311292035618449,0.000268886379297848
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0143505280255479,0.00394050184633106,0.00662714440673903,0.0220739116443568,0.000271590851302138
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0085873308933347,0.00235940702256179,0.0039628931291136,0.0132117686575558,0.000273902420601349
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0223716370933052,0.00615401144465967,-0.0344334995248381,-0.0103097746617722,0.000278725535550973
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD109,CD109 antigen,39858,-0.0120294122633369,0.00331282799230206,-0.0185225551282489,-0.00553626939842485,0.000283029965437482
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0179450515203937,0.00494233775494595,0.00825806952069966,0.0276320335200878,0.000283496272978833
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX3,Syntaxin-3,37388,0.0135446373554818,0.00373433491650507,0.00622534091913188,0.0208639337918318,0.000287726779138844
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR1,Folate receptor alpha,39809,0.00973698086742706,0.00269032692150895,0.00446394010126951,0.0150100216335846,0.000296365736484205
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLN,Mesothelin,39766,0.0185742103856787,0.00515229824773514,0.0084757058201178,0.0286727149512395,0.000313066106384457
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXTL1,Exostosin-like 1,37021,0.0168670829661736,0.00469082768615847,0.007673060701303,0.0260611052310442,0.000324631587313222
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0176319689881355,0.00492582848786799,0.00797734515191422,0.0272865928243567,0.000345301013431766
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSPN,Claspin,39453,0.0120637824541951,0.00338425589617677,0.00543064089768865,0.0186969240107016,0.000365392257486874
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTPN,Myotrophin,39585,0.0113556465563578,0.00318690929320071,0.00510930434168445,0.0176019887710312,0.000367423123180579
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEO1,Neogenin,37411,0.00755715972283618,0.00212108821655895,0.00339982681838063,0.0117144926272917,0.000368083220488984
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN3,Perilipin-3,39868,0.0149919160263419,0.00421554272344079,0.00672945228839796,0.0232543797642859,0.00037713845873887
NMR metabolomics,X23501.Triglycerides in Large VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.0101939006359194,0.00286968301362161,-0.0158184793426177,-0.00456932192922103,0.000383248665944181
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGA,Chromogranin-A,37437,-0.0273370496565358,0.00769967919270042,-0.0424284208742286,-0.012245678438843,0.000385926696828651
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF3,Neurotrophin-3,39866,0.0117307595835647,0.00330520502644862,0.00525255773172539,0.018208961435404,0.000387543581779115
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO4,Roundabout homolog 4,37043,-0.00620368192449533,0.00175271450962124,-0.00963900236335295,-0.0027683614856377,0.000402310817981108
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0130878873362803,0.00370447388892689,0.00582711851398362,0.020348656158577,0.000412037993771737
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0137056020698061,0.00389106661356312,0.00607911150722241,0.0213320926323898,0.000428999126545049
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL3,Follistatin-related protein 3,39803,0.010346822565775,0.00294408927317502,0.00457640759035196,0.016117237541198,0.000441905516523817
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0137916157201889,0.00393525581495805,0.00607851432287109,0.0215047171175066,0.000458523045941787
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOC,Brother of CDO,39585,-0.0080357227618708,0.0023011232622942,-0.0125459243559674,-0.00352552116777416,0.000480577577577422
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIF,Leukemia inhibitory factor,39489,0.0176078284495767,0.00504612862132929,0.00771741635177132,0.0274982405473821,0.000485487093244666
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0116311799255375,0.00333346350162904,0.00509759146234459,0.0181647683887304,0.00048574518654784
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB1A1,Uteroglobin,39903,0.0187368954039543,0.00537276442921603,0.00820627712269093,0.0292675136852178,0.000489075321892325
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0133448482494374,0.00384488509059602,0.00580887347186916,0.0208808230270056,0.00052056123265389
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0229577874473338,0.00663426461929184,0.00995462879352181,0.0359609461011458,0.000540864770659748
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.014971160369913,0.00433141469000876,0.00648158757749585,0.0234607331623302,0.000548835392511263
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMB,Granzyme B,39866,0.0216314719085254,0.00629181504710011,0.00929951441620922,0.0339634294008417,0.000587445750810165
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0166006318180234,0.0048292722312976,-0.0260660053913667,-0.00713525824468006,0.000588595946133922
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0156551562611819,0.00455812501361844,0.00672123123448975,0.0245890812878741,0.000595345489134978
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0234158312980798,0.00682075792027294,-0.0367845168218148,-0.0100471457743449,0.00059844395255207
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARTN,Artemin,39587,0.0150886332448047,0.00440175661723152,0.00646119027503089,0.0237160762145784,0.000609903011571711
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN1,Tetraspanin-1,39585,0.0135858730586398,0.00396549480357437,0.00581350324363408,0.0213582428736456,0.000614056159103921
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSB,Lupus La protein,39489,0.0204134112470622,0.00596492451801891,0.00872215919174517,0.0321046633023793,0.000622662492255115
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK2,Protein AHNAK2,37043,0.0098489950045123,0.00288350612471191,0.00419732300007695,0.0155006670089476,0.000638261296590837
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0125537492666967,0.0036797438129697,-0.0197660471401173,-0.00534145139327608,0.000647809349025449
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0126606120360019,0.00371468528619781,0.00537982887505423,0.0199413951969496,0.000655740229767342
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBLN2,Fibulin-2,37437,-0.0101349197181473,0.00297382063457586,-0.015963608161916,-0.00430623127437865,0.000656196776963791
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G1B,Phospholipase A2,40031,-0.0136573446456275,0.00401151133444774,-0.021519906861145,-0.0057947824301099,0.000664369021011247
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0127118301326905,0.00375723426479971,0.00534765097368308,0.0200760092916979,0.000717942893650052
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.00843117735201375,0.00249230467921042,0.00354626018076132,0.0133160945232662,0.000719008863429876
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0133142314815459,0.00393945057421379,0.00559290835608691,0.021035554607005,0.000727335326915837
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0181438785997313,0.00537047910030141,0.0076177395631405,0.028670017636322,0.000730746320539678
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFD,Complement factor D,37453,0.00605272972390669,0.00179348384136679,0.00253750139482777,0.00956795805298561,0.000740638670793921
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0204019292419697,0.00606035550365908,0.00852363245479786,0.0322802260291415,0.000763587217316204
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0101687957110264,0.00302165091007253,-0.0160912314947686,-0.00424635992728425,0.00076675906988254
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00889386188823852,0.00264631465890608,-0.0140806386196944,-0.00370708515678259,0.000778831254467147
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI1,Neuroserpin,37088,0.0101614384851286,0.00302870281865915,0.00422518096055663,0.0160976960097005,0.000795747918333701
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.0113617902360863,0.00339267699132053,-0.0180114371390746,-0.00471214333309811,0.000813566352963905
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0158638436100456,0.00473833768300441,0.00657670175135699,0.0251509854687343,0.00081625574289995
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERC2,ERC protein 2,37039,0.0246333826953665,0.00736096734292355,0.0102058867032363,0.0390608786874966,0.000820712678554014
NMR metabolomics,X23501.Triglycerides in Large VLDL,RYR1,Ryanodine receptor 1,37021,-0.0110740111317773,0.00332580082744841,-0.0175925807535762,-0.00455544150997843,0.000871698184153387
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0195842723071394,0.00588248940655487,0.00805459307029183,0.0311139515439869,0.000873190098564915
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100G,Protein S100-G,37411,-0.0146623768946899,0.0044111036308685,-0.0233081400111921,-0.00601661377818763,0.000889809995220375
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_DRA,,39799,-0.011528420458221,0.00348303360537851,-0.0183551663247629,-0.00470167459167912,0.00093543340035826
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.0087126060592562,0.00263387041772678,-0.0138749920780007,-0.00355022004051171,0.000942022402271892
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK11,Kallikrein-11,39779,0.00942612344369737,0.00285861316063688,0.00382324164884909,0.0150290052385457,0.000977820788962694
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0187087759615854,0.00567859127748101,0.00757873705772259,0.0298388148654481,0.000987757632284927
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0101788014835516,0.00310320454844166,0.00409652056860593,0.0162610823984972,0.00103994655339624
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00736676955113367,0.00225518523930389,0.00294660648209806,0.0117869326201693,0.00109081273477172
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00960546885060365,0.00294188227708349,-0.0153715581136873,-0.00383937958752001,0.00109715653038584
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0133052987601494,0.00407950996413047,-0.0213011382898452,-0.00530945923045371,0.00111108679895486
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0116119489233465,0.00357535149868695,0.00460425998592009,0.0186196378607729,0.00116593799153406
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH4,Myosin-4,37021,-0.0152448827036895,0.00469506096641414,-0.0244472021978612,-0.00604256320951775,0.00116918625615869
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB44,Ras-related protein Rab-44,37368,0.0134399827009654,0.00414854255573255,0.00530883929172961,0.0215711261102012,0.00119950069736564
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAG,S-arrestin,36991,-0.0168984389492844,0.00521968785101534,-0.0271290271372745,-0.00666785076129437,0.00120905600876921
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPP1,Osteopontin,40012,-0.0142924086790153,0.00441959887020061,-0.0229548224646085,-0.00562999489342208,0.00122370359349652
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0131807535006996,0.00407937441495589,0.00518517964738603,0.0211763273540131,0.00123576136034114
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRELP,Prolargin,39862,0.00702557290175315,0.00217854297928334,0.0027556286623578,0.0112955171411485,0.00126271733236351
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0159834282679515,0.00496826163234558,0.00624563546855415,0.0257212210673488,0.00129803661111937
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.015477626666656,0.00483002146190991,-0.0249444687319995,-0.00601078460131262,0.00135579537730811
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6,Interleukin-6,39788,0.0222358477312764,0.00694830561686502,0.00861716872222093,0.0358545267403318,0.0013760969899149
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL4,Delta-like protein 4,37043,0.027019242957248,0.00846042038327805,0.010436819006023,0.043601666908473,0.00140838412354407
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3D,Protein FAM3D,37382,0.0261167791489199,0.00819691353584778,0.0100508286186582,0.0421827296791815,0.00144496273635972
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH12,Protocadherin-12,37411,0.00791166600601159,0.00248469354285527,0.00304166666201525,0.0127816653500079,0.00145502288780802
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI3,Elafin,39594,0.0165574080091832,0.00520247890152108,0.00636054936220189,0.0267542666561645,0.00146243056472641
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0153213669095471,0.00481458628179649,0.00588477779722595,0.0247579560218682,0.0014640586643058
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL3,Myosin light chain 3,37043,-0.0227650982129937,0.00715695398053373,-0.0367927280148398,-0.00873746841114762,0.00147190796088624
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.013378244435328,0.00420612259532305,-0.0216222447221612,-0.00513424414849484,0.00147281789136746
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0111284246749095,0.00350256599180673,0.00426339533096827,0.0179934540188507,0.0014902757120603
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0161435669689512,0.00509441651088189,0.00615851060762273,0.0261286233302798,0.00153376688565005
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00678284622214001,0.00214434158237444,-0.0109857557235939,-0.00257993672068611,0.00156432684159372
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0217422506016732,0.0068824550511372,0.00825263870144427,0.0352318625019021,0.00158562645805376
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.0053933459924635,0.00171003041005876,-0.00874500559617867,-0.00204168638874834,0.00161376497647322
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0111853847959789,0.00354768729721495,0.00423191769343763,0.0181388518985202,0.00162038180759572
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0161349074553799,0.00515694812129442,0.00602728913764282,0.0262425257731169,0.00175862296447134
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.0187045575678621,0.00598053345643433,-0.0304264031424733,-0.00698271199325078,0.00176628089114656
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0275608772614447,0.00882856654494159,0.0102568868333591,0.0448648676895302,0.00180147063431662
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.0101124424038285,0.00324717032643726,-0.0164768962436456,-0.0037479885640115,0.00184808002445091
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUK1,Guanylate kinase,37021,-0.0126756940102217,0.00407117368881595,-0.020655194440301,-0.00469619358014242,0.00185264404958437
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0214528970573975,0.00689761521144529,0.00793357124296469,0.0349722228718302,0.00187361697483312
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0133089641379798,0.00428069456893675,0.00491880278286378,0.0216991254930958,0.00188016595333581
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0181261491783089,0.00583075631496106,0.00669786680098524,0.0295544315556326,0.00188292432819191
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0198232274571264,0.00637665372882222,0.00732498614863481,0.0323214687656179,0.00188299681671461
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIM,Vimentin,39585,0.0357922588900382,0.0115167321542488,0.0132194638677106,0.0583650539123659,0.0018879061366444
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0237434646721764,0.00765806580683108,0.00873365569078745,0.0387532736535653,0.00193569436917223
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00904646795717536,0.00292005684078344,0.00332315654923982,0.0147697793651109,0.00195210856023087
NMR metabolomics,X23501.Triglycerides in Large VLDL,AREG,Amphiregulin,39788,-0.0141907939482058,0.00458858733888224,-0.023184425132415,-0.00519716276399661,0.00198735562520236
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKCQ,Protein kinase C theta type,39587,0.0131675322471987,0.00426072364607792,0.00481651390088595,0.0215185505935114,0.00200205779048089
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0180570163001151,0.00584968201731,0.00659163954618754,0.0295223930540427,0.00202720583470078
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00830295745054245,0.0026906899376942,0.00302920517266181,0.0135767097284231,0.00203407780142617
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99,CD99 antigen,39858,-0.00579345704294281,0.00188001780837082,-0.00947829194734962,-0.002108622138536,0.00206243192667813
NMR metabolomics,X23501.Triglycerides in Large VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0131080904043558,0.00425458771075078,-0.0214470823174273,-0.00476909849128429,0.00206779792965619
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.0109456110245049,0.00355302827064933,0.00398167561403223,0.0179095464349776,0.00206982241653045
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0130752981622674,0.0042455911588539,0.00475393949091375,0.021396656833621,0.00207606586040049
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0159185461619391,0.00517508742837986,-0.0260617175215636,-0.0057753748023146,0.00210232286041852
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO6,Unconventional myosin-VI,37411,0.0115218767734044,0.00374667029866012,0.00417840298803056,0.0188653505587782,0.00210758210248852
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPTC,Opticin,39788,-0.0132870292296867,0.00432839385704002,-0.0217706811894852,-0.00480337726988829,0.00214608000146936
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFAP,Glial fibrillary acidic protein,39453,0.0131738360853377,0.004292929663932,0.00475969394403095,0.0215879782266444,0.00215340726779829
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0175586571325584,0.0057311073086307,0.00632568680764218,0.0287916274574745,0.00219021357685283
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL28,C-C motif chemokine 28,39815,0.017896341537676,0.00585026258091809,0.00642982687907649,0.0293628561962754,0.00222396082273855
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0222199394123602,0.00726455218880488,0.00798141712230261,0.0364584617024177,0.00222763295225533
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0329261557610977,0.0107649318944842,0.0118268892479087,0.0540254222742867,0.00222782496580031
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMOD4,Tropomodulin-4,36962,-0.0122307379152527,0.00400386954612897,-0.0200783222256655,-0.00438315360483997,0.00225716197521482
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0172527203714109,0.005662344299756,-0.0283509151989327,-0.00615452554388913,0.00231655873819428
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA2,Adenosine deaminase 2,39782,-0.0123308283578888,0.00404892527376269,-0.0202667218944636,-0.00439493482131388,0.00232706647722212
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDK2,Protein sidekick-2,37124,0.0111055447586325,0.00365316726354641,0.00394533692208155,0.0182657525951835,0.00237057372601401
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0179088975423906,0.00590677661138001,0.00633161538408579,0.0294861797006954,0.00243391877806366
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0110732203007681,0.00366481643355305,0.00389018009100417,0.0182562605105321,0.00251928288481492
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAVL4,ELAV-like protein 4,36991,0.025013582242388,0.00829972622859867,0.00874611883433458,0.0412810456504414,0.00258503654405169
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNXB,Tenascin-X,39858,-0.00759798209363168,0.0025255929288124,-0.012548144234104,-0.00264781995315938,0.00263039753397608
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG3,Secretogranin-3,39885,-0.00957655694830468,0.00318421038120384,-0.0158176092954642,-0.00333550460114515,0.00263802687880914
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR4,Proline-rich protein 4,37031,-0.0206595411035464,0.0068702162044392,-0.0341251648642472,-0.00719391734284557,0.00264236184895506
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNG,Interferon gamma,39587,0.0336991587631188,0.0112352736369949,0.0116780224346087,0.0557202950916288,0.0027092905451693
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.020614236938161,0.00688353165786511,0.00712251488874539,0.0341059589875766,0.00275128765764542
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.00746003703861565,0.00249507321985169,0.00256969352770634,0.012350380549525,0.00279483280180545
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0162268888747742,0.00543344994585472,0.00557732698089891,0.0268764507686494,0.00282714932582071
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBB,Inhibin beta B chain,37124,0.0145214846167854,0.00486523997555634,0.00498561426469493,0.0240573549688758,0.00284335297797785
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC1,Syndecan-1,39868,0.0116264479705985,0.00390036785715576,0.00398172697057321,0.0192711689706238,0.00287872888155217
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RA,Interleukin-17 receptor A,39858,0.012869811403443,0.00432756668663825,0.00438778069763205,0.021351842109254,0.00294465950991226
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00926424971816209,0.00311777737179194,-0.0153750933668743,-0.00315340606944989,0.00296953838982484
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.00819515573597937,0.00276622185482893,0.00277336090051466,0.0136169505714441,0.00305518417056494
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0078877664470622,0.00266581544954561,-0.0131127647281716,-0.00266276816595281,0.00309233000147699
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS2,Thrombospondin-2,39858,-0.0104645656610568,0.00353873308827552,-0.0174004825140769,-0.00352864880803682,0.00310950370330377
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHB,Lutropin subunit beta,39477,0.0256421166211003,0.00869101709682366,0.0086077231113259,0.0426765101308746,0.00317817291647607
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRC1,Macrophage mannose receptor 1,37445,0.00796706892772655,0.0027042591699272,0.00266672095466924,0.0132674169007839,0.00322334943448535
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEG1,Protein LEG1 homolog,36703,-0.0202550559494589,0.00687972823177789,-0.0337393232837435,-0.00677078861517421,0.00324407219488351
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFLAM,Pikachurin,37382,0.00884593464285977,0.00301011978480331,0.00294609986464529,0.0147457694210742,0.00330115050116657
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN1,Nectin-1,37056,0.00924698824836839,0.00315172188932454,0.00306961334529229,0.0154243631514445,0.00335256342018731
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0205427602655236,0.00701310517300852,-0.0342884464046203,-0.00679707412642688,0.00340424384968301
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPS,Colipase,39836,0.0198592151495001,0.00679821618092855,0.0065347114348801,0.03318371886412,0.00349130016970099
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEFL,Neurofilament light polypeptide,39438,0.0123670448899495,0.00427171648191787,0.00399448058539051,0.0207396091945086,0.00379564710758236
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0201647050582687,0.00696623475859149,0.00651088493142937,0.033818525185108,0.00380108328563657
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00863933007257789,0.00299247817776885,-0.0145045873010048,-0.00277407284415094,0.00389448860216167
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.00971093693655136,0.0033695968212597,0.00310652716688234,0.0163153467062204,0.00395784392843481
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0128237014161636,0.00445103551165878,0.00409967181331238,0.0215477310190148,0.00396963748290797
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0165855698641407,0.00576227358071753,-0.0278796260823471,-0.0052915136459344,0.00400343960329197
NMR metabolomics,X23501.Triglycerides in Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0103009202780287,0.00357971389127698,0.00328468105112581,0.0173171595049316,0.00401379443589588
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0100305620722972,0.00348613408957916,0.00319773925672206,0.0168633848878724,0.00401658773394599
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0226419994408305,0.00790763385780026,0.00714303707954203,0.0381409618021191,0.00419783892787445
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00917584756566509,0.00321172231160569,0.00288087183491794,0.0154708232964122,0.00428335973753267
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00846988438303809,0.00299550475908375,0.00259869505523393,0.0143410737108422,0.00469680071842369
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0162190378204497,0.00573977043248875,0.00496908777277172,0.0274689878681276,0.00472325506479932
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYAL1,Hyaluronidase-1,39747,0.00629988430542617,0.00223834808936414,0.00191272205027245,0.0106870465605799,0.00489096093127907
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0165565463091709,0.005889183131723,-0.028099345247348,-0.00501374737099387,0.00493936774626693
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0112353328260931,0.00400755497225496,-0.0190901405717128,-0.00338052508047334,0.00506195856518521
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH7B,Myosin-7B,36962,-0.0121049844138376,0.00431848108606625,-0.0205692073425274,-0.00364076148514776,0.00506938023055354
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP2,Guanylate-binding protein 2,39587,0.0163251736154782,0.00582484107020391,0.00490848511787851,0.0277418621130778,0.00507417150112053
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00780872246835879,0.00279281664841796,0.00233480183745959,0.013282643099258,0.00518120638213276
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0166010984189698,0.0059491429189016,0.00494077829792269,0.028261418540017,0.0052689670382629
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00712718522559808,0.00255540429232138,0.00211859281264818,0.012135777638548,0.00529234195654546
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.0100083585067379,0.0035913123685603,-0.0170473307491161,-0.00296938626435971,0.00533034876806645
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELENOP,Selenoprotein P,37453,0.00608328536531888,0.00218304935256072,0.00180450863429986,0.0103620620963379,0.00533380301728123
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0130287767034361,0.00471181236035593,0.00379362447713845,0.0222639289297337,0.00569663147042513
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00897045163678199,0.00324702936496222,-0.0153346291921079,-0.00260627408145604,0.00573974832574967
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0243478530998335,0.0088222830855972,-0.041639527947604,-0.00705617825206295,0.00579145961652996
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0128889104200463,0.00467191052095279,-0.0220458550411138,-0.00373196579897883,0.00580924986511358
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.0076171695238581,0.00276806488918073,0.00219176234106386,0.0130425767066523,0.00593486341313528
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMH,Granzyme H,39585,0.0203245499138398,0.00739929302104092,0.0058219355925996,0.03482716423508,0.00602440390524316
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0112510833056738,0.00409687264112614,0.00322121292906658,0.0192809536822811,0.00603609836736093
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00793650530294581,0.00289178200431514,0.00226861257448813,0.0136043980314035,0.00606845857453669
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCLRE1C,Protein artemis,36962,-0.00835867800949316,0.00304620149218864,-0.0143292329341829,-0.00238812308480343,0.00607841430002992
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0147225614301801,0.00537629350476522,0.00418502616084025,0.0252600966995199,0.00618046790139757
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0157990738564728,0.00580637603612223,0.00441857682567317,0.0271795708872723,0.00651705433504711
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY96,Lymphocyte antigen 96,39749,-0.00942618164964578,0.00346863223326532,-0.0162247008268458,-0.00262766247244575,0.00658384835820861
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.00850641186851736,0.00313722977618316,0.00235744150719837,0.0146553822298364,0.00670782802132015
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN1,Prorelaxin H1,37411,-0.0214704016019381,0.0079199209381786,-0.0369934466407681,-0.00594735656310804,0.00671780197640624
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0113414335612305,0.0041868212163481,0.00313526397718827,0.0195476031452728,0.00676063837076211
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0105501825496433,0.00390091610397074,0.00290438698586068,0.018195978113426,0.00684870581450291
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0150669881324104,0.00557446540703252,0.00414103593462662,0.0259929403301941,0.00688186422363199
NMR metabolomics,X23501.Triglycerides in Large VLDL,BEX3,Protein BEX3,36962,-0.012401650602691,0.00459408985111034,-0.0214060667108673,-0.00339723449451477,0.00695371865395977
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.00946126093357426,0.003510144531044,0.00258137765272802,0.0163411442144205,0.00703897203715277
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRAXIN,Draxin,39749,0.0111276331289619,0.00412890770086878,0.00303497403525914,0.0192202922226648,0.00704510525019472
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCC1,Regulator of chromosome condensation,37368,0.0133594968767375,0.00497496358195989,0.0036085682560961,0.0231104254973789,0.00725433287837808
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0158718739302584,0.00591483696942242,0.00427879347019041,0.0274649543903263,0.00729532291352969
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0201041119106638,0.00749367340466843,-0.0347917117838139,-0.00541651203751372,0.00730947539795101
NMR metabolomics,X23501.Triglycerides in Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00780970511547968,0.00291766811450413,0.00209107561105158,0.0135283346199078,0.00744443752203511
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17C,Interleukin-17C,39587,-0.0174649349358819,0.0065265855111939,-0.030257042537822,-0.00467282733394188,0.00745909232193882
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPJ,Centromere protein J,37169,0.0189944766817809,0.00713079962674799,0.0050181094133548,0.0329708439502069,0.0077374188797834
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0317077016198318,0.0119046909360758,0.00837450738512323,0.0550408958545404,0.00774197534730875
NMR metabolomics,X23501.Triglycerides in Large VLDL,EP300,Histone acetyltransferase p300,37056,0.00772166990915155,0.002907054485889,0.0020238431168091,0.013419496701494,0.00791256452174015
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00526292655234998,0.0019830833658858,-0.00914976994948614,-0.00137608315521382,0.00796430580078041
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0127250502031374,0.00479688441321582,-0.0221269436530404,-0.00332315675323442,0.00799120066641312
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0103467539835451,0.00390352389299459,-0.0179976608138145,-0.00269584715327569,0.00804381264289922
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNLY,Granulysin,39858,0.0132585919607958,0.00500455783366855,0.00344965860680548,0.0230675253147862,0.00807371475958239
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0138046206644955,0.00521177417854482,0.00358954327454762,0.0240196980544433,0.00808894078121612
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOC,Myocilin,39858,-0.0119429984115642,0.00451234330861224,-0.0207871912964442,-0.00309880552668425,0.00813514555829475
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0115265426977,0.00437302430766265,-0.0200976703407188,-0.00295541505468125,0.00840123344790728
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN2,Contactin-2,40030,0.0114588309696755,0.00435149383491215,0.00292990305324768,0.0199877588861033,0.00846376484252721
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0131195710054987,0.00498913648117872,-0.022898278508609,-0.00334086350238841,0.00855778675822579
NMR metabolomics,X23501.Triglycerides in Large VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0155997820070411,0.00594826511295031,-0.0272583816284237,-0.00394118238565849,0.00873517286974625
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00811628128363022,0.00310353373018781,-0.0141992073947983,-0.00203335517246212,0.008926463001178
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX33,Testis-expressed protein 33,37169,-0.010161464788843,0.0038990896110274,-0.0178036804264567,-0.00251924915122934,0.00916784829592996
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON1,Spondin-1,39885,0.0081504896046753,0.00312925953054587,0.0020171409248054,0.0142838382845452,0.00920647550321076
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH3,Neurexophilin-3,37056,0.00759868198126992,0.00291931415250781,0.00187682624235461,0.0133205377201852,0.00925423858496049
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00715089319014563,0.00276483203841573,0.0017318223948508,0.0125699639854405,0.00970786938518525
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00953635676085436,0.00371035133429527,0.00226406814563562,0.0168086453760731,0.0101732297893382
NMR metabolomics,X23501.Triglycerides in Large VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00705754285394598,0.00276502245726697,-0.0124769868701892,-0.00163809883770272,0.0107084725512325
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00666180041371243,0.00261115615281638,-0.0117796664732325,-0.00154393435419233,0.0107438800120107
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00988756389102819,0.0038770468111773,0.00228855214112067,0.0174865756409357,0.010774448185825
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.014545730942095,0.00573654806944795,0.00330209672597699,0.025789365158213,0.0112362040450865
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPS,Calcyphosin,37388,0.0216398698646815,0.00854918497064254,0.00488346732222211,0.0383962724071409,0.0113778770864389
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH23,Cadherin-23,37388,-0.00667522673046946,0.00263884289514739,-0.0118473588049583,-0.00150309465598058,0.0114304003015071
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GL3,Endophilin-A3,37083,0.0205056216619243,0.00810858736529254,0.00461279042595094,0.0363984528978977,0.011454335242723
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0186815985655039,0.00738929214376566,0.00419858596372319,0.0331646111672846,0.0114764507064108
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD55,Complement decay-accelerating factor,39315,0.0062897008809616,0.002493362550392,0.00140271028219329,0.0111766914797299,0.0116597738311503
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.00761520673310233,0.00301889552971763,0.00169817149485577,0.0135322419713489,0.0116615853206874
NMR metabolomics,X23501.Triglycerides in Large VLDL,GKN1,Gastrokine-1,39123,0.00695321123686466,0.00276074551732339,0.00154215002291081,0.0123642724508185,0.0117924088919986
NMR metabolomics,X23501.Triglycerides in Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.010939487171691,0.00434665733509423,-0.0194589355484757,-0.00242003879490628,0.0118556519459576
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP2,Dipeptidase 2,39788,-0.0071713367992358,0.00285371891839309,-0.0127646258792862,-0.00157804771918535,0.0119814257351114
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00708993491958066,0.00282879096865499,-0.0126343652181444,-0.00154550462101687,0.0122105367631206
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00846988636929052,0.00338267613790806,0.00183984113899073,0.0150999315995903,0.0122931537789783
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.0068467915719836,0.00273736986795903,-0.0122120365131833,-0.00148154663078389,0.0123883291519314
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0179838809554483,0.0072086021690482,0.00385502070411386,0.0321127412067828,0.0126152909362755
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNR,Tenascin-R,39749,-0.0102722273838137,0.00412013015775899,-0.0183476824930214,-0.00219677227460613,0.0126705489057452
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00806937840313672,0.00324009252446152,-0.0144199597510813,-0.00171879705519215,0.0127671664086859
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0239108762431842,0.00961227117361185,0.00507082474290493,0.0427509277434634,0.0128754537091494
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM1,Myomesin-1,36991,0.0114590704295635,0.00465573240199097,0.0023338349216612,0.0205843059374658,0.0138569150960611
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0254579225994498,0.010361473007046,0.00514943550563963,0.0457664096932599,0.014021668823814
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB2,Integrin beta-2,39731,-0.00690836523483092,0.00282216200334633,-0.0124398027613897,-0.0013769277082721,0.0143799790700276
NMR metabolomics,X23501.Triglycerides in Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0125658449288277,0.00513459831818052,0.0025020322251939,0.0226296576324616,0.014404483043885
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.00702615775545748,0.00288264304816165,0.00137617738106066,0.0126761381298543,0.0148045015424281
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCA2A,Guanylin,39796,-0.00771836827313151,0.00316709442944975,-0.013925873354853,-0.00151086319141,0.0148184869361249
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00689761954460039,0.00283048093432293,-0.0124453621758733,-0.00134987691332744,0.0148266192274366
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC1,Hamartin,37056,0.0182708523690844,0.00750703481508008,0.00355706413152741,0.0329846406066413,0.0149531558396172
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY6D,Lymphocyte antigen 6D,39761,0.00864024098192092,0.00355308180122845,0.00167620065151315,0.0156042813123287,0.0150366398095281
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN15,Tetraspanin-15,37021,-0.0117631747472813,0.00485237976882952,-0.0212738390941872,-0.00225251040037545,0.015355223540339
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.013265242582845,0.005483350162243,0.00251787626484869,0.0240126089008413,0.015568824067911
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00537682902233362,0.00222292980470208,0.00101988660511755,0.0097337714395497,0.0155826284560497
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.0161414621047396,0.00667929698883017,-0.0292328842028468,-0.00305004000663251,0.0156779409667554
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0697488170933321,0.028885015679858,0.0131341863608104,0.126363447825854,0.0157590622214438
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP9,Matrix metalloproteinase-9,39843,0.0143564570919949,0.00594987966290294,0.00269469295270516,0.0260182212312847,0.0158373971709494
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.0076725258749937,0.00318419647665393,-0.0139135509692354,-0.001431500780752,0.0159852537211175
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0119574216512187,0.00498230657149844,0.0021921007710818,0.0217227425313557,0.0164099655947376
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.00795712065776741,0.00333049386200301,-0.0144848886272933,-0.00142935268824151,0.0169003727120281
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0145574698393996,0.00609536621580498,0.00261055205642184,0.0265043876223774,0.0169389498953587
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK15,Kallikrein-15,37351,0.0117969628370562,0.00495008897737077,0.00209478844140952,0.0214991372327029,0.0171774636139747
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.00767620368659538,0.00322171421954505,0.00136164381628708,0.0139907635569037,0.0172003285352493
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0239181872352298,0.0100432622020796,0.00423339331915387,0.0436029811513058,0.017253257092338
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0160424656601639,0.00674956456935162,0.00281331910423476,0.0292716122160931,0.0174769038986583
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00780206183746803,0.00328788734807796,-0.0142463210397008,-0.00135780263523522,0.017659923156456
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0145960234473694,0.00616075874691499,-0.0266711105913228,-0.00252093630341607,0.0178413003125713
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.0109720207895301,0.00463495640051721,-0.0200565353345438,-0.0018875062445164,0.0179360189596482
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00503529491472524,0.00213803377316472,-0.00922584111012809,-0.000844748719322387,0.0185316012549317
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPN1,Epsin-1,37169,0.00993013977395014,0.00422923172163059,0.00164084559955419,0.0182194339483461,0.0188902342837062
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPN,Asporin,37437,0.00619982406161188,0.00265068202472865,0.00100448729314372,0.01139516083008,0.019352226132191
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0141187271256574,0.0060417580044939,0.00227688143684932,0.0259605728144654,0.019459358886492
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALB,Ras-related protein Ral-B,37056,0.00669566064496781,0.00287340780094426,0.00106378135511707,0.0123275399348186,0.0198097380885247
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00934595653878877,0.00401174516330505,-0.0172089770588667,-0.00148293601871088,0.0198397776031244
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00707219462944134,0.00304113845936247,-0.0130328260097918,-0.0011115632490909,0.0200570853709092
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBN,Ameloblastin,39587,-0.0065191698935069,0.00280370312930832,-0.0120144280269512,-0.00102391176006259,0.0200739376056365
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00940421086598157,0.00404571842663979,-0.0173338189821956,-0.00147460274976757,0.0201146650235641
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.00720550542067844,0.00311255941386036,0.00110488896951215,0.0133061218718447,0.0206267399731985
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0162653154684936,0.00704176803080393,-0.0300671808088693,-0.00246345012811785,0.0209127412503099
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0139621804061198,0.00605109264297752,-0.0258223219863557,-0.00210203882588386,0.0210490263788632
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.00821539263167,0.00356375249123438,0.00123043774885062,0.0152003475144894,0.0211672081120945
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0168973866371234,0.00736520758458169,-0.0313331935029035,-0.00246157977134328,0.021793728806146
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0149648971015456,0.0065253351675132,-0.0277545540298715,-0.00217524017321977,0.0218433557126967
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYMP,Thymidine phosphorylase,39764,0.0152285745554395,0.0066515255113357,0.00219158455322156,0.0282655645576575,0.0220641686937867
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36A,Interleukin-36 alpha,37056,-0.0132298262736531,0.00578082321355342,-0.0245602397722178,-0.00189941277508836,0.0221200017075418
NMR metabolomics,X23501.Triglycerides in Large VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.00942392640707596,0.00412676500171362,0.00133546700371726,0.0175123858104347,0.0224100595567082
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXDNL,Peroxidasin-like protein,37368,0.0133415184218532,0.00584624956046299,0.00188286928334569,0.0248001675603606,0.0225010128847612
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.00822931806177971,0.00361264457739482,0.00114853469008586,0.0153101014334736,0.0227470818500333
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.00938526094953008,0.00412335284237494,0.00130348937847519,0.017467032520585,0.0228516799724818
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0105649943259924,0.00464806777722043,-0.0196752071693445,-0.00145478148264039,0.0230402367933057
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00822211702264982,0.00362031999393549,-0.0153179442107634,-0.00112628983453626,0.0231568662798087
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0146200834035672,0.00644158626308509,-0.027245592479214,-0.00199457432792046,0.0232427097745728
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0143649822755645,0.00632992153032433,-0.0267716284750002,-0.00195833607612879,0.0232613386873157
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0185312571101507,0.00822476385190593,-0.0346517942598863,-0.00241071996041509,0.0242684992624812
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.011049503899286,0.00490422857446571,0.00143721589333322,0.0206617919052388,0.024271962779742
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171B,Protein FAM171B,37368,0.00612825858333458,0.00272265582163235,0.000791853172935182,0.011464663993734,0.024411780052573
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.00866785617778346,0.00386762715902461,0.00108730694609522,0.0162484054094717,0.0250337941258378
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA11,Serpin A11,40052,-0.00896943159543084,0.00401719142102654,-0.0168431267806429,-0.00109573641021882,0.0255782704872484
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0115565363069854,0.0051768349741569,0.00140993975763791,0.021703132856333,0.0256080439788372
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0136472130484123,0.00612272320268153,0.00164667557115648,0.0256477505256681,0.0258343836398564
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPLX2,Complexin-2,36962,-0.00656053949587125,0.00294469602710622,-0.0123321437089994,-0.00078893528274305,0.0259029345279731
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG1,Arginase-1,39754,0.0112938290696904,0.00507850797296328,0.00133995344268235,0.0212477046966984,0.0261726804584364
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.00773625349131354,0.00349745699227187,0.00088123778646068,0.0145912691961664,0.0269834826297793
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.010009315046881,0.00453025168429486,0.00113002174566311,0.018888608348099,0.0271610799891988
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCG22,Protein PBMUCL2,37021,-0.0117539098689064,0.00532525067283253,-0.0221914011876582,-0.00131641855015464,0.0273170652640339
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESPL1,Separin,36962,-0.0115774107336933,0.00528171233500749,-0.021929566910308,-0.00122525455707866,0.0283984436819705
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.00818124663162272,0.0037353092613576,-0.0155024527838836,-0.000860040479361833,0.0285209488850228
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG3,Proteoglycan 3,37437,-0.010736137781027,0.00490957920200885,-0.0203589130169644,-0.00111336254508968,0.0287760673872537
NMR metabolomics,X23501.Triglycerides in Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00477202227063331,0.00218438086123728,0.00049063578260824,0.00905340875865838,0.0289318620825545
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0276800060884908,0.0126724741631337,-0.0525180554482328,-0.00284195672874877,0.0289573199102439
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0128634567746238,0.00590942475731949,-0.02444592929897,-0.00128098425027762,0.0295154212398637
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX2,Peroxiredoxin-2,37249,0.0130091363325953,0.00597763725311617,0.00129296731648763,0.024725305348703,0.0295502005741472
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.00726435327860937,0.003338649216984,0.000720600813320735,0.013808105743898,0.0295820991403858
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0181699040955185,0.0083688713485957,-0.0345728919387661,-0.00176691625227096,0.0299391584635643
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0106731510163101,0.00491723779165111,0.00103536494467395,0.0203109370879463,0.0299819246599611
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL11,Interleukin-11,39587,0.0132521479168322,0.00611393800199223,0.00126882943292743,0.025235466400737,0.0302093706337421
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNN,Tenascin-N,37437,0.00911213876727993,0.0042234363520573,0.000834203517247631,0.0173900740173122,0.030982833918493
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.0057426540517023,0.0026630194546138,0.000523135920659258,0.0109621721827453,0.0310665360722224
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0136101375855665,0.0063667120752532,0.0011313819180702,0.0260888932530628,0.032558720853689
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0184725341089299,0.00864314519741131,0.00153196952200377,0.0354130986958561,0.0325934128518237
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0251834311330523,0.011821602368387,0.00201309049101378,0.0483537717750909,0.0331633331438982
NMR metabolomics,X23501.Triglycerides in Large VLDL,NINJ1,Ninjurin-1,39477,0.0118028362329575,0.00554391998653952,0.000936753059340082,0.022668919406575,0.0332723906192496
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00615228992587209,0.002896935920046,-0.0118302843291622,-0.000474295522581923,0.0337114021228306
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00558559960189901,0.00264205825073539,0.000407165430457655,0.0107640337733404,0.0345241253459271
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.0109203232771703,0.00517316289238782,-0.0210597225462504,-0.000780924008090165,0.0347949645422221
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTKN2,Rhotekin-2,37021,-0.0107641824165522,0.00510744980525813,-0.0207747840348581,-0.000753580798246263,0.0350891927699205
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0116743182858517,0.00554158149597445,-0.0225358180179617,-0.000812818553741825,0.0351645702629717
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0183678129782419,0.00871975642015074,0.00127709039474648,0.0354585355617374,0.0351833461352428
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.0128993110160346,0.00613546883390333,-0.0249248299304852,-0.000873792101584109,0.0355355410655275
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM25,Transmembrane protein 25,37411,-0.00923094653317804,0.00439477499950584,-0.0178447055322095,-0.000617187534146595,0.0357088785940424
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK12,Kallikrein-12,39477,-0.0283999731985672,0.0135301225342609,-0.0549190133657187,-0.00188093303141579,0.0358313105961888
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB1,Lamin-B1,37348,0.0119550019134842,0.00569618820843887,0.00079047302494401,0.0231195308020244,0.0358555235827716
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00428701217131235,0.00204297148798759,0.00028278805485667,0.00829123628776802,0.0358837704488457
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00769557454982288,0.00368206838341649,0.000478720518326556,0.0149124285813192,0.0366356343964747
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0120236549727238,0.00576412246400902,0.000725974943266088,0.0233213350021815,0.0369993478546065
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00736630713331973,0.00356108776307628,0.000386575117690216,0.0143460391489492,0.0386072637277866
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00753561886835033,0.00364623295533809,-0.014682235460813,-0.000389002275887674,0.0387833449314753
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0141596236072114,0.00685168857100734,0.000730314008036968,0.0275889332063858,0.0387887680177374
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0136903853179561,0.00663850203703762,-0.0267018493105499,-0.000678921325362389,0.0392015942384889
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00408203723568784,0.00198222816447905,-0.00796720443806678,-0.000196870033308905,0.0394834559955198
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACHE,Acetylcholinesterase,37124,0.00659995662080862,0.00321515718002321,0.000298248547963125,0.0129016646936541,0.0401151156373749
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00510342189622771,0.00249104733873992,-0.00998587468015796,-0.000220969112297462,0.0405101935119271
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00791537703675511,0.00387467451183812,0.0003210149935524,0.0155097390799578,0.0410866421531726
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPE4,NXPE family member 4,37021,-0.00698926819045858,0.00343456315234587,-0.0137210119690565,-0.000257524411860678,0.041872858261962
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0194755271147529,0.00957206397234144,-0.0382367725005421,-0.000714281728963703,0.0419089764088711
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0136350350335779,0.00671925129654187,0.000465302492355858,0.0268047675748,0.0424529497633582
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00791465644199762,0.00390306874409931,-0.0155646711804323,-0.00026464170356297,0.0426004131323584
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0113173157596502,0.00559995654856198,0.000341400924468714,0.0222932305948317,0.0433003062547569
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0130111024732488,0.0064835812481679,-0.0257189217196579,-0.00030328322683971,0.0447938620015332
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN2,Neuroligin-2,36991,-0.00929242421158609,0.00463062674303073,-0.0183684526279263,-0.000216395795245867,0.0447987298644246
NMR metabolomics,X23501.Triglycerides in Large VLDL,REST,RE1-silencing transcription factor,36962,-0.00702182205452596,0.00350372675022911,-0.013889126484975,-0.000154517624076899,0.045079794873458
NMR metabolomics,X23501.Triglycerides in Large VLDL,MN1,Transcriptional activator MN1,37039,-0.0116352778731131,0.00581125038250024,-0.0230253286228136,-0.000245227123412605,0.0452838199725806
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.00912674676543604,0.00456512699213889,0.000179097860843806,0.0180743956700283,0.0456005819694107
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00720563011149406,0.00360464889544623,-0.0142707419465687,-0.000140518276419455,0.0456307728999984
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERVV_1,,37021,-0.00943705691194946,0.0047281873798562,-0.0187043041764676,-0.000169809647431305,0.0459638203727386
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00650706752870447,0.00326716042450964,-0.0129107019607434,-0.000103433096665578,0.0464255228654255
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.00966744545716372,0.00488197715623419,-0.0192361206833827,-9.8770230944718e-05,0.0476983022667488
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHPK,Sedoheptulokinase,37169,-0.00813212100471267,0.00411264238280454,-0.0161929000750096,-7.13419344157609e-05,0.0480230230290601
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.016748481644635,0.00848764634625334,0.000112694805978471,0.0333842684832916,0.0484849364517822
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.04969039562255,0.0253802422147894,-0.0994356703635373,5.48791184373371e-05,0.0502701209174401
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPE,Coatomer subunit epsilon,39489,0.0090974238104959,0.00465022117073854,-1.70096841516469e-05,0.0182118573051434,0.0504426425630833
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.00563176479989038,0.00287942777161137,-1.19136324679128e-05,0.0112754432322487,0.0505019150865654
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00488471450245683,0.00251864909950519,-0.00982126673748701,5.18377325733474e-05,0.0524710832053735
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00879801668629857,0.00453879747601662,-0.0176940597392911,9.80263666940009e-05,0.0525954826241825
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0100275834033473,0.00517333798389388,-0.000112159045084733,0.0201673258517793,0.0526055464652673
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTNNA1,Catenin alpha-1,36991,-0.00668733069132561,0.00345065225099663,-0.013450609103279,7.59477206277804e-05,0.0526458119166026
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP8,Neutrophil collagenase,39985,0.013610101169974,0.00703832211515554,-0.000185010175730851,0.0274052125156789,0.0531657955230995
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00616464347780759,0.00320954727508153,-0.000126069181352204,0.0124553561369674,0.0547851175749073
NMR metabolomics,X23501.Triglycerides in Large VLDL,KEL,Kell blood group glycoprotein,39489,0.00669572371910358,0.00348766450914174,-0.000140098718814239,0.0135315461570214,0.0548975307504461
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00458722244716711,0.00239715834296228,-0.00928565279937317,0.000111207905038952,0.0556912338984146
NMR metabolomics,X23501.Triglycerides in Large VLDL,MELTF,Melanotransferrin,37437,0.00546104567939738,0.00285463964806271,-0.000134048030805527,0.0110561393896003,0.0557636818332882
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0114457511923472,0.00601599581945426,-0.0232371029984776,0.000345600613783133,0.0571207445279483
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00476737712238332,0.00250812998826542,-0.00968331189938354,0.000148557654616889,0.057353360430839
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH17,Cadherin-17,39868,-0.0123729237361495,0.00652248035663843,-0.0251569852351608,0.000411137762861847,0.0578504016672642
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31,Interleukin-31,37056,-0.0106796522666407,0.00564431197330318,-0.0217425037343149,0.000383199201033576,0.0584983587711294
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00805263242372697,0.00426045636809301,-0.0164031269051893,0.000297862057735325,0.0587682440072766
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00559323540792131,0.00296117624588894,-0.000210670034021013,0.0113971408498636,0.0589295144594751
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAGLN3,Transgelin-3,36962,-0.0110677970973738,0.0058708489651341,-0.0225746610690367,0.000439066874288999,0.0594232797620725
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00902884770482913,0.00480374734261122,-0.0184441924963471,0.000386497086688864,0.0601925694105819
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00856767837927297,0.00456607552965305,-0.000381829658847001,0.0175171864173929,0.0606215718973125
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0086086491480852,0.00459517774002791,-0.000397899222369505,0.0176151975185399,0.0610300818774547
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00632413511651144,0.00337962159695049,-0.0129481934465344,0.000299923213511514,0.0613318008002511
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUCL3,Mucin-like protein 3,36962,-0.00824257073320249,0.00441530909331898,-0.0168965765561077,0.0004114350897027,0.0619495713787864
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB116,Beta-defensin 116,36991,-0.0141889446062136,0.00760326459907167,-0.0290913432203941,0.000713454007966857,0.062040590912698
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP10,Bone morphogenetic protein 10,37124,-0.0051750255736058,0.00278046192419522,-0.0106247309450284,0.000274679797816827,0.0627365299421599
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00853842628243109,0.00458955395868424,-0.00045709947659001,0.0175339520414522,0.062850623960856
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1,DNA topoisomerase 1,37382,0.020687673749888,0.0111808170095213,-0.00122672758877366,0.0426020750885497,0.0642945950417344
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX5,Syntaxin-5,37056,0.00735946041905614,0.00400054691691299,-0.000481611538093324,0.0152005323762056,0.0658474386020454
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00975315230088188,0.0053052367792879,-0.000645111786522415,0.0201514163882862,0.0660223107683194
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.00512041569051145,0.00278938413049436,-0.000346777205257489,0.0105876085862804,0.0664274226402348
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENG,Endoglin,40052,-0.00304951623401513,0.00166383547110823,-0.00631063375738726,0.000211601289357002,0.0668472207014243
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00598460719650252,0.00328147013733713,-0.000447074272678262,0.0124162886656833,0.0682112836362199
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0114765424833963,0.00630485869796361,-0.000880980564612362,0.023834065531405,0.0687370785706375
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0115780906661402,0.00637122421549497,-0.0240656901285104,0.000909508796229913,0.0691980214214011
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00983728819495217,0.00541661327982357,-0.0204538502234064,0.000779273833502032,0.06937270845805
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDRG1,Protein NDRG1,39489,0.0123514758153906,0.00680833587869913,-0.000992862506859742,0.0256958141376409,0.0696707885763913
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00774030660572867,0.00426904665094497,-0.0161076380415808,0.000627024830123473,0.0698356769490592
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00477380507908012,0.00263458631950835,-0.000389984107156249,0.0099375942653165,0.0700121911170278
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.00462074610717598,0.00257410021137308,-0.000424490307115263,0.00966598252146722,0.0726578622356138
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00817068868716283,0.0045519533174319,-0.000751139815003703,0.0170925171893294,0.072678999734395
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD27,CD27 antigen,39913,-0.00683230872907107,0.00382214906493543,-0.0143237208963445,0.000659103438202371,0.0738663907993042
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0140796846130644,0.00789409411922198,-0.0295521090867394,0.0013927398606107,0.0745163912147177
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.005339326847036,0.00301307576896827,-0.000566301660141817,0.0112449553542138,0.0764052886059304
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0117899077837114,0.00665838718733073,-0.0248403466708797,0.00126053110345678,0.0766361727881022
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.0100247392012123,0.00566813122264907,-0.00108479799517988,0.0211342763976045,0.0769814378122856
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.00993055768069872,0.00562143430911741,-0.00108745356517139,0.0209485689265688,0.0773220668826198
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0146377368186892,0.00831405218565851,-0.00165780546520152,0.0309332791025798,0.0783289826327302
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00595411231852916,0.00338209304838056,-0.000674790056296744,0.0125830146933551,0.0783451795871382
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,-0.00552208618515481,0.00314774699508397,-0.0116916702955194,0.000647497925209768,0.0793989387335757
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00897016314042101,0.00511395418070845,-0.00105318705376755,0.0189935133346096,0.0794438881726994
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAP1,Antigen peptide transporter 1,37169,-0.0101153784180409,0.00577709868713305,-0.0214384918448217,0.00120773500873987,0.0799785298513503
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.00760668655638362,0.00434947953010985,-0.000918293322631687,0.0161316664353989,0.0803322097076945
NMR metabolomics,X23501.Triglycerides in Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00822166321943738,0.00470619217649332,-0.0174457998853643,0.00100247344648953,0.0806626104997966
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00731856380080713,0.00419094259187577,-0.000895683679269392,0.0155328112808836,0.0807812256784606
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD160,CD160 antigen,40058,0.00767883013792681,0.00440381327030912,-0.000952643871879052,0.0163103041477327,0.0812343111019521
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC3,Membrane primary amine oxidase,39931,-0.00514175179858561,0.00294920908162885,-0.0109222015985782,0.000638698001406931,0.0812769316919705
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00803115966282777,0.00460778204628053,-0.0170624124735376,0.00100009314788206,0.0813646805065891
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00618776286821789,0.00356691498546776,-0.0131789162397347,0.000803390503298922,0.0828018509939322
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00882541753300664,0.00509020140579647,-0.00115137722235445,0.0188022122883677,0.0829771763598313
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00507149168566271,0.00292591355303881,-0.0108062822496188,0.000663298878293348,0.0830653725081756
NMR metabolomics,X23501.Triglycerides in Large VLDL,RETN,Resistin,39790,0.00693012134753708,0.00400489518772326,-0.000919473220400514,0.0147797159154747,0.0835759393135857
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00734090976521206,0.00424445384397244,-0.015660039299398,0.000978219768973919,0.0837376873722013
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00804946523253475,0.00467471914582657,-0.00111298429328532,0.0172119147583548,0.085107884399421
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO1,Alpha-enolase,39830,0.0133167995865557,0.00776472218559123,-0.00190205589720309,0.0285356550703145,0.0863575183357723
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.011629689358447,0.00681133927817723,-0.0249799143436744,0.00172053562678037,0.0877711334732119
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSND,Barttin,36962,-0.00564703770582151,0.00331031160258507,-0.0121352484468882,0.000841173035245231,0.0880516864324349
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00908970835404288,0.00532922848660774,-0.0195349961877941,0.0013555794797083,0.0881000139695005
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN1,Cerebellin-1,36991,-0.0160559468864782,0.00944645131118255,-0.034570991456396,0.00245909768343963,0.0892147671628476
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEBP1,Heme-binding protein 1,39585,-0.00895632416066707,0.00527856649088758,-0.0193023144828067,0.00138966616147258,0.0897667193355088
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.00476115217309048,0.00282103790165458,-0.000768082114152491,0.0102903864603334,0.0914859942083753
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.0054138287729978,0.00320910931486238,-0.000876025484132468,0.0117036830301281,0.0916196314255419
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.00887127326712826,0.00527330270254811,-0.0192069465641226,0.00146440002986604,0.0925339120290131
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00782210468495745,0.00464983003444298,-0.0169357715524657,0.00129156218255079,0.0925470913586931
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOP56,Nucleolar protein 56,37021,0.0181986365266164,0.0108462230181859,-0.00305996058902792,0.0394572336422607,0.0933947060134094
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00332237492476352,0.00198355269623647,-0.000565388359859965,0.00721013820938701,0.0939611894164013
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.012852355689437,0.00771038988141703,-0.00226000847814042,0.0279647198570143,0.0955562025152529
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAU,Urokinase-type plasminogen activator,39858,-0.00467749452565316,0.00280985976073443,-0.0101848196566927,0.000829830605386329,0.095997818961046
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0101232271677296,0.00609695268089249,-0.00182680008681967,0.0220732544222789,0.0968586450250945
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF12,Fibroblast growth factor 12,37056,0.00762131295339094,0.0046037399597788,-0.00140201736777552,0.0166446432745574,0.0978547559248148
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00646464516930491,0.00390505215134749,-0.00118925704733618,0.014118547385946,0.0978557127232545
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD70,CD70 antigen,39866,-0.00686098593730734,0.00414910989307969,-0.0149932413277435,0.00127126945312884,0.0982275496460255
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.0042432532053828,0.00257638228343818,-0.000806456070156038,0.00929296248092163,0.0995858900661297
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGM2,Phosphoglucomutase-2,37039,0.00975568730030514,0.0059458020440968,-0.00189808470612459,0.0214094593067349,0.100869251959677
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0240177951718058,0.0146610875855827,-0.00471793649593627,0.0527535268395479,0.101399614124488
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPT,Microtubule-associated protein tau,39489,0.00846372521280932,0.00517527762204102,-0.00167981892639109,0.0186072693520097,0.101982275730789
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00601091301078272,0.00370238000021985,-0.00124575178964818,0.0132675778112136,0.104500181112555
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00450563476547202,0.00278521810715737,-0.000953392724556426,0.00996466225550048,0.105748151336997
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17F,Interleukin-17F,39587,-0.0123101517336,0.00761497426561525,-0.0272355012942059,0.00261519782700585,0.105990825994622
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.00777925302155778,0.00482402026343938,-0.017234332737899,0.0016758266947834,0.106853574613692
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA10,Annexin A10,39489,0.0123989811408432,0.00770209957352063,-0.00269713402325722,0.0274950963049437,0.107457716197314
NMR metabolomics,X23501.Triglycerides in Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0146358506505202,0.00910103797138863,-0.00320218377340153,0.0324738850744419,0.107826029831216
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00473975547664826,0.00294982164651082,-0.0105214059038095,0.00104189495051295,0.10812362737705
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL9,Interleukin-9,37169,-0.00898131900354625,0.00562409448303702,-0.0200045441902988,0.00204190618320631,0.110303712963994
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF1,Trefoil factor 1,39789,0.0117770185172261,0.00739092396128595,-0.0027091924468944,0.0262632294813465,0.111080611904404
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLHL41,Kelch-like protein 41,37411,0.00799616913580828,0.00501947681060987,-0.00184200541298706,0.0178343436846036,0.111177142367339
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36G,Interleukin-36 gamma,37021,0.0105497344257606,0.00662565192555529,-0.00243654334832774,0.023536012199849,0.111351197356639
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM132A,Transmembrane protein 132A,37043,0.00981329557135968,0.00616379516241354,-0.00226774294697085,0.0218943340896902,0.1113892274458
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00419723504524954,0.00264300419238423,-0.000983053171823553,0.00937752326232263,0.112294091300028
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANK2,Ankyrin-2,37021,-0.0110636607333886,0.00698157647924801,-0.0247475506327147,0.00262022916593752,0.113059954676732
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00599685712026061,0.00378437169075112,-0.00142051139361158,0.0134142256341328,0.113072104451491
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00396489238993402,0.00250538412228871,-0.00887544526961988,0.000945660489751843,0.113547655936773
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00628546493008813,0.0039759384850178,-0.014078304360723,0.00150737450054675,0.113930469201319
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00414240746925635,0.00263019123700052,-0.00929758229377737,0.00101276735526467,0.115288921712931
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00519903351732254,0.00330117591817003,-0.00127127128229071,0.0116693383169358,0.115302723295062
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.00975036285523571,0.00624083140971118,-0.0024816667077982,0.0219823924182696,0.118229606318877
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRXN3,Neurexin-3,37039,0.00537453184586346,0.00344538702590646,-0.0013784267249132,0.0121274904166401,0.11880254399547
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD82,CD82 antigen,37169,-0.00645585710608618,0.00413863991918477,-0.0145675913476883,0.00165587713551596,0.118807708467888
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.00856770423009151,0.00550596905774553,-0.0193594035832727,0.00222399512308972,0.119709681482741
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00856353683710118,0.00551478077853981,-0.0193725071630392,0.00224543348883684,0.120487048786671
NMR metabolomics,X23501.Triglycerides in Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00728317546391345,0.00469526156542574,-0.0164858881321479,0.00191953720432099,0.120883637973264
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00857770232127102,0.00553907501648178,-0.00227888471103328,0.0194342893535753,0.121506694698603
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRTN,Neurturin,39587,0.00752230386228906,0.00487807829131592,-0.00203872958869015,0.0170833373132683,0.123078413653045
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR1B,Cornifin-B,37169,0.013267972196569,0.0086088423115409,-0.00360535873405112,0.0301413031271892,0.123291201646035
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00969744350345174,0.0063293306856963,-0.0221029316474165,0.002708044640513,0.125511005398821
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP4,Caspase-4,37169,-0.0247738281143132,0.01619014670933,-0.0565065156646,0.00695885943597363,0.125996108708984
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB5,Integrin beta-5,39913,0.00568030773062671,0.00372796767159669,-0.00162650890570279,0.0129871243669562,0.127603140667407
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.0108216739502343,0.00710567074625637,-0.0247487886128968,0.00310544071242819,0.12779171029844
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00608971825137265,0.00399998450839464,-0.0139296878878261,0.00175025138508084,0.127924085873456
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00300261923941261,0.00197918599934698,-0.000876585319307459,0.00688182379813268,0.129265882437328
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGN,Secretagogin,39587,-0.00640825849265138,0.00423496166969775,-0.014708783365259,0.00189226637995622,0.130254085674737
NMR metabolomics,X23501.Triglycerides in Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.0108890787667529,0.00720187710213729,-0.025004757886942,0.00322660035343614,0.130563558506532
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.00455673360925766,0.00305325757010275,-0.010541118446659,0.00142765122814372,0.135613788914858
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTOA,Otoancorin,36991,-0.00776564078482275,0.0052052606321547,-0.017967951623846,0.00243667005420047,0.135753795888522
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0124333229038708,0.00835705846730052,-0.0288131574997799,0.00394651169203819,0.136837347647492
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00869640402733554,0.00584827663564206,-0.020159026233194,0.00276621817852291,0.137037747449374
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELB,Transcription factor RelB,37056,0.0071813665663064,0.00483237691585079,-0.00229009218876114,0.0166528253213739,0.13727813650894
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00710202778171561,0.00479920671178737,-0.00230441737338763,0.0165084729368189,0.138940955802047
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00569280822575121,0.00385929050023848,-0.0132570176062186,0.00187140115471621,0.140207668294479
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSMB,Beta-microseminoprotein,39780,0.00968792658057919,0.00658984402887048,-0.00322816771600695,0.0226040208771653,0.141546344539196
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00560919793462787,0.00382568028042286,-0.0131075312842567,0.00188913541500093,0.142618546214793
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX1B,Syntaxin-1B,37039,0.00610204648043201,0.004173659623425,-0.00207832638148098,0.014282419342345,0.143754804170135
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.00431965629426044,0.00295628081401566,-0.00147465410121025,0.0101139666897311,0.143985650051873
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00923287701740371,0.00632256780759154,-0.0216251099202831,0.0031593558854757,0.14422586515622
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00665132395648892,0.00456231182339296,-0.00229080721736128,0.0155934551303391,0.144896226510475
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAND5,DAN domain family member 5,37056,-0.00769037527964264,0.0052754325831783,-0.0180302231426721,0.00264947258338684,0.144927333000079
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1,Integrin beta-1,39862,0.00309454937393166,0.00213256747057336,-0.00108528286839213,0.00727438161625545,0.146774136406487
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00611678558265959,0.00425519189647494,-0.0144569616997505,0.0022233905344313,0.150602583958371
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTN,Titin,37021,-0.00966153511747772,0.0067228745781994,-0.0228383692907485,0.0035152990557931,0.150709463301291
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP73,Tumor protein p73,37039,-0.00486643331937848,0.00339949346078177,-0.0115294405025108,0.0017965738637538,0.15230575778316
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00566588448254808,0.00396114466603617,-0.013429728027979,0.00209795906288281,0.152635634333341
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCC,Netrin receptor DCC,37039,0.00316913319140816,0.00222088745415567,-0.00118380621873695,0.00752207260155327,0.153613086600455
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0116902509361361,0.0081957158695619,-0.0277538540404774,0.00437335216820522,0.153780900565747
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.00499590472396474,0.00351138821999729,-0.0118782256351594,0.00188641618722994,0.154821759014101
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00918840005788888,0.00646895854899254,-0.0218675588139143,0.00349075869813649,0.155519945894655
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00201885827507933,0.00142160769253453,-0.00076749280228834,0.004805209352447,0.15559478673304
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00636024549559564,0.00447871901722578,-0.00241804377816689,0.0151385347693582,0.155597312704669
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00669216265976138,0.00471675258675543,-0.00255267241027927,0.015936997729802,0.1559782970531
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00794441000412071,0.00560123737439426,-0.00303401524969205,0.0189228352579335,0.156114016122853
NMR metabolomics,X23501.Triglycerides in Large VLDL,WIF1,Wnt inhibitory factor 1,40030,-0.00464293338355826,0.00329198404394693,-0.0110952221096942,0.00180935534257772,0.15844809456414
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00731126256407626,0.00519353753601211,-0.00286807100650747,0.01749059613466,0.159225407607816
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00438229925405449,0.0031302293598832,-0.00175295029131658,0.0105175487994256,0.161538302204721
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGB,Secretogranin-1,39952,0.00542339517653609,0.00387446890678585,-0.00217056388076416,0.0130173542338364,0.16159917499295
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00751517092201252,0.00537403137799098,-0.0030179305788498,0.0180482724228749,0.162009593613903
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS2,Podocin,37056,-0.0139535817991643,0.0100254868359837,-0.0336035359976923,0.00569637239936362,0.164003128052443
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00457987155750522,0.00329690603054355,-0.00188206426236014,0.0110418073773706,0.164812992501471
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNG,Uracil-DNA glycosylase,37368,0.00471173280429428,0.00340759792213173,-0.00196715912308391,0.0113906247316725,0.166775484243274
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,0.0164297187628626,0.0118837562090081,-0.00686244340679328,0.0397218809325184,0.166830633189074
NMR metabolomics,X23501.Triglycerides in Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00467923308899804,0.00339361457357546,-0.0113307176532059,0.00197225147520987,0.16796928106489
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.00881691702751122,0.00640176776285991,-0.0037305477876942,0.0213643818427166,0.168454466907239
NMR metabolomics,X23501.Triglycerides in Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00675546076821096,0.00492121075007526,-0.0164010338383585,0.00289011230193655,0.169861871483399
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00649232228338584,0.00474596866381277,-0.0157944208644589,0.00280977629768718,0.171346140361228
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.0061474176887165,0.00450893783625992,-0.0149849358477859,0.00269010047035294,0.172784501851407
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.00781990213825286,0.00575520904284091,-0.019100111862221,0.00346030758571533,0.174244655994788
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKAP12,A-kinase anchor protein 12,37124,-0.0028108724364975,0.00207364836805263,-0.00687522323788065,0.00125347836488565,0.175274928652277
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.010416205035207,0.00770514089934685,-0.00468587112751285,0.0255182811979268,0.17644232078828
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0110283153195311,0.0081744137916191,-0.00499353571204234,0.0270501663511045,0.177319696774268
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0091456536028094,0.00677989066339088,-0.00414293209743673,0.0224342393030555,0.177376355868396
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAN,Neurocan core protein,40009,0.00486161149506992,0.00360601193581722,-0.00220617189913183,0.0119293948892717,0.177614203995549
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00458008530583858,0.00340275514990778,-0.00208931478798067,0.0112494853996578,0.178323771623767
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAL,Galanin peptides,39931,-0.00850099693749226,0.00632414728887376,-0.0208963256236848,0.00389433174870031,0.178898700790849
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00477191335259138,0.00355386463756497,-0.0117374880422187,0.00219366133703597,0.179379698894505
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00513214710714852,0.00382607572521669,-0.0023669613142762,0.0126312555285732,0.179826557514829
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1B,Protein phosphatase 1B,37056,0.00839511337618355,0.00626356511291491,-0.00388147424512968,0.0206717009974968,0.180167946614367
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00646882384091934,0.00485715203388513,-0.0159888418273342,0.00305119414549551,0.182940368749981
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00807975435059614,0.00608073745429868,-0.0199979997610215,0.00383849105982927,0.183954886017466
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00629659095918993,0.00474166822111827,-0.0155902606725817,0.00299707875420188,0.184225103423901
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTN,Neuroplastin,39477,0.0109408547696344,0.0082480846283123,-0.00522539110185774,0.0271071006411265,0.184702742128916
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00565611178404486,0.00427211660757527,-0.0140294603348924,0.00271723676680267,0.185539405229597
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR2,Toll-like receptor 2,37169,-0.00293928761597599,0.00222909907882382,-0.00730832181047067,0.00142974657851869,0.187325927984672
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN4,Alpha-actinin-4,39587,0.00405796388964965,0.00308525701971449,-0.00198913986899076,0.0101050676482901,0.188436404186086
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP13,Collagenase 3,39489,-0.00414168908132677,0.00315405388451447,-0.0103236346949751,0.00204025653232159,0.189157751744786
NMR metabolomics,X23501.Triglycerides in Large VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00645075416280143,0.00491838211534105,-0.0160907831088699,0.00318927478326702,0.189691555881854
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPO,Lactoperoxidase,39344,-0.00769644395967846,0.00587165805466689,-0.0192048937468256,0.00381200582746864,0.189952001259212
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00380280074720699,0.00291003429911131,-0.00950646797346516,0.00190086647905118,0.191306523161967
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00439899527595815,0.00338049704058731,-0.00222677892359298,0.0110247694755093,0.193179591967285
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLNL,Mesothelin-like protein,37039,-0.00463414560480015,0.0035631847196183,-0.011617987655252,0.00234969644565171,0.193430877905729
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_A,,37411,0.0041101960901355,0.00317102971705554,-0.00210502215529336,0.0103254143355644,0.194938725259612
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00967322921317242,0.00746329305613571,-0.0243012836031984,0.00495482517685357,0.194961272271317
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,-0.005185338799245,0.00401284627142584,-0.0130505174912396,0.00267983989274964,0.196311768644286
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0123869927380262,0.00958801806751192,-0.00640552267429719,0.0311795081503495,0.196405492711416
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG4,Proteasome assembly chaperone 4,37056,0.00703182534656169,0.00544693023403426,-0.00364415791214546,0.0177078086052688,0.196736579858944
NMR metabolomics,X23501.Triglycerides in Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00627306134458275,0.00486415988864883,-0.00326069203716895,0.0158068147263345,0.197191465979651
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00351691195770525,0.00275638522157841,-0.00891942699199894,0.00188560307658845,0.202004173852709
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00544386167923004,0.00426820310895671,-0.0138095397727852,0.00292181641432511,0.202174012920436
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1A,Interleukin-1 alpha,39587,0.00669059154225126,0.00524667919525127,-0.00359289968044123,0.0169740827649438,0.202255529126928
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.0040223855201146,0.00316510112280224,-0.010225983720807,0.00218121268057778,0.203802646649309
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPA33,Cell surface A33 antigen,39788,0.0163098017890531,0.0128868388589056,-0.00894840237440187,0.0415680059525081,0.205668764332529
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.00812145031877192,0.00642139222974657,-0.00446447845153135,0.0207073790890752,0.205979709309561
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00362399314802109,0.00286688556575471,-0.00199510256085814,0.00924308885690031,0.206220456665985
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH2,Growth hormone variant,39477,0.0204076453485355,0.016146016747867,-0.0112385474772838,0.0520538381743548,0.20626934055943
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM2,Isthmin-2,37437,-0.00550139229169839,0.00437284954539729,-0.0140721774006771,0.00306939281728031,0.20838464834948
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP7,Retinoid-binding protein 7,37382,0.00742084473700199,0.00592206335537411,-0.00418639943953127,0.0190280889135353,0.210196689207408
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHIT1,Chitotriosidase-1,39906,0.0185446924866354,0.0148097486783073,-0.0104824149228468,0.0475717998961176,0.210517087174289
NMR metabolomics,X23501.Triglycerides in Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00533815817089526,0.00427105112432139,-0.00303310203277466,0.0137094183745652,0.211377614136813
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK1,Kallikrein-1,39720,-0.0152953120566625,0.0123399692744234,-0.0394816518345323,0.00889102772120727,0.215181124340313
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.0036146388203668,0.00292308380096585,-0.00934388307025986,0.00211460542952628,0.216262973709703
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00695768044275315,0.00564745081082143,-0.00411132314645686,0.0180266840319632,0.217969105479391
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00564325976875771,0.00458610460774797,-0.00334550526242831,0.0146320247999437,0.218527182109832
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5A,Cytochrome b5,36962,0.00864681118677282,0.00703601547094334,-0.00514377913627613,0.0224374015098218,0.219117955182325
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.00708126633630954,0.00576310801016394,-0.00421442536361177,0.0183769580362309,0.219197419521501
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00942149875171899,0.00767304507165077,-0.00561766958871652,0.0244606670921545,0.219517853920791
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTH3,Cytohesin-3,36962,0.00870555824900772,0.00710003430748464,-0.00521050899366217,0.0226216254916776,0.220172155662492
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00611357257255769,0.0049934910392446,-0.0159008150094771,0.00367366986436173,0.220857858331074
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B4,Protein ATP1B4,36962,-0.00502080853234022,0.00411176440267598,-0.0130798667615851,0.0030382496969047,0.222076299463377
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRC,Chymotrypsin-C,39856,0.00739831150708096,0.00606772461274508,-0.0044944287338994,0.0192910517480613,0.222752398920426
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00561409780586143,0.00460696566730224,-0.00341555490205097,0.0146437505137738,0.223010367317618
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00619294618164866,0.00509460202218091,-0.0161783661451232,0.00379247378182592,0.224163031254506
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.00414907108399073,0.0034200612076868,-0.0108523910510569,0.00255424888307539,0.225087724976098
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00624081094851753,0.00514570057134865,-0.0163263840683609,0.00384476217132582,0.225220032297887
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00758135109500578,0.00625747608208944,-0.0198460042159011,0.00468330202588953,0.22569995176494
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00428152829454066,0.00354911980052479,-0.00267474651448793,0.0112378031035692,0.227698490963212
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00486590505340594,0.00409272383308738,-0.0128876437662572,0.00315583365944532,0.23449409749175
NMR metabolomics,X23501.Triglycerides in Large VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00876784441037447,0.00738351252676975,-0.0232395289628432,0.00570384014209425,0.235056032659419
NMR metabolomics,X23501.Triglycerides in Large VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.00294507766513147,0.0024894923445749,-0.00193432733023533,0.00782448266049827,0.236825201421085
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.00629739576081647,0.00533697266957485,-0.0167578621931832,0.00416307067155025,0.238035126008264
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF5,Fibroblast growth factor 5,39587,-0.00383634385555672,0.00325406298943171,-0.0102143073148429,0.00254161960372943,0.238440046505992
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO1,R-spondin-1,39749,-0.00408182716166935,0.00346512803106406,-0.0108734781025549,0.00270982377921621,0.238825024367011
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00733435052071118,0.00625392408331959,-0.0195920417240176,0.00492334068259521,0.240913479716531
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171A2,Protein FAM171A2,37411,0.0180939462802755,0.0154312559659482,-0.0121513154129829,0.0483392079735339,0.240996217735056
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSN,Gelsolin,37383,-0.00214610549802537,0.00183142724474579,-0.00573570289772712,0.00144349190167639,0.241289444388511
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.00687906293686056,0.00588321231372213,-0.00465203319803481,0.0184101590717559,0.242315517478391
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVPL,Envoplakin,37169,-0.00377735318501542,0.00323278861312091,-0.0101136188667324,0.00255891249670157,0.242646059821199
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00347740997335601,0.00297757246402695,-0.00235863205613681,0.00931345200284882,0.242880816143055
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00384180785353464,0.00329148410775976,-0.0026095009976745,0.0102931167047438,0.243148830217155
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO6,Coronin-6,36991,-0.00434111947913368,0.00372406967155286,-0.0116402960353773,0.00295805707710994,0.243760032705692
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDAN1,Codanin-1,37388,0.00257787318914343,0.00221506305567195,-0.0017636503999736,0.00691939677826046,0.244528744083448
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.004068085249681,0.003499734148471,-0.00279139368132216,0.0109275641806842,0.245094119074987
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.00777080961002165,0.00671714407631991,-0.00539479277956538,0.0209364119996087,0.247349633862472
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00681906343065381,0.00590042030426986,-0.00474576036571512,0.0183838872270227,0.247825075066223
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH22,Cadherin-22,37169,-0.00327479166440604,0.00284661469719921,-0.0088541564709165,0.00230457314210442,0.249993160241125
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00606953000162015,0.00533350745667873,-0.0165232046167105,0.00438414461347016,0.2551411147292
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00512018434045101,0.00453799114982395,-0.014014646994106,0.00377427831320394,0.259213128682745
NMR metabolomics,X23501.Triglycerides in Large VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00298529483228177,0.0026528759407961,-0.00221434201167858,0.00818493167624212,0.260476492341303
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0148249974994804,0.0132184239373088,-0.0407331084166057,0.0110831134176448,0.262077707020848
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00568487997445491,0.00506982698175956,-0.0156217408587036,0.00425198090979383,0.262173651831129
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA5,Annexin A5,39415,0.00332743699163952,0.00297353912187207,-0.00250069968722973,0.00915557367050878,0.263150716583506
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD177,CD177 antigen,39844,-0.0136707810743277,0.0122610114408424,-0.0377023634983788,0.0103608013497233,0.264875806968367
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00597539907079291,0.00537305732954594,-0.0165065914367029,0.00455579329511713,0.26611380041905
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.0070487317250923,0.00635109735455918,-0.0053994190898437,0.0194968825400283,0.267083030125802
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROK1,Prokineticin-1,39866,0.007049374619159,0.00636021973001853,-0.00541665605167732,0.0195154052899953,0.267725641122916
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00835434843210537,0.00754136263780545,-0.023135419202204,0.00642672233799331,0.267966950551117
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00990276126587565,0.00897244743764524,-0.0274887582436603,0.00768323571190902,0.269749803027202
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.0100667843469287,0.00914808212719159,-0.0279970253162242,0.00786345662236678,0.271166774862931
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTO1,Protein LTO1 homolog,39587,0.00434255478565481,0.00396496330254173,-0.00342877328732698,0.0121138828586366,0.273431771079914
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAN,Brevican core protein,39749,-0.00357810708680052,0.00326985639570262,-0.00998702562237766,0.00283081144877661,0.273852988632202
NMR metabolomics,X23501.Triglycerides in Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00605408473488096,0.00553627942748024,-0.00479702294298031,0.0169051924127422,0.274181499465186
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00661256712434813,0.00607156974229473,-0.00528770957054954,0.0185128438192458,0.276124987941971
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL2,Chordin-like protein 2,39868,0.00601354433231286,0.00553059498517302,-0.00482642183862627,0.016853510503252,0.276910362461897
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00567433978227687,0.00525205415868722,-0.0159683659333038,0.00461968636875008,0.279981650101389
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00271733641610252,0.00251620910373104,-0.00764910625941535,0.00221443342721032,0.2801920425504
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.0049360420375782,0.00457083921021124,-0.0138948868895922,0.00402280281443582,0.280206678142868
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF8,SLAM family member 8,39477,0.00550411517234179,0.00511155713615328,-0.00451453681451865,0.0155227671592022,0.281587093736159
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00336481790153046,0.00313519914857689,-0.00278017242968025,0.00950980823274117,0.283183632898801
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00517672440946107,0.00482751108881256,-0.00428519732461155,0.0146386461435337,0.28358787531657
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC8,Histone deacetylase 8,37056,0.0066412318010923,0.00620838948605102,-0.0055272115915677,0.0188096751937523,0.284765405842924
NMR metabolomics,X23501.Triglycerides in Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.00922322924486542,0.00862470786297465,-0.00768119816656489,0.0261276566562957,0.284910956292296
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSP90B1,Endoplasmin,39405,0.00706525935272832,0.00662771573962323,-0.0059250634969332,0.0200555822023898,0.286432397302517
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00806317286608091,0.00758949430130202,-0.0229385816966329,0.00681223596447105,0.288067439050479
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.0030500923772149,0.00287972576318446,-0.00259417011862664,0.00869435487305645,0.289542395701293
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL1,Delta-like protein 1,39913,-0.00295119736767893,0.00279168477813206,-0.00842289953281777,0.00252050479745992,0.290464305248368
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEF,Thyrotroph embryonic factor,37021,0.00440348121263209,0.00416901363259482,-0.00376778550725376,0.0125747479325179,0.290877721231595
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00389944353947546,0.0037068287466289,-0.00336594080391718,0.0111648278828681,0.292833078026929
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00882069831082085,0.00841076955673422,-0.0253058066420199,0.00766441002037822,0.2943175079835
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.00339644146887303,0.00325334850161603,-0.00298012159429439,0.00977300453204045,0.296508869250297
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX9,Transcription factor SOX-9,37039,0.00276003821136144,0.00265366670931671,-0.00244114853889932,0.00796122496162219,0.298319619748851
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00472114786758974,0.00455482963371462,-0.0136486139496704,0.00420631821449092,0.299981172527146
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB2,Beta-crystallin B2,37388,0.00577846404920321,0.00558045771911318,-0.00515923308025862,0.016716161178665,0.300462333256744
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEB,Nebulin,37021,-0.0038129653561516,0.0036902436516162,-0.0110458429133194,0.00341991220101615,0.30150322986929
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00641578942461773,0.00621006686006101,-0.00575594162110185,0.0185875204703373,0.301563115396849
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.00350171051613204,0.00339615301426467,-0.00315474939182671,0.0101581704240908,0.302518140249612
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00582796176570432,0.00565459505885073,-0.0052550445496431,0.0169109680810517,0.302719577385403
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00800831607433265,0.00781368592905517,-0.0233231404952808,0.00730650834661547,0.305425107394626
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.0106222054571943,0.0103657398450739,-0.0309390555535392,0.00969464463915065,0.305503357372715
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.0062973206300214,0.00614893866422504,-0.0183492404119025,0.00575459915185967,0.30579212217339
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00500814727822848,0.00492968502368399,-0.00465403536819213,0.0146703299246491,0.309687930241729
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00272165486881451,0.0026899211171971,-0.00255059052089181,0.00799390025852082,0.31165010980221
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF9,Fibroblast growth factor 9,36931,0.0040246942934485,0.00397816726917172,-0.00377251355412807,0.0118219021410251,0.311702350320424
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00283936045307263,0.00280972541064476,-0.00266770135179109,0.00834642225793636,0.312248245903039
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00398311531590075,0.00394910414935806,-0.00375712881684105,0.0117233594486426,0.313175699698196
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLON5,IgLON family member 5,36962,0.00911919823783411,0.00905433285453367,-0.00862729415705189,0.0268656906327201,0.3138745619799
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN5,Contactin-5,39897,-0.00355863747742199,0.00353396002380926,-0.0104851991240881,0.00336792416924417,0.313958162437716
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9orf40,Uncharacterized protein C9orf40,37382,0.00784114022757718,0.00779184899452911,-0.00743088380169988,0.0231131642568542,0.314276784772463
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00787605041161878,0.00783030829673721,-0.00747135384998616,0.0232234546732237,0.314510311965321
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLINT1,Clathrin interactor 1,36962,-0.00480369464902018,0.00480302486763407,-0.0142176233895829,0.00461023409154259,0.3172614974276
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.00580245802358015,0.00580328332793893,-0.0171768933463404,0.00557197729918015,0.317394634317925
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1B,Lithostathine-1-beta,40052,0.00532876707057121,0.00533611182715953,-0.00513001211066147,0.0157875462518039,0.317991998324191
NMR metabolomics,X23501.Triglycerides in Large VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00382975048142388,0.00386073640061696,-0.00373729286378535,0.0113967938266331,0.321228352920866
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.0020723123574786,0.00210002414002032,-0.00204373495696122,0.00618835967191842,0.323756358278456
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDNRB,Endothelin receptor type B,37056,0.00452057395208259,0.00458253240714571,-0.00446118956592301,0.0135023374700882,0.323915991690568
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00446948887800644,0.00456288858935119,-0.0134127505131348,0.00447377275712189,0.327332751963726
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00264194816535441,0.00272944365534229,-0.00270776139911648,0.0079916577298253,0.333090158904358
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB5,Serpin B5,39585,0.00460644266541473,0.00477998067587234,-0.00476231945929505,0.0139752047901245,0.335213766166815
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL21R,Interleukin-21 receptor,37056,-0.00513884423244456,0.00534106984270018,-0.0156073411241369,0.0053296526592478,0.335998107978438
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00358038540100668,0.00372310292815959,-0.0108776671401995,0.00371689633818611,0.336234547635959
NMR metabolomics,X23501.Triglycerides in Large VLDL,YY1,Transcriptional repressor protein YY1,37056,-0.00262257262960919,0.00272793050078846,-0.00796931641115457,0.00272417115193619,0.336379709037979
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.00805058651329389,0.00837879616071689,-0.024473026988299,0.00837185396171121,0.336656075983918
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.00252349324111023,0.00263259887719364,-0.00263640055818931,0.00768338704040976,0.337797085116781
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM2,Intercellular adhesion molecule 2,40052,-0.00294549942203599,0.00307553851101263,-0.00897355490362074,0.00308255605954876,0.33821914065281
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPGN,Epigen,37368,-0.00469022242349471,0.00490316130177165,-0.0143004185749671,0.00491997372797772,0.338800898098732
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.00341717182043389,0.00357546626466198,-0.00359074205830358,0.0104250856991714,0.339224764307817
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXOSC10,Exosome component 10,37021,-0.0057256894234714,0.0059921529706972,-0.0174703092460379,0.00601893039909511,0.339326659889266
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00365363412213049,0.00383345351482423,-0.003859934766925,0.011167203011186,0.340560930514376
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL33,Interleukin-33,39587,0.00364925745517418,0.00384631873408072,-0.00388952726362404,0.0111880421739724,0.342754082012915
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.00404039251431517,0.00426641406046267,-0.00432177904419167,0.012402564072822,0.343644453482932
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00803810008574641,0.00849805932565378,-0.0246942963640278,0.008618096192535,0.344229624774041
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00327214853887132,0.00348773465233319,-0.00356381137970173,0.0101081084574444,0.348162300394854
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00479526776397506,0.00515264063630204,-0.0148944434111271,0.00530390788317694,0.352054960318707
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00727200525214354,0.00781462336994272,-0.0080446565529442,0.0225886670572313,0.352093644668844
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00666400693776052,0.00716901580673063,-0.00738726404343151,0.0207152779189526,0.352617639827408
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA6C,Semaphorin-6C,37056,0.00238328933163932,0.00257203690293641,-0.00265790299811604,0.00742448166139468,0.354143136241447
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0156051782299214,0.0168489357128692,-0.0174187357673023,0.0486290922271451,0.354365655089701
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00364784508675886,0.00396093514849674,-0.00411558780429475,0.0114112779778125,0.357090531013294
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00323174975031337,0.00351992562554815,-0.003667304475761,0.0101308039763878,0.358567383689436
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.0022761425548549,0.00248511144865018,-0.00259467588449945,0.00714696099420925,0.359730112930607
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.00233594893236803,0.00255239902617822,-0.00733865102367735,0.00266675315894129,0.360101862911855
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMCN2,Hemicentin-2,37100,0.00505664944764003,0.00558530364072962,-0.00589054568819003,0.0160038445834701,0.365296963069714
NMR metabolomics,X23501.Triglycerides in Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00307296577600465,0.00339699376927103,-0.00973107356377587,0.00358514201176657,0.365686840293868
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,-0.0053194650045236,0.00591806517430818,-0.0169188727461676,0.00627994273712043,0.368747954028382
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A3,Protein S100-A3,37368,0.00397636691792441,0.0044343548284419,-0.00471496854582172,0.0126677023816705,0.369885258301013
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBQLN3,Ubiquilin-3,37021,-0.00413560940853262,0.00461903659522079,-0.0131889211351654,0.00491770231810014,0.370621601376898
NMR metabolomics,X23501.Triglycerides in Large VLDL,REN,Renin,39868,-0.00578119069194875,0.00647311578395314,-0.0184684976284969,0.00690611624459941,0.371812831109617
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTTG1,Securin,37169,0.00365601161662385,0.00409876962828793,-0.0043775768548205,0.0116896000880682,0.372420944583498
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGF,Beta-nerve growth factor,39749,0.00107115246893834,0.00120732151395386,-0.00129519769841122,0.0034375026362879,0.374977161252226
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00242637674842053,0.00275009002069085,-0.00296379969213353,0.00781655318897459,0.377635714036158
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00467351565199082,0.00529716021717949,-0.0150559496776626,0.00570891837368097,0.377647975476748
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF2,Trefoil factor 2,39908,0.004892179231985,0.00560584397469123,-0.00609527495840982,0.0158796334223798,0.382843643211439
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00418911471699167,0.00480024114287794,-0.00521935792304909,0.0135975873570324,0.382849298155307
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00358616635843148,0.00411752068951796,-0.00448417419302373,0.0116565069098867,0.383795787003299
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0145691155939577,0.0167278555302222,-0.0473557124331932,0.0182174812452778,0.383797248545139
NMR metabolomics,X23501.Triglycerides in Large VLDL,POF1B,Protein POF1B,37056,0.0038679891120034,0.00444516703409093,-0.00484453827481483,0.0125805164988216,0.384230943087707
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00350957249410924,0.00403397960717309,-0.0114161725241685,0.00439702753595,0.384311914356882
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00393770737125442,0.00453150993310974,-0.0128194668401495,0.00494405209764067,0.384884049453404
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL19,Interleukin-19,39419,0.00583525714002959,0.00674032149000547,-0.00737577298038113,0.0190462872604403,0.38665496053609
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00221710938313157,0.00256278939579813,-0.00280595783263277,0.00724017659889591,0.386991006105773
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0123161897192436,0.0143147180609585,-0.015740657680235,0.0403730371187222,0.389591296772286
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL12,Stromal cell-derived factor 1,39587,-0.003369493951935,0.00391750119028886,-0.0110477962849012,0.00430880838103117,0.389739831581603
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00472096129673094,0.00551557926018128,-0.0155314966466862,0.00608957405322436,0.392050960604661
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00243758672037824,0.00285006736422317,-0.00314854531349916,0.00802371875425565,0.392413303439828
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00411327625965517,0.00481370617677769,-0.00532158784682911,0.0135481403661394,0.392847666683471
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN2,Prorelaxin H2,37095,0.0119061053714688,0.0139636066629118,-0.0154625636878384,0.039274774430776,0.393867419405458
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00412068953312955,0.00486422803235393,-0.0136545764765433,0.00541319741028415,0.396929226008013
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.00904780700549564,0.0107011576352316,-0.0300220759705495,0.0119264619595583,0.397847775804693
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.0031111126689196,0.00369065528542023,-0.00412257169050406,0.0103447970283433,0.399260273636395
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC1,Sialoadhesin,39931,0.00344512455879592,0.00410481249358248,-0.00460030792862573,0.0114905570462176,0.401319558448733
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00213556644595604,0.00254625204363004,-0.00712622045147093,0.00285508755955884,0.401647499988819
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR3,Folate receptor gamma,39858,-0.0154680980489096,0.0185780624660433,-0.0518811004823546,0.0209449043845353,0.405082689380361
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.00948474444838872,0.0114467597687008,-0.0129509046982649,0.0319203935950423,0.407347860820306
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00371785036344108,0.00453463455759131,-0.01260573409632,0.00517003336943788,0.412300165138381
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00500611769162829,0.00610750070231744,-0.00696458368491389,0.0169768190681705,0.412417993145075
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00464510158309701,0.00581397487746304,-0.00675028917673055,0.0160404923429246,0.424331033725327
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00513151132752456,0.00643435434621407,-0.0177428458461041,0.00747982319105502,0.425164669136297
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00200865975391441,0.00252096645523438,-0.00694975400617379,0.00293243449834498,0.425591826712214
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3G,Semaphorin-3G,37124,0.00342946841838301,0.0043090791630708,-0.00501632674123577,0.0118752635780018,0.426121628844909
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.00260593687427318,0.0033041622039748,-0.00908209479406379,0.00387022104551743,0.430308937478627
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.00734162719695787,0.00939912897290685,-0.0110806655899395,0.0257639199838553,0.434759724178926
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.00642213212560846,0.00826772900065117,-0.00978261671566783,0.0226268809668847,0.437305573054613
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASN,Vasorin,39642,0.0020843808262414,0.00268489475709934,-0.0031780128976733,0.00734677455015611,0.437562175239588
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD8,Frizzled-8,36991,0.00324664403823954,0.00418237515290291,-0.00495081126145016,0.0114440993379292,0.437604738741504
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00592950223341851,0.00769365766802281,-0.0210090712627432,0.00915006679590621,0.440898432154852
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.0042708240697139,0.00557384193616081,-0.00665390612516128,0.0151955542645891,0.443555489038249
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00439320635368331,0.00577621388543278,-0.0157145855691316,0.00692817286176495,0.446928494389702
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00391783825706256,0.00515721402662406,-0.00619030123512059,0.0140259777492457,0.44745666012408
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.00347387647122527,0.0045770337091989,-0.0124448625412551,0.00549710959880458,0.447878152177702
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00244151726295057,0.00322698139542186,-0.00388336627207628,0.00876640079797741,0.449306193099936
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.00415386944166615,0.00550995461883665,-0.014953380494586,0.00664564161125367,0.450932090010582
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDSN,Corneodesmosin,39992,0.00310657481315305,0.00415538664476596,-0.00503798301058824,0.0112511326368943,0.454711235476669
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00241040644742497,0.00324315122763752,-0.00876698285359451,0.00394616995874456,0.457353608991012
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00541393425641367,0.00728748003834355,-0.019697395131567,0.00886952661873968,0.457549909815565
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00340178759477255,0.00462291577643619,-0.00565912732704238,0.0124627025165875,0.461831054230389
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM3,Paralemmin-3,37021,0.00546998913609697,0.00743705419624137,-0.00910663708853611,0.0200466153607301,0.462045218193036
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN2,Transcobalamin-2,40012,-0.00211004555233374,0.00287323002968664,-0.00774157641051955,0.00352148530585206,0.462727221991049
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESR1,Estrogen receptor,37056,0.00428649640140828,0.00584065227880439,-0.00716118206504832,0.0157341748678649,0.463018375032514
NMR metabolomics,X23501.Triglycerides in Large VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00708742919549592,0.0097108641010332,-0.026120722833521,0.0119458644425291,0.465497561638237
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00388991983449636,0.00537478209611733,-0.00664465307389361,0.0144244927428863,0.4692389871448
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00240002234809299,0.00332624243744639,-0.00891945752548792,0.00411941282930194,0.470589191965725
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00343327795232161,0.00476664515249742,-0.0127759024512166,0.00590934654657333,0.471370788477661
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00209342896367788,0.00291577704016482,-0.00362149403504517,0.00780835196240093,0.472788693305207
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2BP,LRP2-binding protein,37039,-0.0056166271234654,0.00783109991155712,-0.0209655829501173,0.00973232870318655,0.47325062696045
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN1,Transcobalamin-1,37235,0.00240359037052601,0.00335841744724475,-0.00417890782607371,0.00898608856712572,0.47419443698365
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22,Interleukin-22,37368,-0.00458795731321768,0.00643167981214248,-0.0171940497450169,0.00801813511858157,0.475649365512563
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.00123287132938471,0.00172958181925411,-0.00215710903635336,0.00462285169512277,0.475972669674151
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00437238747818046,0.00613694029736185,-0.00765601550464877,0.0164007904610097,0.47618624867962
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN4,Nectin-4,39913,-0.00205267617089993,0.00288924378783133,-0.00771559399504932,0.00361024165324947,0.477432674787348
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.005206291377481,0.00734273606884968,-0.00918547131746436,0.0195980540724264,0.478312429232575
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00283848939203395,0.00401022921862768,-0.0106985386605442,0.00502155987647632,0.479074367255585
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00442231600905359,0.00627672311226847,-0.00788006129099261,0.0167246933090998,0.481097814425495
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.0038943628878635,0.00553273626347136,-0.0147385259642674,0.00694980018854036,0.481522156945251
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNB2,Ephrin-B2,37039,-0.00416163845998585,0.00591584569470614,-0.0157566960216099,0.00743341910163818,0.481773376648138
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR1,Toll-like receptor 1,37056,-0.00180295126263676,0.00256391937440722,-0.00682823323647491,0.0032223307112014,0.481942757490636
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.00471266269515094,0.00671031960123513,-0.0178648891135718,0.0084395637232699,0.482503646179264
NMR metabolomics,X23501.Triglycerides in Large VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00543764343591459,0.00776570848724318,-0.0206584320709112,0.00978314519908204,0.483807287331623
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.00319941364420037,0.00458485370453121,-0.0121857269050815,0.00578689961668081,0.485300214943767
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN1,Neuroligin-1,37039,-0.0045952128019624,0.00660728214145714,-0.0175454857992184,0.00835506019529359,0.486768679034304
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00270117522787801,0.0038987252398838,-0.00494032624229424,0.0103426766980503,0.488425074755071
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHH,Sonic hedgehog protein,37056,-0.00295967139504765,0.00428807292469728,-0.0113642943274543,0.00544495153735902,0.49007418888797
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00357023110225102,0.00521468985870179,-0.0137910232253065,0.00665056102080448,0.493577681752327
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.0032153387812766,0.0047345943802922,-0.0124951437666493,0.00606446620409611,0.497076337136258
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00241758355356156,0.0035687488732559,-0.00457716423802,0.00941233134514312,0.498143993678279
NMR metabolomics,X23501.Triglycerides in Large VLDL,GJA8,Gap junction alpha-8 protein,36962,0.00395279694093289,0.00586499422878171,-0.00754259174747926,0.015448185629345,0.500345877532884
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL4,Myosin light chain 4,37043,-0.00343751854481032,0.00510271267646138,-0.0134388353906746,0.00656379830105399,0.500536177510403
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTA2,"Actin, aortic smooth muscle",39585,-0.00285245805578777,0.00424434119933192,-0.0111713668064783,0.00546645069490279,0.50155445735488
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00221523339701761,0.00329820770311438,-0.0086797204951218,0.00424925370108657,0.501819888403388
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L,Seizure 6-like protein,39913,0.0017754406318284,0.00264558452863134,-0.00340990504428903,0.00696078630794583,0.502169166283781
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF20,Fibroblast growth factor 20,37056,-0.00282124823570935,0.00422223502229755,-0.0110968288794125,0.00545433240799384,0.504025060279148
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.00688567821638929,0.0103322841433808,-0.0133655987046371,0.0271369551374157,0.505152076520235
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00175731772358273,0.00267564022778058,-0.00700157257003267,0.00348693712286721,0.511329210333543
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRP15,RRP15-like protein,36991,0.00581445337808371,0.00888335555248261,-0.0115969235047822,0.0232258302609496,0.512779646277217
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5L,CD5 antigen-like,37380,-0.00297716465471214,0.00459096986508144,-0.0119754655902718,0.00602113628084748,0.51668379318796
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3,Interleukin-3,36962,-0.00379223080017128,0.0058541130097511,-0.0152662922992834,0.00768183069894088,0.517132694664251
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00530956133612114,0.00822752542748547,-0.0108163885017504,0.0214355111739927,0.518717207712506
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL6,Fc receptor-like protein 6,39866,-0.00417996333289117,0.00647810897542526,-0.0168770569247247,0.00851713025894233,0.518778086612253
NMR metabolomics,X23501.Triglycerides in Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00426912185326634,0.0066768707683633,-0.0173557885592584,0.00881754485272572,0.522580505510094
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBN2,Fibrillin-2,37039,0.00376164010692609,0.00590268081814245,-0.00780761429663312,0.0153308945104853,0.523955788632828
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00337168024695546,0.00530560842116534,-0.0137706727524395,0.00702731225852861,0.52511745931543
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.0024810291463309,0.00391195588520765,-0.0101484626813379,0.00518640438867609,0.525950225970272
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.0039415224947628,0.00624690905295511,-0.00830241924902923,0.0161854642385548,0.528080536243964
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB118,Beta-defensin 118,36991,0.00358984437788657,0.00570814098544809,-0.00759811195359169,0.0147778007093648,0.529426095255323
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS1,"Nitric oxide synthase, brain",39489,-0.0033303787867967,0.0053058261029481,-0.013729797948575,0.00706904037498157,0.530220554780306
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.00207390178878446,0.00330768009711175,-0.00855695477912349,0.00440915120155458,0.530672797975911
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASQ2,Calsequestrin-2,37021,0.00299756268689008,0.00479325033409538,-0.00639720796793687,0.012392333341717,0.531738032618988
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA7A,Semaphorin-7A,40002,0.00165268394186512,0.00264575104545836,-0.00353298810723326,0.00683835599096349,0.532205766164311
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMCH,Pro-MCH,37021,-0.00506024613982925,0.00814650588325334,-0.0210273976710058,0.0109069053913473,0.534508137209416
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.0029848943858199,0.00481946245201893,-0.012431040791777,0.0064612520201372,0.535700208315517
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00308681706989874,0.00499869789115044,-0.0128842649365536,0.00671063079675613,0.536899569123387
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELL,L-selectin,37453,-0.00136752204251746,0.00222371954289552,-0.00572601234659269,0.00299096826155777,0.538584460242392
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00470448744193032,0.007653189363491,-0.0197047385943727,0.010295763710512,0.538757263358432
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00222093908143143,0.00361640097031552,-0.00486720682038698,0.00930908498324984,0.539140253865914
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00393829089682734,0.00644431379299079,-0.0165691459310893,0.00869256413743461,0.541126278267405
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00276042034777529,0.00453396198921566,-0.011646985846638,0.0061261451510874,0.542646155475996
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.00434479092638755,0.00714647823953005,-0.00966230642309134,0.0183518882758664,0.543220974359858
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00276876214983512,0.00459266068637785,-0.00623285279546547,0.0117703770951357,0.546607440025067
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00681402327727721,0.0113595132442755,-0.0154506226815027,0.0290786692360571,0.548615107311645
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00413559837041726,0.00697487278360712,-0.00953515228545269,0.0178063490262872,0.553239416343343
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRING1,SREBP regulating gene protein,36962,0.0034728050736672,0.00587916682679853,-0.00805036190685791,0.0149959720541923,0.55473377635985
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNW1,Interferon omega-1,37021,-0.00205088273342637,0.00348088299004962,-0.00887341339392362,0.00477164792707088,0.555747543732156
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRNN,Cornulin,39397,0.00371871336919079,0.00635151270636998,-0.00873025153529438,0.0161676782736759,0.558230369866436
NMR metabolomics,X23501.Triglycerides in Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00371830330118568,0.00635081354546479,-0.0161658978502967,0.00872929124792531,0.55823198121479
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00202829775221914,0.00346990832315827,-0.00882931806560936,0.00477272256117107,0.558867627070536
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00348361843065199,0.00597731967164017,-0.00823192812576273,0.0151991649870667,0.560033802194412
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00522452961641463,0.009007267650073,-0.0124297149777284,0.0228787742105577,0.561901033246777
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA3,Carbonic anhydrase 3,40017,0.0033845175550051,0.00591843518350598,-0.00821561540466662,0.0149846505146768,0.567424641821254
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00428992350629465,0.00753472285595387,-0.0190579803039642,0.0104781332913749,0.569125492651181
NMR metabolomics,X23501.Triglycerides in Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.0055289800798519,0.00984419180342282,-0.0137656358548568,0.0248235960145606,0.57436477991706
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN4,Prefoldin subunit 4,36962,0.00299136800719332,0.00534219994329793,-0.00747934388167062,0.0134620798960573,0.575522713646208
NMR metabolomics,X23501.Triglycerides in Large VLDL,TG,Thyroglobulin,37368,0.00597101596247319,0.0106762600436687,-0.0149544537231174,0.0268964856480637,0.575980090970644
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.0028016199584158,0.00501431300783301,-0.0126296734537685,0.00702643353693689,0.576359190270671
NMR metabolomics,X23501.Triglycerides in Large VLDL,JUN,Transcription factor AP-1,39587,0.00284159299741403,0.00510083549048854,-0.0071560445639435,0.0128392305587716,0.577478079060323
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00394485169665332,0.00709269418202687,-0.00995682890011934,0.017846532293426,0.578093716936732
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD10,Frizzled-10,37039,0.00326985227830201,0.00588189118227568,-0.00825865443895832,0.0147983589955623,0.578275990031947
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0078489204036846,0.0141365387733453,-0.0355565363994414,0.0198586955920722,0.578752153101367
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20,Interleukin-20,39587,0.00266241239008877,0.00479801490921824,-0.00674169683197897,0.0120665216121565,0.578971820636683
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00211283594128716,0.00383466615746305,-0.00962878160991474,0.00540310972734042,0.581652979847787
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.00244743228608986,0.00445981389979133,-0.00629380295750114,0.0111886675296809,0.58316782222488
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR4,Toll-like receptor 4,37056,0.00144890290571719,0.00270894938374661,-0.00386063788642617,0.00675844369786055,0.592757152526102
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A16,Protein S100-A16,39456,-0.00325781188234207,0.00610660946128053,-0.0152267664264519,0.00871114266176777,0.593702396589269
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.00243485419079101,0.00466383408794417,-0.0115759690031616,0.00670626062157957,0.601629487998619
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13,Interleukin-13,39587,0.00248570200628174,0.00479006749130839,-0.0069028302766827,0.0118742342892462,0.603817981604897
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSD1,Tryptase delta,37411,0.00185859041917048,0.00359261363676364,-0.00518293230888625,0.00890011314722721,0.604929673392089
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00256419704611591,0.00499368914547679,-0.0123518277712504,0.00722343367901859,0.607618959439726
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX2,Transcription factor SOX-2,37391,0.00119771191300964,0.00233388290846496,-0.00337669858758168,0.00577212241360095,0.607830831557899
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00293788777508002,0.00575087287207994,-0.00833382305419667,0.0142095986043567,0.609456544009826
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKIV2L,Helicase SKI2W,37021,0.00201585363429172,0.00395735387850852,-0.00574055996758497,0.00977226723616842,0.610484389235582
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00362315737868978,0.00713101696971199,-0.0103536358819457,0.0175999506393253,0.611402797846842
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMP,Olfactory marker protein,36991,0.00240340977445446,0.00477657704090643,-0.00695868122572214,0.0117655007746311,0.614856211120582
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRND,Prion-like protein doppel,37388,-0.0025039561778107,0.00499201157820248,-0.0122882988710876,0.00728038651546617,0.615962272661546
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00253981015148812,0.00506844584082466,-0.0124739639995044,0.0073943436965282,0.616307469597798
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00203463564610366,0.00407123665391707,-0.0100142594877811,0.0059449881955738,0.617253377520673
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53BP1,TP53-binding protein 1,37056,-0.00431030523711108,0.00864274749691081,-0.0212500903310563,0.0126294798568341,0.617985438062935
NMR metabolomics,X23501.Triglycerides in Large VLDL,NENF,Neudesin,37368,0.00536854221053234,0.010787575073673,-0.0157751049338666,0.0265121893549313,0.61873196374414
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0016520823832237,0.00333797676374266,-0.00489035207371191,0.00819451684015931,0.6206525671552
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00201275321895504,0.00407612389716827,-0.0100019560574049,0.00597644961949476,0.621461951806874
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNPO1,Transportin-1,37169,-0.00171594652686677,0.00347802972731067,-0.00853288479239568,0.00510099173866214,0.621761144459935
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00194800566524077,0.00398136510067515,-0.00585546993208252,0.00975148126256406,0.624651025939938
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00390736087454891,0.00799427161281577,-0.01176141148657,0.0195761332356678,0.625012654896071
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGN,Mimecan,39858,0.00188045044013464,0.00387871025098813,-0.00572182165180208,0.00948272253207137,0.627815402719341
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00227738344970171,0.00479010402102477,-0.0116659873309103,0.00711122043150684,0.634484827319292
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.00119586939379013,0.00254772415771494,-0.00618940874291142,0.00379766995533116,0.638800591887229
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00207482493366875,0.00451804992099887,-0.00678055291148904,0.0109302027788265,0.646075107776078
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAPPA,Pappalysin-1,39587,0.002129612998156,0.00466324103010584,-0.00701033942085144,0.0112695654171634,0.647906745594917
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00243511484601559,0.00533710253919702,-0.0128958358228417,0.00802560613081056,0.648209449606533
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALLD,Palladin,37056,-0.00182567245022376,0.0040021869334475,-0.00966995883978085,0.00601861393933334,0.64827617122445
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00217534856490423,0.00476922052153629,-0.0071723236573069,0.0115230207871154,0.648309468236957
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP15,Matrix metalloproteinase-15,37437,0.0022149936653884,0.00486759136192367,-0.007325485403982,0.0117554727347588,0.649081103345188
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00230983937316846,0.0050866790704487,-0.0122797303512479,0.00766005160491099,0.649767396665663
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRAS,GTPase Hras,37161,0.00433145119037009,0.00959791376128198,-0.0144804597817426,0.0231433621624828,0.651787256258171
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00556487451548824,0.0124713613118258,-0.0188789936556903,0.0300087426866668,0.655450102682734
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0030959688552696,0.00694292084378019,-0.0167040937090788,0.0105121559985396,0.655662937370316
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00250027371490559,0.00561484926338798,-0.013505378271146,0.00850483084133486,0.656111387431985
NMR metabolomics,X23501.Triglycerides in Large VLDL,MB,Myoglobin,40052,0.00226562958475928,0.0050924090480349,-0.00771549214938912,0.0122467513189077,0.656395585479546
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,-0.00309543896929521,0.00703995273074065,-0.0168937463215469,0.0107028683829565,0.660164528655522
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10,Interleukin-10,39587,-0.00341576644724907,0.00777865660423805,-0.0186619333915556,0.0118304004970575,0.660580363837119
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00445303668267806,0.0101570271396989,-0.0154547365111318,0.0243608098764879,0.661089547733653
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4C,Semaphorin-4C,39788,-0.00121244996403874,0.00278073173624659,-0.00666268416708205,0.00423778423900457,0.662829351052601
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2,Interleukin-2,39587,0.00131873151355061,0.00306202948017016,-0.00468284626758289,0.00732030929468412,0.666712508812488
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.0016621931032705,0.00387606980484514,-0.00925928992076698,0.00593490371422598,0.668050598809818
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00216539569484072,0.005058615673217,-0.00774949102466459,0.012080282414346,0.668613590304375
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00145392791659399,0.00341900847401089,-0.00524732869246735,0.00815518452565534,0.670662333269845
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.0030343931689102,0.00717362639902388,-0.0110259145731766,0.017094700910997,0.672307261852255
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH17,Protocadherin-17,39868,-0.00144048823330238,0.00343391663477419,-0.00817096483745979,0.00528998837085503,0.674864851586244
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,-0.00110060281577459,0.0026327128435896,-0.00626071998921021,0.00405951435766102,0.675916893617801
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL1,Interferon lambda-1,39489,0.00184382767459019,0.00441293675088612,-0.00680552835714659,0.010493183706327,0.676082074124482
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL25,Interleukin-25,36903,-0.00140160696162496,0.00337092067172071,-0.00800861147819754,0.00520539755494762,0.677567943708608
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCIN,Adseverin,36991,0.00300244744987264,0.00726366538532654,-0.0112343367053674,0.0172392316051127,0.679355805854076
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB7,Integrin beta-7,40030,-0.00183044678637584,0.00446887089280131,-0.0105894337362664,0.00692854016351472,0.682105271003088
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00196212076380449,0.0048268072613842,-0.00749842146850854,0.0114226629961175,0.684378273144519
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCLN,Nicalin,39587,-0.00210038029239994,0.0051797928228675,-0.0122527742252202,0.00805201364042035,0.685119180353771
NMR metabolomics,X23501.Triglycerides in Large VLDL,RUVBL1,RuvB-like 1,39477,0.00403378777779268,0.00997778767825463,-0.0155226760715864,0.0235902516271718,0.68601474176398
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00175354410915323,0.00436259821698924,-0.00679714839614567,0.0103042366144521,0.687727562117639
NMR metabolomics,X23501.Triglycerides in Large VLDL,HK2,Hexokinase-2,39585,-0.00107571635980876,0.00268632841505614,-0.00634092005331879,0.00418948733370128,0.688837082580106
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00162425275812232,0.00410990438160445,-0.00967966534606704,0.0064311598298224,0.692698358872433
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME3,Nucleoside diphosphate kinase 3,39885,-0.000918792107373121,0.0023415696592014,-0.00550826863940787,0.00367068442466163,0.694780469933359
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.000951726955097232,0.0024358137754167,-0.0038224680447195,0.00572592195491396,0.696008581423653
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3A,Uroplakin-3a,36991,-0.00182629169440991,0.00468988213843174,-0.0110184606857361,0.00736587729691631,0.696978451001022
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN7,Septin-7,37169,-0.00190750426958667,0.00504019647487712,-0.0117862893603458,0.00797128082117248,0.705096190491634
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSV,Cathepsin L2,39967,0.00152024940237556,0.00402252859194291,-0.00636390663783254,0.00940440544258365,0.705484773851953
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC25A,M-phase inducer phosphatase 1,36962,-0.00154005396914115,0.00409162942464976,-0.00955964764145469,0.00647953970317238,0.70663206204325
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00275893451653269,0.00738001432345183,-0.0117058935574329,0.0172237625904983,0.70853040564018
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00151564991367174,0.00405968505562101,-0.00947263262268892,0.00644133279534543,0.708900111802315
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF6,Fibroblast growth factor 6,37056,0.00149758749650776,0.00402680657480811,-0.00639495339011615,0.00939012838313166,0.709969924201192
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSTN,Osteocrin,37039,-0.00151128858429097,0.00410736502369943,-0.00956172403074185,0.00653914686215991,0.712919398944708
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00244161435499867,0.00669045837002021,-0.0106716840502409,0.0155549127602383,0.715162220535113
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBR1,T-box brain protein 1,37039,-0.00172288107431014,0.00473416551856891,-0.0110018454907052,0.00755608334208492,0.715919871216771
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRX,Cone-rod homeobox protein,39585,-0.00382268773702372,0.0106302964601302,-0.024658068798879,0.0170126933248315,0.719148781463629
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLLT1,Protein ENL,36962,-0.0025009714471052,0.0070078669425138,-0.0162363906544322,0.0112344477602218,0.721186974269594
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00159463064874895,0.00448903520431093,-0.00720387835170047,0.0103931396491984,0.722424525471914
NMR metabolomics,X23501.Triglycerides in Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00404446018070806,0.011387074190134,-0.0263631255933707,0.0182742052319546,0.722460493164681
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00132852429936669,0.00376830811411495,-0.00871440820303199,0.00605735960429862,0.724430018137911
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA3,GDNF family receptor alpha-3,39709,-0.000943450828231892,0.00271497850628279,-0.00626480870054616,0.00437790704408237,0.728221495651991
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD48,CD48 antigen,39908,0.000968291508378323,0.00284415773199886,-0.00460625764633944,0.00654284066309609,0.733522653861059
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGR,Progesterone receptor,37056,-0.0034969572874591,0.010320171502406,-0.0237244934321749,0.0167305788572567,0.734730520317896
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,-0.00102075716067544,0.00301807292262795,-0.00693618008902622,0.00489466576767533,0.73520570133114
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI2B,Protein EVI2B,36962,-0.00135447948990395,0.00404865399475441,-0.00928984131962259,0.00658088233981469,0.737969494880361
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.00271148065153759,0.00820296535658654,-0.0187892927504472,0.013366331447372,0.740989624867506
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC9,Histone deacetylase 9,36991,-0.00207549342301501,0.00631093305466439,-0.0144449222101572,0.0102939353641272,0.742257174887265
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00143803996976052,0.00439905056926546,-0.00718409914599977,0.0100601790855208,0.743750323055658
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.0010960526355309,0.0033656597376178,-0.00550064045019999,0.00769274572126179,0.744688555099344
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX101,Testis-expressed protein 101,37039,0.00154164239107018,0.00477569056226766,-0.00781871111097444,0.0109019958931148,0.746843987440914
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRN1,Neuritin,37411,-0.00108888933865103,0.00345780149325759,-0.00786618026543591,0.00568840158813385,0.752836358985855
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.000696103366824155,0.00221360018121438,-0.00364255298835604,0.00503475972200435,0.753171636439795
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUOX2,Dual oxidase 2,39585,-0.00217458226561252,0.00700522224971345,-0.0159048178750509,0.0115556533438258,0.756243402724314
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00154992402189125,0.00504146515504071,-0.011431195725771,0.00833134768198854,0.758516970550758
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.00124598267047231,0.00411050790513394,-0.00681061282359022,0.00930257816453483,0.761801283374699
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHC1,SHC-transforming protein 1,36962,-0.00338758425833833,0.0113483679475724,-0.0256303854355803,0.0188552169189036,0.765319825848477
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00178235853457576,0.00601479157694948,-0.0100066329562452,0.0135713500253967,0.766983223894897
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.00170491684818052,0.00577047125059929,-0.0130150404993551,0.00960520680299409,0.767650695258726
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.00218488794868107,0.00745103826021058,-0.0124191470413317,0.0167889229386938,0.769348926504873
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.00200342098295647,0.00684890434165731,-0.0114204315266919,0.0154272734926048,0.769895846452957
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.000999160586628413,0.00345615416919918,-0.00577490158500197,0.0077732227582588,0.772512408394959
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.0021335783984363,0.00755139755264618,-0.0126671608047502,0.0169343176016228,0.777533253511983
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00112446050890288,0.00402964573777558,-0.00677364513713725,0.00902256615494301,0.780213042765131
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.000596527477680425,0.00213956163351846,-0.00359701332401575,0.0047900682793766,0.780396336346654
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM25,RNA-binding protein 25,36962,-0.00123405488932623,0.00448420964086487,-0.0100231057854214,0.00755499600676891,0.7831668586636
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,0.00106139791685555,0.00386348012807711,-0.00651102313417558,0.00863381896788668,0.783531122963562
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKLR,Pyruvate kinase PKLR,39881,0.00171955194636234,0.00628116193763354,-0.0105915254513994,0.0140306293441241,0.784270018081515
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000938155473436489,0.00354067488507621,-0.00787787824818586,0.00600156730131289,0.791040334250493
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAYN,Layilin,39713,-0.00083402060274177,0.00316802920266147,-0.00704335783995824,0.0053753166344747,0.792352335781859
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.00302183984995134,0.0116532816201614,-0.0258622718254676,0.0198185921255649,0.795397587330194
NMR metabolomics,X23501.Triglycerides in Large VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.000726471025863215,0.00280856727612923,-0.00477832083535007,0.0062312628870765,0.79589897396991
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN7,Tetraspanin-7,36991,0.00239189115718524,0.00925808190426065,-0.0157539493751656,0.0205377316895361,0.796135374242334
NMR metabolomics,X23501.Triglycerides in Large VLDL,WNT9A,Protein Wnt-9a,39587,0.000713576041918639,0.00276391086433523,-0.00470368925217842,0.0061308413360157,0.796274292802119
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC2,Stanniocalcin-2,39831,0.000668345436692041,0.00259977080062948,-0.00442720533254174,0.00576389620592582,0.797121409250192
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.000790705710023529,0.00313530336579781,-0.00535448888694017,0.00693590030698723,0.80089416182794
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.000570612731049405,0.00226999955511032,-0.00387858639696682,0.00501981185906563,0.801530307041814
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00135991384518577,0.00544081052622675,-0.0120239024765902,0.00930407478621865,0.802632291678575
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.0018273114671761,0.00733239726575357,-0.0161988101080531,0.0125441871737009,0.803201121409739
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.000792934826709796,0.00321797330960701,-0.00710016251353953,0.00551429286011994,0.805370146395743
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00157866836330342,0.00641146095327802,-0.0109877951051215,0.0141451318317284,0.805510505877605
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL5A1,Collagen alpha-1(V) chain,37124,0.000951756429371008,0.0038908994825678,-0.00667440655646188,0.0085779194152039,0.806761506168456
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.00183846315960307,0.00754957040576542,-0.0166356211549033,0.0129586948356972,0.807607222901491
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.000737767448791561,0.00311304022359349,-0.00536379138945169,0.00683932628703481,0.812666231547286
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00069169772696748,0.00292401713145659,-0.0064227713046224,0.00503937585068744,0.813003224424847
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17A,Interleukin-17A,39558,-0.00096287358086948,0.0041605095545715,-0.00911747230782963,0.00719172514609067,0.816982497601591
NMR metabolomics,X23501.Triglycerides in Large VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.00181483988923264,0.00812701437528896,-0.0141141082863337,0.017743788064799,0.823298072022398
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.000782640855795432,0.003667962179468,-0.00640656501596186,0.00797184672755272,0.831040032053344
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.00134452927667022,0.00630736351532871,-0.0110179032133741,0.0137069617667145,0.831199074415797
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00105517550030997,0.00497778073782917,-0.0108116257464551,0.0087012747458352,0.832128158142466
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.000661897982009095,0.0031269064361125,-0.0054668386327714,0.00679063459678959,0.832360825873178
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK3,Prostate-specific antigen,37437,-0.00156028573967037,0.00773535698264037,-0.0167215854256455,0.0136010139463048,0.840147792101415
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF15,Growth/differentiation factor 15,40052,0.000814127006902266,0.00416514874826496,-0.00734956453969705,0.00897781855350159,0.845033979974837
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000815956424480156,0.0042019149185244,-0.00905170966478799,0.00741979681582767,0.846032608829941
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAX,Integrin alpha-X,37169,0.000990954121379686,0.00519274007611858,-0.00918681642781273,0.0111687246705721,0.848658144147602
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSCA,Prostate stem cell antigen,37382,-0.00467109815136104,0.0249300079191918,-0.0535339136729769,0.0441917173702548,0.851374530953735
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI16,Peptidase inhibitor 16,37445,-0.000433866432295461,0.00234506044981623,-0.00503018491393527,0.00416245204934435,0.853221680111147
NMR metabolomics,X23501.Triglycerides in Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00147324740344772,0.0082439175373426,-0.0176313257766392,0.0146848309697438,0.858170363972397
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHDC3L,KH domain-containing protein 3,36962,0.00115771438428239,0.00652754765932033,-0.0116362790279855,0.0139517077965503,0.859229746143423
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.0015847740593198,0.0089388567026638,-0.0159353850779013,0.0191049331965409,0.859282961203723
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.00054959275111673,0.00316063357107015,-0.00674443455041422,0.00564524904818076,0.861957040124654
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00102208031905,0.00590661499309738,-0.0105548850674209,0.0125990457055209,0.862622685490601
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSG1,Tryptase gamma,37056,-0.000446710866671218,0.00264312185377973,-0.00562722970007948,0.00473380796673705,0.865792305865472
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5,Interleukin-5,39587,-0.00238622209557813,0.0141783443785364,-0.0301757770775095,0.0254033328863533,0.866349064280251
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.000577879626098402,0.00347985701591339,-0.00739839937728865,0.00624264012509184,0.868108981547661
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTN3,Myeloblastin,39421,-0.000750868776233499,0.00454203684568231,-0.00965326099377082,0.00815152344130382,0.868697861654349
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKZF2,Zinc finger protein Helios,39477,-0.00147005044351403,0.00923850450945142,-0.0195775192820388,0.0166374183950108,0.87357471692373
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2B,Alpha-amylase 2B,38832,0.000728404452896628,0.00472149670643405,-0.0085257290917141,0.00998253799750736,0.877395731170908
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTLA,B- and T-lymphocyte attenuator,36962,-0.00127829871786654,0.00851668510465897,-0.0179710015229981,0.015414404087265,0.880693191674997
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.000991010480036989,0.00667315077627422,-0.0140703860015345,0.0120883650414605,0.881944808115385
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.000498943622498369,0.00342712564807967,-0.00721610989273453,0.00621822264773779,0.8842496139404
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.000556139437124123,0.00388951401465871,-0.00706730803160696,0.0081795869058552,0.886304769789002
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAV,Integrin alpha-V,40030,0.000230027391184501,0.00162441686267041,-0.00295382965964951,0.00341388444201851,0.887392885967161
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,-0.00104519812130378,0.00753512603443679,-0.0158140451487999,0.0137236489061923,0.889681331522505
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.000425016234512051,0.00313841575751563,-0.00572627865021859,0.00657631111924269,0.892278861598802
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000538020571646799,0.00401301927554499,-0.00840353835171498,0.00732749720842138,0.893350239123545
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN6,Prefoldin subunit 6,37039,-0.000852312207058538,0.00648141943164708,-0.0135558942930868,0.0118512698789697,0.895381116315946
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF3,Trefoil factor 3,39839,-0.000613707972264081,0.00476179403769822,-0.0099468242861526,0.00871940834162444,0.897452902223609
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,-0.000517554310442292,0.00402415349420521,-0.00840489515908451,0.00736978653819992,0.897666309776034
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPN3,Calpain-3,37368,0.000470175655953721,0.00369883844240854,-0.00677954769116701,0.00771989900307445,0.898851740711333
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,-0.000401974853839556,0.00322932400173723,-0.00673144989724452,0.00592750018956541,0.900939938877665
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL24,Interleukin-24,39587,-0.00057630303701798,0.00463985910599466,-0.00967042688476752,0.00851782081073156,0.901152957589263
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.000696038071062223,0.00563135428930478,-0.0103414163359751,0.0117334924780996,0.901633454490688
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3B,Sodium channel subunit beta-3,36991,-0.0005370363643961,0.00437044185994868,-0.0091031024098955,0.00802902968110331,0.902204643680503
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD2,Leiomodin-2,36991,-0.000761434423264468,0.00630185471168292,-0.013113069658163,0.0115902008116341,0.903829884412842
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00110036638431351,0.00943602145627087,-0.0173942356699774,0.0195949684386044,0.907168215328314
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,0.000649373170780176,0.00582607827640284,-0.0107697402509694,0.0120684865925297,0.911253492897896
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.000619974614186099,0.0057864427756441,-0.0107214532260763,0.0119614024544485,0.914677472446402
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4,Interleukin-4,39587,-0.000945650646092984,0.00887072685679577,-0.0183322752854127,0.0164409739932267,0.915104891169166
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN15,Lipocalin-15,37411,0.000633460212114519,0.00608907715770694,-0.0113011310169911,0.0125680514412201,0.917145319295837
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,-0.000586935385393945,0.00575832991384017,-0.0118732620165207,0.0106993912457328,0.91881504272814
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.000429207613423586,0.00424834958896184,-0.00789755758094162,0.00875597280778879,0.919528731090929
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.000397352364577523,0.00410183894201501,-0.0076422519617719,0.00843695669092695,0.922829671347759
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000217971890602496,0.00234584152750872,-0.00437987750331459,0.00481582128451958,0.925969744849889
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABO,Histo-blood group ABO system transferase,37445,-0.00130053288421102,0.0140912131682038,-0.0289193106938906,0.0263182449254685,0.926465903272688
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTR,Methionine synthase,37021,0.000542886291740509,0.00633071428647002,-0.0118653137097407,0.0129510862932218,0.931663000227118
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF174,Zinc finger protein 174,37056,0.000313555563905466,0.0037518905175504,-0.00704014985049332,0.00766726097830426,0.933397452916716
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP1,Retinol-binding protein 1,37039,-0.000566938588117837,0.00689811201390048,-0.0140872381353628,0.0129533609591271,0.934498860686449
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH4,Cadherin-4,36991,-0.000325207045730059,0.00459876427970095,-0.00933878503394392,0.00868837094248381,0.94362471965864
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL2,Interferon lambda-2,36991,-0.000418436794362899,0.0060881178065916,-0.0123511476952824,0.0115142741065566,0.945205524810484
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKKL1,Dickkopf-like protein 1,39788,0.000554191510247289,0.00826044515821765,-0.0156362809998593,0.0167446640203539,0.946511066043235
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG2,"Arginase-2, mitochondrial",37368,-0.000279056746629351,0.00430933740992825,-0.00872535807008872,0.00816724457683002,0.948368994072731
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL3A1,Collagen alpha-1(III) chain,37437,-0.000138419179611491,0.0022855988332515,-0.00461819289278443,0.00434135453356145,0.951709366910669
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.000228718243795155,0.00429388262344849,-0.00818729169816388,0.00864472818575419,0.957520580369703
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL6B,Myosin light chain 6B,37039,0.000460728297599721,0.00908050349055756,-0.0173370585438931,0.0182585151390925,0.959534914746364
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF3,Fibroblast growth factor 3,37056,0.000149142035678369,0.00302436312108456,-0.00577860968164736,0.0060768937530041,0.960670179843189
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.000242864089953624,0.00494735705787434,-0.00993968392338734,0.00945395574348009,0.960848584256329
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF830,Zinc finger protein 830,37368,0.000379169132415024,0.00791795525702055,-0.0151400231713453,0.0158983614361753,0.961806805735714
NMR metabolomics,X23501.Triglycerides in Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,-0.000153968686450799,0.00328857220409664,-0.00659957020648021,0.00629163283357861,0.962657927479559
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.000133818239211927,0.00293247080026556,-0.00588146100773243,0.00561382452930857,0.963603220271001
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,-0.000217546417469757,0.00488615669455805,-0.00979441353880353,0.00935932070386401,0.964488165963173
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMA1,Proteasome subunit alpha type-1,39477,-0.000173343972546599,0.00456578210668443,-0.00912227690164809,0.00877558895655489,0.969715365034324
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR5,Proline-rich protein 5,37056,-0.000174886229453111,0.00467767622696104,-0.00934313163429676,0.00899335917539053,0.970176671356263
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAGE2A,G antigen 2A,36962,0.000213184326479335,0.00598907328694158,-0.0115253993159262,0.0119517679688848,0.971605403070466
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.000115286854444157,0.00351643610367173,-0.00677692790875243,0.00700750161764074,0.973846423870569
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.000178502014994732,0.00623177692338123,-0.0123927847848219,0.0120357807548325,0.977149084195927
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTF,Ciliary neurotrophic factor,36991,8.75141815406033e-05,0.00333423115033769,-0.00644757887312126,0.00662260723620247,0.979060579564482
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC5D,Netrin receptor UNC5D,37056,6.36348379692559e-05,0.0026146464412702,-0.00506107218692033,0.00518834186285884,0.980583500780735
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMI,N-myc-interactor,37311,0.000153319919037863,0.00708987073555045,-0.013742826722641,0.0140494665607167,0.982747247077853
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGN,Cingulin,37039,-7.95942587773581e-05,0.00381716435801104,-0.007561236400479,0.00740204788292428,0.98336429413583
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS8,Regulator of G-protein signaling 8,39587,-0.000104503570747259,0.00646405108209648,-0.0127740436916564,0.0125650365501618,0.98710145899395
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-9.05250094813096e-05,0.00633218591314395,-0.0125016093992435,0.0123205593802808,0.988594037500241
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2A,Pancreatic alpha-amylase,39246,-5.71533236695023e-05,0.00461943193771167,-0.00911123992158437,0.00899693327424537,0.990128688816164
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2,T-cell surface antigen CD2,37021,-4.13546449874029e-05,0.00377278345592814,-0.00743601021860655,0.00735330092863175,0.991254482111974
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM1,Neural cell adhesion molecule 1,39931,2.02655699784291e-05,0.00294115901586709,-0.00574440610112106,0.00578493724107792,0.994502437361844
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL2,Podocalyxin-like protein 2,39913,1.81442953199267e-05,0.00269943295944172,-0.00527274430518585,0.0053090328958257,0.994637126073965
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA11,Carbonic anhydrase-related protein 11,39477,3.04953254744831e-06,0.00308198882068343,-0.00603764855599207,0.00604374762108697,0.999210530689319
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOPH1,Enolase-phosphatase E1,37368,4.68936883753031e-07,0.00548262992179289,-0.0107454857098303,0.0107464235835978,0.999931757098374
